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Novel Tools For Interventional Magnetic Resonance Imaging
by Martin Alexander Rube
Magnetic Resonance Imaging (MRI) provides unique advantages such as supe-
rior soft tissue contrast, true multiplanar imaging, variable contrast mechanisms,
measurement of temperature changes, perfusion and diffusion, and no ionizing ra-
diation. Despite considerable research efforts in the field of interventional MRI,
numerous challenges remain including restricted access to the patient, high acous-
tic noise and a shortage of MRI-safe devices.
Novel methods and devices are presented in this thesis with the primary objec-
tive of enabling effective MRI-guided interventions, particularly abdominal needle
and common catheter-based endovascular interventions. Firstly, a set of MRI-safe
devices (guidewires, micro guidewires, catheters and micro catheters) were devel-
oped with passive or inductively coupling resonant markers for MRI visualisation.
Secondly, a method was implemented for wireless tracking and dynamic guidance
of instruments. Thirdly, a framework of technologies was developed for in-room
display, wireless MRI remote control and multi-user communication along with a
dedicated user interface and imaging protocol.
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These implementations were assessed in regards to MRI-safety, performance and
usability and evaluated for MRI-guided liver biopsies, balloon angioplasty proce-
dures and also for mechanical thrombolysis. Flow phantoms, Thiel soft-embalmed
human cadavers with partially re-established perfusion and a porcine model were
used for in vitro, ex vivo and in vivo validation, respectively.
The results demonstrate that these interventions are experimentally feasible and
practical when using the presented developments: automated device tracking and
equipment designed for MRI-guided interventions streamlined procedural work-
flow. Specifically, it was shown that fast and accurate needle placements along
complex trajectories were feasible using a wireless interactive display and control
device with a dedicated user interface for interventions. Moreover, safe and effi-
cacious balloon angioplasties of the iliac artery were practical using the described
framework of technologies along with a dedicated MRI protocol. Finally, it was
demonstrated that these developments could be adapted and applied to MRI-
guided endovascular mechanical thrombolysis of the middle cerebral artery.
The technologies, described in this thesis have been shown to overcome many of
the present limitations and should therefore be useful for enabling MRI-guided
interventions while not further constraining the operating physician in an already
complex environment. Nevertheless, it is acknowledged that many crucial issues
remain to be solved in the field of iMRI and in the context of the presented
research. In particular further device optimisations, improvements of the tracking
implementation along with further in vivo evaluations are required before moving
towards clinical evaluation. This thesis sets the groundwork for moving ahead
with the eventual clinical realisation of optimised MRI-guided interventions.
1Chapter 1
Introduction
1.1. Background and Motivation 2 Chapter 1. Introduction
Advances in modern medicine, including the development of minimal access
surgery [1], have aimed to minimise the invasiveness of medical treatments. This is
a substantial achievement because pain, discomfort, and disability, or other mor-
bidity as a consequence of a medical procedure is more frequently related to trauma
involved to approach a target area rather than the procedure itself [2]. However,
minimizing the invasiveness of procedures can lead to a significant increase in
procedural complexity [3, 4] and technology required. Comprehensive information
beyond the skin is indispensable if minimal access techniques are conducted. Med-
ical imaging can provide this crucial information and has revolutionised medicine
since the discovery of X-Rays by W. C. Roentgen in 1895 [5]. Since then, many
imaging technologies such as X-Ray, Ultrasound, Computer Tomography (CT),
Magnetic Resonance Imaging (MRI) or nuclear imaging have evolved for diagnosis
and treatment of disease [6].
1.1 Background and Motivation
With the first in vitro images using nuclear magnetic resonance (NMR) in 1974
[7], MRI is considered as one of the most significant advances of the last century
in the field of medical technology [8]. MRI is non-invasive, does not use ionizing
radiation and provides contrast between normal and abnormal soft tissues superior
to any other imaging modality [9]. Magnetic Resonance (MR) can provide true
multi-planar imaging capabilities with variable contrast mechanisms and allows to
measure perfusion [10], diffusion [11], temperature changes [12] and also biochem-
ical and biophysical tissue characteristics (i.e. chemical tissue composition [13],
neural connectivity and neural activity [14]).
Moreover, MRI can be used intra-operatively in neurosurgery [15] and i.e. to
guide minimally invasive procedures [16]. Despite the broad spectrum of MRI-
guided therapeutic applications, MRI was conventionally developed for diagnostic
imaging and efficient patient throughput [17]. For more than two decades [18],
extensive research has been attributed to interventional MRI (iMRI) applications
and technologies. However, iMRI has primarily been performed in academic and
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research centres [19] due to numerous remaining challenges. These include a re-
stricted access to the patient [15], high acoustic noise levels [20], the need for
MRI-safe devices [21, 22] and high costs [23] related to MRI.
The aim of this thesis is to incorporate the advantages of high field MRI
(≥ 1.5 T) for endovascular and percutaneous interventions while providing the
interventionalist with the safety, confidence and efficacy that they are used to
from other imaging modalities such as X-Ray fluoroscopy, CT or ultrasound. It
should also be beneficial by reducing ionizing radiation exposure to clinical staff,
paediatric or pregnant patients and in minimally invasive procedures with long
intervention times.
1.2 Current iMRI Challenges
Significant developments in the field of MRI have contributed to make iMRI faster
and safer [24, 25] and the patient access has significantly improved with modern
open or short and wide bore MRI systems [24]. However, the following key chal-
lenges have not been fully addressed in the past, yet are critical for successful
implementation of iMRI:
(i) Device Visualisation and Tracking
Most commercially available interventional devices, such as needles, catheters,
guidewires or implants, are not designed with MRI compatibility [21, 22] in mind
and can interact with the different electromagnetic (EM) fields of MRI scanners
[21, 26]. One of the largest hurdle to overcome is the shortage of MRI-safe de-
vices in particular in the context of endovascular interventions [23, 27]. Novel
approaches for material selection as well as innovative strategies are required for
developing devices for iMRI. Safe and versatile device visualisation is crucial in
this regard because conventional MRI-safe device materials [28] do not contribute
to the MR signal [4], may cause imaging artefacts [9, 29, 30] or create safety risks
for the patient [31–36].
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(ii) Real-Time Guidance
Instant image display, similar to X-Ray fluoroscopy or ultrasound-guided proce-
dures, is a necessity for any image-guided procedure and also a key requirement
for iMRI. However, as Michael Lustig stated: ”MRI is burdened by an inherently
slow data acquisition process” [37]. Image acquisition time has been considerably
reduced in MRI over the past decades and temporal resolutions comparable to X-
Ray fluoroscopy can be achieved using ultra-fast pulse sequences [38] in combina-
tion with improved computer performance and advanced reconstruction techniques
such as parallel imaging [39, 40] or compressed sensing [37]. Closed-loop control
of MR image acquisition and in-room display opens a new dimension [41] for in-
teractive near real-time MRI (rtMRI). Generally, scanner manufacturers provide
product (i/Drive Pro Plus [42], GE Healthcare, Waukesha, WI, USA) or work in
progress user interfaces (Interactive Front End [43] (Siemens, Erlangen, Germany)
and eXTernal Control [44] (Philips Healthcare, Best, the Netherlands)) that allow
continuous data acquisition and image display. These applications, however, allow
a very limited selection of pulse sequences and only basic modifications of param-
eters during imaging. On the contrary, a more versatile research platform [45]
(RTHawk, HeartVista, Palo Alto, CA, USA) has been proposed that allows for
fundamental changes of the image acquisition scheme during MRI scanning. To
date, this research framework has not received regulatory approval (U.S. Food and
Drug Administration (FDA) / CE marking). Major shortcomings of all currently
available user interfaces are that these are not tailored to specific interventional
applications and are limited to a single MRI scanner manufacturer and cannot be
used across multiple platforms i.e. on partner sites with a different MRI scanner
and software.
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(iii) Interactive MRI Remote Control
The EU directive 2004/40/EC has set fixed limits for occupational exposure to EM
fields, which were based on guidelines of the International Commission for Non-
ionizing Radiation Protection (ICNIRP). Commissioned studies [46, 47] demon-
strated that these exposure limits, would adversely impact several aspects of diag-
nostic and interventional MRI within the EU [48]. As result the implementation
of the directive was postponed to allow for substantive revisions [4, 48]. The di-
rective 2004/40/EC has recently been replaced by the directive 2013/35/EU, in
which MRI is treated as a special case with an exemption (or derogation) from
exposure limits [49].
An integral part of iMRI procedures is that the operating physician manipu-
lates interventional devices (in the scanner room) and the scanner operator (in the
control room) adjusts the scan acquisition to identify the device and its manip-
ulations. However, adjustments can require multiple gestures, intense discussion
between operator and physician (if a communication system is in place) or may
necessitate the operator stopping or pausing the scan to enter the scanner room.
This can cause significant workflow interruptions and delays. Moreover, if a major
change to the current scan acquisition (e.g. change of pulse sequence) is required,
the current scan must be aborted and a new scan started, including adjustment
of parameters, orientation, pulse sequence download and pre-scanning processes,
resulting in additional delays. Thus, the physician in the scan room needs table
side controls to operate [23] and adjust the scan acquisition without delay.
(iv) Communication
The fast switching gradient fields (in the kHz range) of current MRI scanners result
in significant noise levels and noise protection is required during scanner opera-
tion in contrary to silent imaging technologies such as X-Ray, ultrasound or CT.
Previous studies [50–52] have demonstrated that this gradient noise (ranging be-
tween 70 and 110 dB [53]) obstructs communication between operating physician,
assisting staff, patient and scanner operator. Preceding experiments in Dundee
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[54] have also identified that this created a major workflow challenge, resulting in
a significant increase in intervention time and safety concerns.
(v) Workflow
Although MRI has previously widely been used for guiding and monitoring a va-
riety of interventions in the research domain, most studies focused on challenging
procedures including stem cell therapy [55], cardiac electrophysiology mapping
[56, 57] and heart valve repairs and replacements [58]. However, the iMRI work-
flow is still greatly compromised by complex MRI operation, limited access to
and communication with the patient and the requirement to ensure MRI safety
throughout a procedure [21]. At present, iMRI is well established in the field of
breast biopsy but other application such as local injections, tumour ablations or
solid tumour biopsies are primarily limited to research centres [19]. Dedicated
training facilities and programs are available at very few centres only (i.e. Dundee
or organised by MR:Comp GmbH (Gelsenkirchen, Germany)). Previous studies
have identified that interventionalists experience and appropriate training would
significantly influence the success and procedure time of MRI-guided interventions
[59]. As a consequence, MRI has not been widely accepted for guiding interven-
tions in clinical routine.
1.3 Experimental Models for iMRI
Device developments, evaluations and practical training on in vitro, ex vivo and
in vivo models are essential in interventional radiology as the complexity of pro-
cedures and devices is continuously increasing [60]. In the context of this thesis
tissue mimicking phantoms were used to assess the performance of developed de-
vices and applications, in particular during initial development stages. These in
vitro models mimic one or several tissue properties such as dielectric properties,
density, viscosity and relaxation properties for MRI. Additionally anatomically
correct polymer-based models were used in the context of this thesis that resem-
ble parts of the human vasculature and its pathologies. Moreover, perfusion pumps
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can be connected to these vessel replica models to simulate blood flow under nor-
mal physiologic or diseased conditions [61].
Vessel replica models depict the correct anatomy of interest in great detail.
However, these models are mainly polymer-based and cannot mimic biologic tis-
sue effects. Fresh or frozen human cadavers represent anatomically correct ex vivo
models with organic variances but have a limited shelf life time [61]. The em-
balming protocol, developed by Professor Thiel of the University of Graz, Austria,
represents a cadaver preservation technique that maintains full flexibility of the
limbs [62]. Thiel soft-embalmed cadavers, opposed to formalin fixed ones, retain
their natural colours and flexibility, features that are of considerable interest in
interventional procedures. Although, this embalming method has originally been
developed for dissections, the Thiel cadaver model has successfully been used for
laparoscopic surgery [63], neurosurgery [64], and oral surgery [65]. Thiel soft-
embalmed cadavers present a feasible model for ultrasound-based regional anaes-
thesia [66] and are also suitable for MRI [67]. Moreover, Thiel embalmed cadavers
were used for micro-vascular exercise because of the excellent condition of fine
anatomical structures [68]. Thiel embalmed cadavers have been further developed
in Dundee as a model for iMRI research and training with re-established respira-
tory motion (see Figure 1.1) and partial re-perfusion [61, 69].
A major limitation of human cadavers is that, at present, correct physiologi-
cal conditions cannot be re-established and that potential complications cannot be
simulated. Thus, in vivo models are required before clinical application of novel
developments. The domestic swine is a frequently used animal model for inter-
ventional research due to the numerous similarities between human and porcine
anatomy [60, 70] and was therefore also used in the context of this thesis.
1.4 Thesis Outline
In this thesis methods and related devices are described that have been devel-
oped to enable dynamic MRI control and rtMRI guidance for percutaneous and
endovascular interventions. This thesis is structured in several blocks as follows:
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Figure 1.1: Sequential MR images (top: coronal / bottom: axial) of a Thiel
soft-embalmed human cadaver with mechanical ventilation - The images were
obtained with a sequential multiphase acquisition (B0 = 1.5 T, FIESTA, TE/TR
= 5.2 / 10.9 ms, FA = 60◦, FOV = 40 cm x 40 cm, Matrix = 256 x 256,
Slice thickness = 5 mm, phases = 30). The red arrow indicates a balloon
catheter (filled with 1:100 Gadolinium doped saline solution) inserted in the
right quadrant of the liver.
Firstly, lead-in materials (Chapters 1 and 2), secondly, a block with technical de-
velopments (Chapters 3 through 5) and thirdly, a block with pre-clinical validation
studies (Chapters 6 and 7). The final chapter (Chapter 8) summarizes the main
findings, limitations and potential future research directions. A brief summary of
each chapter is provided in the following section.
Chapter 2: Magnetic Resonance Imaging
This thesis like ”any novel work rests on an accumulation of previous and cur-
rent literature” [71]. This chapter reviews the basic principles, key concepts and
acquisition methods for MRI. The NMR phenomenon, spin excitation and image
formation based on tissue specific relaxation effects and practical implementations
are presented. Specific aspects and considerations for interventional applications
are also described in this chapter.
Chapter 3: Visualisation of MRI Safe Interventional Devices - (Chal-
lenge [i])
In this chapter device visualisation methods for guidewires and catheters are pre-
sented. Polymer-based guidewires were developed in collaboration with EPFlex
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Feinwerktechnik GmbH (Dettingen/Erms, Germany). Passive MRI visualisation
was accomplished using superparamagnetic iron-oxide (SPIO) or iron-platinum
alloy (FePt) nanoparticles (nPs) incorporated under the final coating. Addition-
ally, a set of catheters was prepared with different marker configurations according
to the head shape of a catheter. Phantom and Thiel soft-embalmed human ca-
daver experiments are presented demonstrating the capability of these devices for
MRI-guided endovascular interventions.
Visualisation of the (head) shape and orientation of catheters was feasible
using multiple wirelessly connected resonant circuits (wRC) or a single wRC on
the tip and passive FePt nPs markers along the shaft. A single wRC on the tip
was found satisfactory for uncomplicated catheter navigation during MRI with
low and intermediate flip angle (FA) (<45◦). The quality factor (Q) of a wRC
significantly affected the signal characteristics in MRI and during very low FA
(<5◦) imaging, signals were mainly detected in close proximity of the wRC while
background signals were suppressed. This information can be used for automated
device tracking and will be described in Chapter 5.
Although susceptibility-based visualisation was more difficult to depict in
MRI, it was found acceptable for device navigation in the current study. The
induced susceptibility artefacts were manipulated by changing imaging parameters
(mainly the echo time (TE)) or the concentration of the nPs. Dedicated pulse
sequences [72, 73] enabled positive contrast of FePt and SPIO nPs markers while
the background was suppressed. However, automated tracking similar to [74] was
neither achieved for SPIO nor FePt nPs.
All visualisation techniques in this study did not require a connection between
device and MRI scanner, thereby simplifying instrument handling and avoiding
elongated electrically conductive structures, which are the major source of instru-
ment heating in MRI [75]. Heating experiments according to ASTM F2182-09
[36] confirmed that no significant radio frequency (RF) induced heating (<0.6 ◦C)
occurred for the wRC with the highest Q (≈ 65). Both nPs markers were found
negligible for guidewire handling and mechanical performance. On the contrary,
the wRCs applied to the surface resulted in a significant increase in diameter and
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stiffness of catheters. Further studies are required to achieve a miniaturised wRCs
design and to fully assess the mechanical performance in particular during more
complex device manipulations.
Chapter 4: Mobile Technology to Improve Workflow of iMRI - (Chal-
lenges [ii - iv])
In this chapter a wireless interactive display and control device combined with a
platform independent web-based User Interface (UI) was developed and evaluated
for improving workflow of iMRI. The novel iMRI-UI provides image acquisition of
up to three independent slices of various pulse sequences with different contrast
weightings. Pulse sequence, scan geometry and important parameters can be
changed on the fly via the iMRI-UI on a tablet computer for improved lesion
detection and interventional device targeting.
The components and setup were tested and found conditionally MRI-safe to
use according to current ASTM standards. Despite minor temporary touchscreen
interferences at a close distance (<20 cm) no other mal functions, degraded MRI
quality or imaging artefacts were observed.
The iMRI-UI was validated for core biopsies in a liver phantom (n = 40) and
Thiel soft-embalmed human cadavers (n = 24) with mechanical ventilation. The
3D root-mean-square distance error was 2.8 ± 1.0 (phantom) / 2.9 ± 0.8 mm
(cadaver) and overall procedure times ranged between 12 - 22 minutes (phantom)
/ 20 - 55 minutes (cadaver). The wireless MRI control setup enabled fast and
accurate interventional biopsy needle placements along complex trajectories and
improved the workflow for percutaneous interventions using MRI guidance in a
pre-clinical trial.
Chapter 5: Wireless Tracking of Interventional Devices - (Challenge [i])
In this chapter a robust method for wireless tracking and dynamic guidance of
interventional devices equipped with a wRC is presented. Device tracking is crucial
for iMRI because conventional device materials do not contribute to the MR signal,
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may cause susceptibility artefacts and are generally invisible if moved out of the
scan plane.
The proposed method uses a weak spatially-selective excitation pulse with
very low FA, a Hadamard multiplexed tracking scheme and also employs phase-
field dithering. This method results in reduced background signal intensities while
maintaining a local signal enhancement resulting from the point-source marker.
Device tracking was interleaved with various user-selectable fast pulse sequences re-
ceiving a geometry update from the tracking kernel in less than 30 ms. The phase-
field dithering has significantly improved our tracking robustness for catheters with
small diameters (4-6 French (F)). The volume root mean square distance error was
2.81 mm (standard deviation: 1.31 mm).
This wireless device tracking approach provides a feedback loop, intuitive
iMRI scanner interaction, does not constrain the physician and delivers very low
specific absorption rates (SAR). Devices with wRC can be exchanged during a pro-
cedure without modifications to the setup or the pulse sequence. Balloon angio-
plasties of the iliac artery are presented in flow phantom and Thiel soft-embalmed
human cadaver experiments, demonstrating the capability of this technique for
iMRI. Position information for a single tracking coil was satisfactory for balloon
angioplasties of the iliac artery but further studies are required for more complex
navigation and catheter shapes before animal trials and clinical application.
Chapter 6: Applications to Specific Interventions: Pre-clinical Iliac An-
gioplasty - (Challenges [i-v])
In this chapter an improved framework of technologies (Chapters 3 through 5)
for in-room image display, control, communication and techniques for MRI-guided
vascular interventions was extended and validated for safe, fast and efficient MRI-
guided angioplasty of the iliac arteries. MRI was used for interactive real-time
imaging during endovascular utilisation of novel or modified devices such as guidewires
and catheters and also for pre-, intra- and post-procedural visualisation and mea-
surement of vascular morphology and flow. A detailed analysis and comparison of
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the X-Ray angiography workflow was conducted1 and applied to solely MRI-guided
balloon angioplasty of the common iliac artery in perfused arterial phantom (n =
39) and in vivo experiments (n = 6) in a porcine model.
MRI-guided iliac angioplasty procedures (39 procedures in 6 sessions) were
successfully performed in vitro using a conventional closed bore (60 cm) 1.5 T MRI
scanner (located in a research centre) with progressive adaptation of the technique
and workflow. Safe and efficacious solely MRI-guided endovascular interventions
were found to be feasible and practical using an improved framework of technolo-
gies along with an optimised workflow. In particular the real-time flow analysis
was found to be helpful for pre- and post-interventional assessments. The novel
setup and protocol enabled a reduction in table time for the MRI-guided proce-
dures to a minimum of 6 minutes and 33 seconds with a mean procedure time of
9 minutes and 2 seconds, which is comparable to the mean procedure time of 8
minutes and 42 seconds for the standard X-Ray-guided procedure.
The presented in vivo experiments (6 procedures in 3 pigs) confirmed that
MRI-guided iliac angioplasty procedures were feasible (mean procedure time: 25
minutes and 42 seconds) but the workflow was constrained because only parts of
the developed framework could be applied to the wide (70 cm) and short (120 cm)
bore 1.5 T MRI scanner located in a clinical centre (excluding modifications to
pulse sequences).
The results of this study illustrate the feasibility of endovascular interven-
tions such as common iliac angioplasty, solely using MRI guidance and a novel
framework of technologies. It was shown that dedicated equipment designed for
interventions and a streamlined iMRI workflow improved the procedural efficacy.
However, design optimisation of the MRI-safe catheters and further in vivo ex-
periments, in particular using the entire framework of technologies, are required
before clinical evaluation.
1Please note, the workflow analysis was not scope of this thesis but will be published in the
associated Ph.D thesis ”Workflow analysis, modelling and simulation for improving conventional
and MRI-guided vascular interventions” by F. Fernandez-Gutierrez.
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Chapter 7: Applications to Specific Interventions: Pre-clinical Endovas-
cular Recanalisation in Acute Ischemic Stroke - (Challenges [i-v])
Although many methods and technologies are introduced in Chapters 3 through
6, this chapter will demonstrate how these can be applied to MRI-guided en-
dovascular mechanical thrombolysis (clot retrieval). There are three key motives
for this study: Firstly, performing diagnosis and treatment in the same imaging
modality can save crucial time to initiate treatment (i.e. caused by preparation,
patient handling and transfer), which is considered the primary disadvantage of
endovascular stroke therapy [76]. Secondly, using MRI avoids ionising radiation
and nephrotoxic and allergenic iodine-based contrast media [77]. Thirdly, MRI is
the only imaging modality that can visualise the blood vessels and the state of
the brain parenchyma facilitating critical decision making during a procedure as
the viability of brain tissues can be evaluated and tissues at risk for irreversible
infarction can be detected [78].
A set of customised micro guidewires and catheters was prepared for iMRI
visualisation with passive susceptibility markers or wRCs. Experiments were con-
ducted in a perfused vascular phantom (recanalisation of the middle cerebral artery
(MCA)), Thiel soft-embalmed human cadavers (recanalisation of the MCA) and
a living pig (angioplasty of the right carotid artery) to assess the feasibility of
MRI-guided recanalisation. The in vitro and ex vivo experiments were performed
in a conventional closed bore 1.5 T MRI scanner using a pulsatile flow pump and
artificial blood clots, which were inserted into the MCA (M1 or M2 segment) in
case of the phantoms.
To the authors’ knowledge, this is the first time that re-perfusion of a brain
in a Thiel soft-fixed cadaver has been established. Optimisations of the setup and
protocol are required because MR angiography (MRA) revealed that perfusion of
the brain resulted in considerable extravasation and thus loss of discernible brain
structure. Therefore, all subsequent cadaver experiments were performed without
perfusion. Instead a diluted Thiel solution doped (1:100) with Gadolinium (Gd)
was injected. MRA enabled generating 3D roadmaps, which were used during
device navigation. In vivo experiments (single case study) were performed in a
1.4. Thesis Outline 14 Chapter 1. Introduction
porcine model using a short and wide bore 1.5 T scanner located in a clinical
centre. Therefore, only minor modifications to the setup and no modifications to
pulse sequences were permitted, which excluded device tracking and generating
3D roadmaps for the animal study.
Solely MRI-guided recanalisations of the MCA were found to be feasible in
the flow phantom (n = 9/9) and Thiel soft-embalmed human cadavers (n = 7/9).
Automated device tracking was possible during the initial stages of each interven-
tion but manual scan plane alignments were required above the C4 segment of the
internal carotid artery due to the catheter diameter at the location of the wRC.
The initial animal experiments validated the devices for interventions such as bal-
loon angioplasty of the carotid artery (n = 2/2) using MRI guidance. Manual scan
plane alignments to localise a particular device were feasible but generally time
consuming.
The results of this study demonstrate that MRI-guided endovascular mechan-
ical thrombolysis using rtMRI guidance is experimentally feasible. However, much
research is required before MRI becomes a feasible imaging modality for guiding
interventions in acute ischemic stroke. In particular device, protocol and cadaver
model optimisations along with further animal experiments, are required to vali-
date successful blood clot removals before clinical evaluation. However, it is hoped
that this preliminary study can set the stage for further research in the field of
MRI-guided stroke therapy.
Chapter 8: Summary and Outlook
This chapter gives a summary of the main findings presented in this thesis, put in
a broader context, and proposes potential directions of future research in the field
of iMRI.
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2.1 Spin and Relaxation
This section reviews the NMR phenomenon, the basic principles of spin excitation
and tissue dependent relaxation mechanisms.
2.1.1 Nuclear Magnetic Resonance Phenomenon
All atoms with odd number of protons and/or neutrons have a spin correlating
with an intrinsic magnetic moment m that is directly proportional to the quantised
angular momentum J .
m = γ · J = γ · ~ ·mz (2.1)
The gyromagnetic ratio γ is a proportionality constant and characteristic for
each nucleus. mz is the spin angular momentum quantum number and ~ is Planck’s
constant h divided by 2pi. If a nucleus is affected by an external magnetic field
B0, the moment m experiences a torque Tm and precesses about the field direction
of B0. The angular precession frequency ω0 is proportional to the external field
strength and can be expressed by the Lamor Equation 2.2.
ω0 = γ ·B0 (2.2)
Nuclei possess only discrete energy levels according to quantum mechanics1
and these are termed states. A nucleus affected by a magnetic field B0 has 2 ·mz
+ 1 possible values for the angular momentum J . In the human body Hydrogen
(1H) predominates, as living tissue contains about 60 - 80 percent water (H2O)
[79] and hydrocarbons as well as proteins with Hydrogen content. According to
quantum mechanics, the proton has only two possible states (Figure 2.1) with the
values mz=±12 and the two energy states, parallel ↑ or anti-parallel ↓ in respect
to B0, depend on the internal energy E [80]. In thermal equilibrium and without
external magnetic field, the numbers of protons in each state of energy are evenly
1Generally, quantum mechanics is required to describe the NMR phenomenon but in the
context of this thesis classical mechanics is consulted as intuitive representation and is mostly
sufficient once an ensemble of spins according to Niels Bohr’s ”principle of correspondence” is
considered (see Figure 2.1) and their average behaviour can be measured [26].
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distributed. The energy gap ∆E (see Figure 2.1) between those two discrete energy
bands E− and E+ (or E ↑ and E ↓) can be expressed by Equation 2.3.
∆E := E+ − E− = γ · ~ ·B0 = ~ · ω0 (2.3)
The ratio between the number of spins in the energetic preferred state lower
n ↑ and upper energy state n ↓ can be described by the Boltzmanns distribution
2.4.
n ↑
n ↓ = e
− ∆E
kB ·T (2.4)
Whereas, kB is the Boltzmann constant and T represents the absolute tem-
perature. The difference between the spins in the upper and lower state creates a
net magnetisation M0, which is a vector field representing the density of induced
magnetic moments m and is generally expressed by Equation 2.5 per unit volume
(the proton density PD represents the number of Hydrogen atoms in a particular
volume [26]).
M0 =
PD · γ2 · ~2 ·B0
4 · kB · T (2.5)
2.1.2 Magnetic Susceptibility
The magnetic susceptibility χ is a quantitative measure, specific for each tissue
and defines by how much a substance becomes temporarily magnetised when an
external magnetic fieldB0 is applied [26]. Generally, the susceptibility is dependent
on the temperature. However, with few exceptions (i.e. during interventional
thermal treatments) the tissues relevant for MRI can be considered at constant
temperature and, thus, χ may ordinarily be taken to be a scalar and isothermal
quantity. For most substances (without initial magnetisation), the magnetisation
M is a function of the applied field [81] B0 and can be written as following:
M = χ · B0
µ
(2.6)
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(a) External field B0 (b) Spin ensemble (c) Energy states for Hydrogen
Figure 2.1: Schematic representation of precessing spins and discrete states for
Hydrogen - (a) An external magnetic field B0 determines the z-axis of the MRI
coordinate system (CSMRI). Each nucleus experiences a torque and precesses
with the Lamor frequency about the axis of B0. The proton has only two
discrete states, E− and E+ and a small surplus of spins (b) is aligned in the in
the favoured lower energetic state E−. This statistical distribution is determined
by Equation 2.4 and creates a net magnetisation M0, which can be used for MRI.
Figure (c) illustrates the two discrete energy bands E− and E+. The energy
gap ∆E between is directly proportional to B0 and the transition between E−
and E+ is also determined by Equation 2.2 [26].
µ represents the magnetic permeability that is determined by µ = µ0 · µr
with the permeability of free space µ0 and the material dependent term µr. The
permeability and the susceptibility are related by the following equation:
µ = µ0(1 + χ) (2.7)
Most human body tissues are diamagnetic (generally χ < 10−5), for instance,
the susceptibility of air and dense bone is close to zero, while iron-containing
molecules such as haemoglobin and blood breakdown products have the highest
susceptibility [26]. Although the susceptibility χ of tissues is small, the differences
between various tissues and air are sufficient to set up substantial local magnetic
field gradients G that show up in MRI [26]. If an object with volume V and
magnetic susceptibility χ is positioned in a static magnetic field B0, it will expe-
rience the magnetic force Fm in direction of the strongest field gradient G. This
is described by Equation 2.8.
Fm =
χ
µ0
·B0 · dB0
dr
(2.8)
Whereas, the field gradient G at the position of the object is defined by dB0
dr
.
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2.1.3 Excitation
The sections 2.1.1 and 2.1.2 explained that an external magnetic field B0 creates a
net magnetisation M0 in a large ensemble of protons. However, this is not directly
measurable if M0 is aligned in parallel to the external magnetic field B0 because
this magnetisation is very small (in the order of µT [26]) compared to B0 (0.2 - 7
T for full body scanners).
A second EM field B1 is required that can rotate the magnetisation M0 into
the transverse plane where a sensitive receiver can detect a measurable signal s(t).
This radio frequency (RF) field is produced by a transmit coil that is orientated
perpendicular to B0. The Maxwell equations [82] form the basis for EM consider-
ations and, thus, the basis of the field distribution of this oscillating B1 field. The
RF waveform is produced either linearly or circularly polarised [8, 26] and requires
a carrier frequency f1 that fulfils the resonance condition f1 =
ω0
2pi
.
This RF waveform can be used to rotate M0 away from the longitudinal
direction (z-axis) by a certain, so called flip angle (FA). This angle α is the angle
between the main field B0 and the magnetisation vector M immediately after the
excitation pulse has terminated [8]. Typically a FA α = 90◦ or lower is applied
to tip the magnetisation vector into the transverse plane (Pxy). The kinetics of
the magnetisation M in the clockwise rotating reference frame (the precession of
the spins appears stopped at ω = −ω0 and M becomes a stationary vector [8]) is
given by Equation 2.9.
(
dM
dt
)rot = γM × (B0 + ω
γ
+B1)
(ω=−ω0)
= γM ×B1 (2.9)
2.1.4 Relaxation
An RF pulse transfers protons from the lower energy state E− to the high energy
state E+ (see Figure 2.1). The state E+ is also stable for the proton and an external
field is required to return to E−. Once the B1 field has been switched off, how-
ever, the magnetisation M relaxes back to equilibrium (longitudinal axis) because
neighbouring protons, other nuclei or molecules also possess intrinsic magnetic
moments [26], which stimulate this so called spin-lattice or T1 relaxation effect.
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Additionally, a second relaxation effect in the transverse plane (Pxy) occurs as
soon as the initial magnetisation M0 is tipped away from the longitudinal axis.
This transverse T2 relaxation arises from energy exchange between spins and is
called spin-spin relaxation. This decay of transverse magnetisation is a result of
the loss of phase coherence between spins, which arises from either intrinsic or
extrinsic magnetic field inhomogeneities [26].
Figure 2.2: Spin excitation and relaxation - The top row illustrates the trans-
verse plane (Pxy) and the bottom row illustrates the plane Pxz with the z-axis
from bottom to top. A hard RF pulse with FA α = 90◦ rotates the spins into the
transverse plane (Pxy). The RF pulse is then switched off and the spins start to
dephase in the transverse plane (top) and to recover towards the longitudinal
axis (bottom). Note, the first and the last image show the net magnetisation
M0 in equilibrium. Please also note, individual spins are not diminishing in size
but the net magnetisation is.
Figure 2.2 illustrates these relaxation processes. Initially, an RF excitation
pulse with a FA α = 90◦ is used to rotate the magnetisation M0 into the transverse
plane. The spins simultaneously start to recover along the z-axis (with the time
constant T1) and to dephase in the transverse plane (with the time constant T2).
Figure 2.3 illustrates the oscillating decaying signal in the transverse plane
after an RF excitation pulse. This signal is described as free induction decay (FID)
and induces a corresponding oscillating voltage in a receive coil, which is sensitive
to magnetisation perpendicular to B0. The black dotted line represents the T2
decay and the blue dotted line represents the T1 recovery (Figure 2.4).
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Figure 2.3: Free Induction Decay (FID) - The spins are exemplary shown in
the transverse plane for three points in time.
Figure 2.4: Relaxation times - The longitudinal magnetisation exponentially
recovers with the time constant T1 = 0.63 ·M0 and the traverse magnetisation
decays with the time constant T2 = 0.37 ·M0
Felix Bloch derived three differential equations (Equations 2.10) to describe
the transition of magnetisation during excitation and relaxation. These equations
represent the MRI signal that is detected [26] using receive coils.
dM
dt
= γ ×B = γ ·

(MyBz −MzBy)i
+(MzBx −MxBz)j
+(MxBy −MyBx)k
 (2.10)
The following limiting conditions can be applied to solve Equations 2.10 [26]:
1. The B1 field can be neglected, once the RF pulse is switched off B1 = 0. 2.
It can be assumed that the spin system was in equilibrium (Mx(0) = My(0) =
0;Mz(0) = M0) and the RF excitation was applied with a FA α = 90
◦ along the
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positive x-axis. Hence, the magnetisation immediately after the RF pulse can be
expressed by Mx(0) = Mz(0) = 0 and My(0) = M0. A solution of the differential
equations 2.10 with limiting conditions 1 and 2 can then be expressed by Equation
2.11.

Mx
My
Mz
 =

M0 · sin(ω0t)e
−t
T2
M0 · cos(ω0t)e
−t
T2
M0 · (1− e
−t
T1 )
 (2.11)
2.2 Image Formation
The signal intensity (SI) in MRI is determined by the local proton density (PD)
and the tissue specific T1 and T2 values (Figure 2.5). However, spatial encoding
is required to create two-dimensional (2D) images. Lauterbur has proposed [7] to
use linear magnetic field gradients G for spatial localisation, which is discussed in
the following.
Figure 2.5: Tissue dependent relaxation times and contrast weightings - Re-
laxation curves for two different tissues - the solid lines represent the T2 decay
and the dotted lines the T1 recovery. Two exemplary time points (ti1 and ti2)
indicate the signal difference that can be used to create image contrast in MRI.
2.2.1 Slice Selection
A linear magnetic field gradient G applied during RF excitation results in a selec-
tion of spins that precess with the Lamor frequency depending on their location
in space. An RF pulse is applied with a narrow range of frequencies ∆f centred
about the Lamor frequency f0. E.g. the bandwith is expressed by ∆f =
γ
2pi
·z ·Gz if
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a linear magnetic field gradient Gz is applied along the z-axis to create a transverse
slice with a slice thickness z.
2.2.2 Frequency Encoding
Linear magnetic field gradients can also be employed during data acquisition to
make the magnetic field and thus the precession frequency a function of position. A
range of frequencies can be encoded in a single repetition. For instance if a constant
gradient Gx is applied along the x-axis, the magnetic field B(x) = B0 +Gx ·x and
the precession frequency ω(x) = ω0 + γ ·Gx · x are functions of the x-position.
2.2.3 Phase Encoding
Again, magnetic field gradients form the basis of this encoding technique. With
an RF excitation pulse, spins start to dephase in the transverse plane as described
in Section 2.1.4. If for instance, a linear gradient Gy is applied for phase encoding
along the y-axis then the dephasing process of the spins is speed up or slow down
depending on their position y along the phase encoding axis. The spins will return
to their original precession frequency once the phase encoding gradient is switched
off, however, the phase difference will remain encoded until the signal decays due
to T2 relaxation [26]. Other than for slice selection and frequency encoding this
is a stepwise approach and multiple repetitions with different gradient amplitudes
are required to encode all information that is required for a complete image. This
is illustrated in Figure 2.6 for 3 different gradient amplitudes. Three-dimensional
(3D) imaging can also be achieved by applying the phase encoding principle on a
second axis.
The received signal s(t) as sum of all contributing spins can be expressed by
solving the Bloch equations 2.10 for Mxy = Mx + iMy:
s(t) =
∫
x
∫
y
∫
z
M0(x, y, z) · e−i2pi[kx(t)·x+ky(t)·y+kz(t)·z]dxdydz (2.12)
The raw data matrix (k-space) can be filled (see Figure 2.6) line by line using
a spatially selective slice excitation (I), a varying phase (II) encoding gradient
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Figure 2.6: Pulse sequence diagram that demonstrates how k-Space is filled
symmetrically with (I) a slice select gradient, (II) a phase encoding gradient and
(III) a frequency encoding gradient. The three different colours for the phase
encoding gradient represent a k-space line for the maximum positive, negative
and zero amplitude, respectively
amplitude and frequency (III) encoding gradients to encode all required spatial
frequencies.
2.2.4 Reconstruction
Images are graphical representations of the spatial distribution of the properties of
an examined object [7]. The signals that are received in MRI contain a spectrum
of spatial frequencies because magnetic gradient fields are applied for encoding
[7]. A mathematical operation is require to generate an image with interpretative
voxels from those spatial frequencies. In 1973, Lauterbur proposed to combine
several projections obtained by rotating the object about an axis perpendicular to
the gradient and then reconstructing the object [7] i.e. via back-projection.
The most frequently used reconstruction method in MRI is a mathematical
operation known as Fourier transform (FT) and was firstly applied to MRI [83] in
1975. If a signal i.e. in time domain contains only a single oscillating frequency,
then its FT will contain one single peak at this particular frequency. If a signal,
however, is composed of a full spectrum of frequencies, its FT provides a histogram
of that spectral content [8]. The complex FT F (k) of a function f(x) can be written
as 2.13 with the two real variables x and k.
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FT [f(x)] = F (k) =
∞∫
−∞
f(x)e−2piikxdx (2.13)
If F (k) is known, the function f(x) can be calculated by performing an inverse
Fourier transform FT−1 according to 2.14.
FT−1[F (k)] = f(x) =
∞∫
−∞
F (k)e+2piikxdk (2.14)
The FT can also be extended to two or more dimensions. For instance, the two
dimensional FT F (kx, ky) of a function f(x, y) with the two independent variables
x and y can be defined as 2.15.
FT [f(x, y)] = F (kx, ky) =
∞∫
−∞
∞∫
−∞
f(x, y)e−2piikxxe−2piikyydxdy (2.15)
However, MR signals are received, sampled and digitised with a discrete (fi-
nite) number of complex data points. So instead of a FT, a discrete Fourier
transform (DFT) is the practically more efficient operation [8]. The DFT can also
be extended to two and more dimensions. The 2D DFT D(kx, ky) for a rectilinear
input matrix NxM of complex numbers can be written as 2.16
DFT [f(x, y)] = D(kx, ky) =
M−1∑
x=0
N−1∑
x=0
f(x, y)e−2pii(
kxx
M
+
kyy
N
) (2.16)
Because a large number of particular values are sampled in MRI [8] the com-
putationally faster fast Fourier transform (FFT) algorithm [84] is most widely used
to compute the DFT for image reconstruction in MRI.
2.3 Implementation for Clinical Imaging
In MRI, the FID is not measured directly, instead echos are created with dedi-
cated pulse sequences. An MR pulse sequence describes the RF and gradient field
activity to generate an image and can be described graphically by a pulse sequence
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diagram. All imaging pulse sequences contain a means of exciting and localizing
MR signals [26] and the pulse sequence diagram is illustrating basic hardware ac-
tivity (see Figure 2.7) to fill k-space and collect data. The vertical axis of the pulse
sequence diagram represents the gradient or RF waveforms while the horizontal
axis indicates the timing. Gradient waveforms can, generally, be split up in slice
selection GS, frequency GFE and phase encoding GPE gradients.
Figure 2.7: The basic hardware components and architecture of an MRI scan-
ner (this figure is a modification of Figure 9.1 found in [26] on p. 168)
Pulse sequences can be split into two categories depending on the way an
echo is formed: Spin Echo (SE) or Gradient Recalled Echo (GRE) pulse sequences.
Both pulse sequence types begin with an RF excitation and use the two parameters
echo time (TE) and repetition time (TR) for data acquisition. TE is the time
between the maximum amplitude of the RF excitation and the time when an echo
is formed, TR is the time between the same successive two RF excitations.
Spin Echo (SE)
The pulse sequence diagram for a single echo SE pulse sequence is illustrated in
Figure 2.8. In SE sequences [85] an RF pulse with α = 90◦ flips the spins into
the transverse plane (Pxy). The spins then dephase in the transverse plane and
a refocusing RF pulse (α = 180◦) is applied to flip the spins over. This reverses
their phase angles and the dephasing direction while the precession frequency is
kept constant. The spins that fanned out clockwise before the RF pulse will now
rephase anticlockwise and the spins that fanned out anticlockwise will now rephase
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clockwise, respectively. An echo will form after the same time interval (TE/2) as
between the excitation pulse and the refocusing pulse.
Figure 2.8: Spin Echo (SE) pulse sequence diagram (bottom) and spin dia-
grams (top) - The top row illustrates the transverse plane (Pxy) and the row in
the middle illustrates the plane Pxz with the z-axis from bottom to top. Note,
for simplicity no gradient activity is shown for slice selection, frequency and
phase encoding.
The signal sSE, considering a net magnetisation M0 in equilibrium and ne-
glecting T1 relaxation during the RF excitation pulse, can be expressed [8] accord-
ing to the Bloch equations 2.10 as the following:
sSE = M0(1− 2e−
TR−TE2
T1 + e
−TR
T1 ) · e−TET2 (2.17)
Hence, SE sequences can generate PD, T1 and T2-weighted contrasts accord-
ing to the combination of the parameters TE and TR.
Gradient Recalled Echo (GRE)
GRE imaging is suitable for fast imaging [86] implementations. The pulse sequence
diagram of a GRE sequence is illustrated in Figure 2.9. GRE pulse sequences use
an RF excitation pulse but the longitudinal magnetisation is not inverted with
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Table 2.1: Parameter combination to generate various contrast weightings in
Spin Echo imaging [8]
Contrast Weighting Echo time (TE) Repetition time (TR)
T1 Short (≤20 ms) Short (<700 ms)
T2 Long (≥80 ms) Long (>2000 ms)
PD Short (≤20 ms) Long (>2000 ms)
a refocusing RF pulse. Instead an echo [8] is generated by gradient reversal on
the frequency encoding axis. Firstly, a prephasing gradient with area A causes
rapid dephasing in the transverse plane (much faster than the normal FID), then
a readout gradient with opposite polarity (area B + B = 2A) causes rephasing
and an echo is formed (at the point where area A = B).
Figure 2.9: Gradient Recalled Echo (GRE) pulse sequence diagram. Note, for
simplicity no gradient activity is shown for slice selection and phase encoding
The spins accumulate phase in the transverse plane during the entire echo
time because no refocusing pulse is used and the two opposite gradients only
speed up or slow down the dephasing process. Hence, local field inhomogeneities
contribute to the phase evolution of the spins and the factor e
−TE
T2 is replaced by
e
−TE
T∗2 in the signal equation for sGRE in GRE images.
1
T ∗2
=
1
T2
+
1
T ′2
(2.18)
Whereas T∗2 is related to T2 by the parameter T
′
2 that is inversely proportional
to the magnetic field inhomogeneity ∆B in each imaging voxel [8] T′2 ∝ 1/(γ ·∆B).
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The magnetic field inhomogeneities are caused i.e. by susceptibility effects due to
the imaging object in the scanner and also non-ideal imaging hardware.
Generally, excitation pulses with much smaller FA than α = 90◦ are used in
GRE imaging. This enables rapid repetition and acquisition times because the
lengthy T1 recovery period is significantly reduced compared to SE imaging. The
longitudinal component M(α)z of the magnetisation vector after a small FA RF
pulse is not zero as illustrated in Figure 2.10. However, the transverse component
M(α)xy is substantial and large enough to be used for imaging. The longitudinal
component M(α)z is not much smaller than the equilibrium value M0. Hence, the
T1 recovery and full relaxation can be achieved in a very short time.
Figure 2.10: Response of magnetisation during small FA excitation in GRE
imaging. The small FA (α) excitation pulse tips the fully relaxed magnetisation
vector M0 towards the transverse plane Pxy. The new magnetisation vector
~M(α) has a large transverse component M(α)xy = M0 · sin(α) compared to the
longitudinal component M(α)z = M0 · cos(α)
Table 2.2: Parameter Combination to Generate Various Contrast Weightings
in Gradient Recalled Echo Imaging [26]
Contrast Weighting Echo time (TE) Flip angle (FA) α
T1 Short (<15 ms) Large (> 50
◦)
T2 Long (>20 ms) Small (< 40
◦)
PD Short (<15 ms) Small (< 40◦)
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2.4 Interventional Application of MRI
MRI was primarily developed as diagnostic tool but has experienced a rising de-
mand over the past three decades to be used for guiding and monitoring treat-
ments. MRI is an appealing modality for guiding interventions as it provides
contrast between normal and abnormal soft tissues more precisely than any other
imaging modality [9]. Utilizing MRI for interventions can provide several benefits
for the patients as well as the clinical staff due to its unique potential. MRI can
achieve soft-tissue characterisation, multi-planar imaging, temperature monitor-
ing, functional information and near real-time imaging (rtMRI) without exposure
to ionizing radiation. Moreover, interventional MRI (iMRI) allows for instant
evaluation of therapeutic goals throughout the intervention [4, 9]. Hence, great
research efforts have been undertaken to develop new hardware, software, proce-
dures and novel imaging suites [51] that integrate MRI into the clinical workflow
of minimally invasive procedures.
Dedicated iMRI scanners have been developed, manufactured and evaluated
[87, 88]. Moreover, open and low field MRI systems (B0 ≤ 1.0 T) have been used
for non-vascular interventions using MRI guidance [89–91]. However, these sys-
tems have not developed into mainstream products [26] because the access to the
patient is still significantly restricted (small vertical gap and a large distance to
overcome between magnet cover and iso-centre). To date, the magnet design for
high field (≥1.5 T) MRI systems is restricted to cylindrical closed-bore configura-
tions [92] and systems with a field strength of 1.5 T are used for the majority of
interventional procedures due their wide availability [92] and challenges at higher
field strengths [23]. These challenges include the necessity for careful shimming
and adjustment of the RF frequency to avoid artefacts, increased dark banding
artefacts in steady-state free precession sequences, flow artefacts, and SAR re-
strictions [93] as SAR is proportionally to the square of B0 [8]. Furthermore, the
higher field strength possesses larger safety hurdles to overcome for devices and
equipment in the scan room.
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2.4.1 Fast Pulse Sequences for Interventions
A great spectrum of MRI pulse sequences has been developed over the years.
However, there is no single pulse sequence that meets all requirements for iMRI
[42, 94] and a variety of pulse sequences are used during the course of a single
procedure.
Interventions have high demands on acquisition speed, spatial resolution and
quality of MR images [42]. Therefore, the focus of this section will be on pulse
sequences that allow high frame rates and are suitable for interventional imaging.
Requirements for iMRI are for instance, suitable image quality and high SNR,
good tissue contrast and avoidance of artefacts. Furthermore, it may be required
that a pulse sequence is sensitive or insensitive to flow and that multiple contrast
weightings can be achieved during the course of an intervention.
Cartesian Pulse Sequences
Spoiled steady state sequences such as fast low-angle shot (FLASH) [86] are fre-
quently used for iMRI as these can provide a variety of contrast weightings [42].
The FLASH pulse sequence takes advantage of small FA excitation that eliminate
long waiting periods. After a small excitation interval (without data-acquisition)
the spin system reaches a steady state for the longitudinal magnetisation Mz,
which is dependent on the repetition time of the RF pulses, their FA, and T1.
Once the system reaches a steady state, images can be acquired without time
constraints [86] and residual magnetisation in the transverse plane Mxy is spoiled
by gradient and/or RF spoiling before the next repetition [26]. The approach to
steady state by RF spoiling is illustrated in Figure 2.12.
Steady-state free precession (SSFP) [95] or fully balanced steady-state free
precession (bSSFP) [96] pulse sequences are frequently used for iMRI because they
can achieve T2/T1 contrast [95, 96] and are particular useful to distinguish vessels
from surrounding tissue employing high FAs [42, 97]. The residual magnetisation
in the transverse plane Mxy is rewound before the next repetition, i.e. by balancing
or reverting the total gradient area for one or more axis to zero. In a SSFP
sequence this can be achieved by adding a second gradient with the same area A
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and polarity behind the readout gradient with the area = 2B in Figure 2.9. All
gradients are balanced in fully balanced sequences such as bSSFP and additionally
phase-alternating RF excitation pulses are used (see Figure 2.11). However, bSSFP
is prone to banding artefacts due to off-resonance effects that cause oscillating MR
signal from excitation to excitation [26].
Figure 2.11: Pulse sequence diagram of a balanced steady state free preces-
sion (bSSFP) sequence. All gradients are balanced and phase-alternating RF
excitation pulses (+ and - α) are used.
In their original implementations [86, 95, 96], the pulse sequences that were
described in the last paragraph use a Cartesian readout scheme to fill k-space.
The scan time is then determined by tscan = NEX · NPE · TR. Whereas, NEX
is the number of excitations (or averages) and NPE represents the number of
phase encoding steps. Pulse sequences with Cartesian readout scheme can be
accelerated by re-using specific k-space data [42] points that were acquired in
another time-frame i.e. with techniques such as sliding window reconstruction or
keyhole methods [98, 99] or by using interpolation methods such as zero padding.
Zero padding (or zero filling) describes an effective and widely used reconstruction
method for image interpolation. It does not add any information content to the
raw data but can effectively increase spatial resolution without increasing the scan
time [100].
Non-Cartesian Pulse Sequences
Other fast imaging techniques are based on segmented image acquisition where
large parts or the whole k-space are acquired in a single TR using non-rectilinear
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Figure 2.12: The longitudinal magnetisation is approaching steady state with
a low excitation angle. Simulation performed in SpinBench (Version 1.3.2,
HeartVista, Inc., Palo Alto, CA, USA) employing RF spoiling and following
parameters: FA = 15◦, TR = 5 ms, T1 = 800 ms.
k-space trajectories (example trajectories are illustrated in Figure 2.13). To date,
most clinical MRI pulse sequences use a rectilinear (Cartesian) k-space trajectory
[37]. However, certain non-rectilinear trajectories, such as radial or spiral trajecto-
ries can provide many benefits for iMRI [42] for instance high temporal resolution
or motion insensitivity.
Figure 2.13: Three different non-rectilinear k-space trajectories: At the left
side a spiral trajectory, in the middle a radial trajectory and on the right side
an echo planar trajectory.
A spiral trajectory is a very efficient method of traversing k-space using os-
cillatory gradients [42] and is frequently used in cardiac imaging. Pulse sequences
with an echo planar (EPI) trajectory can also achieve high frame-rates, but suffer
from poor SNR, and reduced resolution if large ROIs are examined. Further-
more, these sequences are prone to geometrical distortions and artefacts at tissue
boundaries, which make EPI sequences less favourable for abdominal [101] and
interventional imaging.
Pulse sequences with a non rectilinear or a non-uniformly sampled k-space
trajectory, however, cannot be directly reconstructed with FT or FFT and require
advanced reconstruction techniques. A fast and frequently used method for image
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reconstruction of such sequences is called gridding. Gridding is an interpolation
method that re-samples the data employing a convolution function to a rectilinear
k-space grid before a subsequent FFT [8].
As discussed in Section 2.3, SE pulse sequences are less prone to field inho-
mogeneities than GRE sequences. Hence SE sequences are well suited for imaging
of susceptibility artefact prone areas and for imaging interventional devices that
have paramagnetic components. The main drawback of SE sequences is that the
acquisition time is generally much longer than in GRE sequences. However, a Sin-
gle Shot Fast Spin Echo (SSFSE) [102] with half-Fourier acquisition can achieve
sub-second temporal resolution with a single echo-train and provide excellent T2-
weighted contrast. This pulse sequence is used in a variety of clinical applications
such as abdominal imaging and has also been used in percutaneous interventions
performed using MRI guidance [103]. The major drawback of SSFSE imaging is
that many refocussing RF pulses are required, which result in a significant accu-
mulation of applied RF energy and SAR limitation issues (SAR is proportional to
the B1 amplitude), in particular if used for iMRI. The focus of this thesis is on
percutaneous and endovascular interventions and specific considerations for these
applications are described in the following.
2.4.2 Percutaneous Interventions
Percutaneous interventions under image-guidance have become an important tool
for diagnosis and treatment. In particular, MRI can be valuable for guiding inter-
ventions where conventional and well established image-guidance methods such as
CT or ultrasound cannot achieve the required sensitivity [24, 59, 104] in terms of
lesion detection and avoids potential risks of ionizing radiation and iodine contrast
agents [77]. MRI provides superior soft-tissue contrast and native visualisation of
blood vessels without the need of contrast agents along with different contrast
mechanisms for image acquisition. MRI provides true multi-planar imaging ca-
pabilities with arbitrary orientation and consequently allows to interactively align
the scan plane according to a instrument trajectory [105]. MRI can be utilised to
characterise lesions before, after and moreover during an intervention [24, 106].
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MR-guided percutaneous interventions, such as bone and soft-tissue biopsies
(breast, liver, kidneys, prostate), drainages, therapeutic instillations (pain therapy
and embolisation) and thermal treatments such as tumour ablations [107–109]
(uterine fibroids, bone, liver, prostate, breast, brain), have been reported. These
were clinically demonstrated using either open low-field [110–113] or closed bore
high-field MRI systems [19, 59, 114]. Moreover, robotic assisted and MRI-guided
percutaneous interventions (spine and prostate) have been demonstrated [115–117]
but have not made the transfer into clinical routine in virtue of remaining workflow
challenges, shortage of MRI-safe devices and high costs associated with MRI (see
also Section 1.2).
2.4.3 Endovascular Interventions
X-Ray fluoroscopy-guided catheter-based procedures are state of the art treatment
of cardiovascular disease. X-Ray provides high temporal and spatial resolution,
is cost-effective and widely available. Limitations of X-Ray are poor visualisa-
tion of soft tissues (such as those of the cardiovascular system) and the need for
nephrotoxic and allergenic iodine-based contrast media [77]. Interventions can be
time-consuming resulting in significant ionizing radiation dosage, which can accu-
mulate for the patient throughout the procedure(s) [118]. Moreover, clinical staff
working in an angiography suite can be exposed to radiation [118] from several
procedures every day. A recent long-term study [119] concludes that an increase
in cancer risk is still likely with current low-dose X-Ray technology.
Cardiovascular applications of iMRI have substantial clinical potential [23,
120] because MRI provides superior soft-tissue contrast, sufficient spatial and tem-
poral resolution [23, 92] and multi-planar 3D reconstructions. MR angiography
(MRA) can furthermore visualise the anatomy of vessels and its pathologies [23]
and also assess the morphology of the vascular wall [121]. Another big advantage
is that endovascular procedures are performed according to Seldinger [122] and
the percutaneous access site (transfemoral access) can be located in front of the
MRI scanner while the the region of interest is positioned in the iso-centre of the
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MRI scanner [23]. iMRI has been demonstrated for a variety of endovascular pro-
cedures including stenting [123], filter deployments [124, 125], embolisation [126],
cardiac electrophysiology mapping during catheterisation [56, 57] and heart valve
repairs and replacements [58].
The following section describes the key device categories that are relevant for
the research presented in this thesis and outlines distinct requirements for these
devices if intended for use during MRI-guided interventions.
2.4.4 Interventional Devices
The EM fields of MRI scanners (see Section 2.3) can interact with electrically
conductive interventional instruments such as needles, guidewires [22, 92, 127],
metall-braided catheters [51] and implants [21, 36]. In this context, it is important
that novel medical implants and devices are designed, assessed and evaluated in
terms of MRI usability, performance and safety [21]. The U.S. Food and Drug
Administration (FDA) and the International Standards Organization (ISO) have
also recognised the need for standardised tests to address MRI safety issues for
active and passive medical devices and implants [30, 36, 128–130].
The magnetic susceptibility [29, 81] (see Section 2.1.2) and the electrical con-
ductivity of device components are important parameters for MRI safety [21] and
can furthermore be responsible for imaging artefacts [22, 29, 81]. The degree of ac-
ceptable image degradation related to a device [30] has to be defined and evaluated
for each interventional application [81].
2.4.4.1 Cannulae
Percutaneous needle interventions require needle visualisation relative to surround-
ing tissues [29] to avoid damage to critical structures such as main vessels. The
freehand technique is the most frequently used method for percutaneous interven-
tions using MRI guidance [19, 24, 59, 104, 105, 114, 131] and closely resembles
the workflow typically used for CT or ultrasound-guided percutaneous procedures
[19]. As rather rigid needles are employed, the most common approach is to make
use of the susceptibility artefact caused by the instruments itself [29, 105]. This
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approach requires manual scan plane adjustments but is generally well accepted
[25, 29, 105, 111, 114] for device visualisation during MRI-guided percutaneous
procedures. Thus, no further investigations were performed for cannula visualisa-
tion during percutaneous interventions in the context of this thesis.
2.4.4.2 Guidewires
Guidewires are one of the most commonly used tool in the vascular specialists
workshop [132] and play a key role for endovascular interventions. The most fre-
quently used diameters are 0.035” or 0.038” during interventions on major vessels
and 0.014” or 0.016” for branches and small vessels [132]. Most commercially
available guidewires for X-Ray fluoroscopy contain tapered stainless steel rods
covered with fine wire spirals or nitinol [22] wire with polymer coating to achieve
the required mechanical performance. These components can lead to attraction
forces (if ferromagnetic), imaging artefacts and significant local RF induced tissue
heating [32, 33, 133] if used during MRI operation.
To date few concepts, in vitro [27, 134], animal [135, 136] and first-in-man
[137] studies of MRI-compatible guidewires have been published. And only re-
cently the first MRI-safe guidewire has been approved for clinical use. This MRI-
safe guidewire received the CE mark in October 2012 based on the collaboration
and testing [134, 138] with the author according to ISO 13485 and is described
in Section 3.2.1.1. Due to RF induced heating risks and the small diameters of
guidewires, the choice of visualisation methods for iMRI is constrained. In this the-
sis it is therefore proposed to employ passive visualisation methods for guidewires
[138]. It should be noted that passive visualisation represents one approach to the
problem of visualisation of guidewires in MRI and other methods might be feasi-
ble. For instance guidewires incorporating micro receive coils for active tracking
have also been proposed [133, 139, 140]. However, studies reported that locally
measured temperatures [140] were significantly higher during high SAR conditions
than the relevant IEC limits [141]. Moreover, the small diameter of guidewires con-
stitutes a significant challenge for producing guidewires with incorporated micro
coils and adequate mechanical properties.
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2.4.4.3 Catheters
Catheters are thin and flexible tubes and are used for a variety of medical dis-
ciplines to treat disease. In this thesis catheters for endovascular procedures are
considered exclusively, which can be used percutaneously using the Seldinger tech-
nique [122]. The Seldinger technique achieves access to the vascular system by
inserting a catheter over a flexible guidewire through a puncture hole after with-
drawal of a puncture needle [122]. A broad array of catheter choices (size, head
shape, stiffness) is commercially available for endovascular procedures. Passing a
guidewire into the catheter head can modify the head shape [132], which allows
entering specific vessel branches. Most catheters are produced with polymeric
materials such as polyethylene, polyurethane, polyamide, polytetrauorethylen, or
a combination of these [132]. These materials can generally be considered MRI
compatible [28]. However, most commercially available catheters are developed for
X-Ray fluoroscopy and contain para- or ferromagnetic materials used as braiding in
order to improve mechanical and handling performance [22]. This can compromise
MRI safety and cause severe imaging artefacts.
2.4.5 Device Visualisation
Suitable visualisation techniques are required to identify and guide instruments to
the intended target area. In this context, it can be distinguished between passive
identification techniques [142–144], inductively coupling resonant markers [145]
and active tracking techniques [146].
2.4.5.1 Passive Markers
Three mechanisms can be used to passively visualise devices in MRI (see Figure
2.14). Firstly, the displacement of water within a voxel by the device itself (ab-
sence of water protons), secondly by materials that locally affect the T1 and T2
relaxation properties (predominantly one or the other) of the surrounding tissue
and thirdly locally induced field inhomogeneities [29] caused by materials with a
severely different magnetic susceptibility χ compared to surrounding tissues.
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Figure 2.14: Passive device visualisation in MRI - The images (B0 = 1.5 T,
FGRE, TE/TR = 3/25 ms, FA = 78◦, Matrix = 224 x 224, FOV = 22 cm x 22
cm, Slice thickness = 2 mm) display a short section of a polymer catheter (∅ = 2
mm (6-F)) inserted into a phantom. Figure (a) shows the catheter without any
marker substance while the signal void (black dot) is caused by displacement of
surrounding water protons. Figure (b) shows the same catheter coated with a
Gadolinium-based marker (similar to [147]) and (c) with a marker containing
FePt nanoparticles (nPs) (similar to [148]).
A very high spatial resolution or devices with large diameters are required
in order to use the displacement of surrounding water protons alone. If devices
with a small diameter and a sufficient temporal resolution are requirements then
the second and third method are superior i.e. integrating MRI contrast agents
[147] or other paramagnetic substances such as dysprosium-oxide [143] or stainless
steel [149] into an interventional device. The main benefit is that these markers
are very simple to incorporate into small devices, do not require modifications to
the MRI scanner hardware and can be used during most standard imaging pulse
sequences. The drawback of paramagnetic substances is that these are relatively
expensive and a relatively large volume is required for passive device visualisation.
Contrast agents i.e. containing Gadolinium (Gd) ions (Gd3+) [150] make use
of the T1-shortening effect [147] of surrounding water protons due to the param-
agnetic properties of Gd. The advantages of this device visualisation approach are
that the visualisation is independent of the orientation with respect to the static
magnetic field B0 [144] and that Gd-based contrast agents are widely available and
generally well-tolerated in most patients [150]. Gd-based contrast agents are also
useful for visualisation of larger devices with multiple lumen, catheters that can
be flushed (while no guidewire is present) or devices with a large fluid reservoir
(such as balloon catheters).
Para- or ferromagnetic substances have a susceptibility that is significantly
different from water and their appearance in MRI is beyond what is expected on
the grounds of displaced water alone [29] as the material disturbs the magnetic
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field beyond the voxel [151]. A very small quantity of super-paramagnetic or fer-
romagnetic materials, with a magnetisation M > 10−4 T causes dipole magnetic
field distortions (Figure 2.15) and intravoxel dephasing due to a significant differ-
ence in magnetic susceptibility [151] between the material and surrounding tissues
in the field of view (FOV). The size and shape of these dipole artefacts are greatly
dependent on the marker material [152], the imaging pulse sequence including se-
quence parameters [138] and the orientation in regards to the main magnetic field
B0 [153]. As a result the accuracy of passive device visualisation is limited [29].
However, passive markers made from superparamagetic nanoparticles (nPs) [138]
can be realised at micro metre scales and can therefore be applied to small and
delicate interventional devices such as guidewires. An additional benefit is that
passive visualisation can be employed for different field strengths without mod-
ifications to the interventional device. However, the marker size in MR images
varies because the susceptibility artefact is dependent on the field strength [153].
Figure 2.15: Dipole magnetic field distortion caused by a superparamagentic
(FePt) marker (similar to [148]). MR images (left: coronal, right: axial) were
acquired with a FSPGR sequence (TE/TR = 10 / 100 ms, FA = 60◦, FOV = 24
cm x 24 cm, Matrix = 256 x 256, Slice thickness = 5 mm) and the background
was then subtracted.
It has previously been shown [72, 153–156] that paramagnetic substances can
also exploit positive contrast in dedicated pulse sequences. Positive contrast can
i.e. be generated by employing dephasing gradients [156], known as the white
marker phenomenon, or a method based on a SSFP sequence where gradients de-
phase any signal at the centred TE while local gradient fields induced by the marker
substance compensate for intrinsic dephasing [72]. Another approach makes use
of selective excitation [154] or selective suppression [155] using spectrally selective
RF pulses. Exploiting positive contrast has also been extended for automated
device tracking using a single paramagnetic ring marker attached to a guidewire
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[149]. A dedicated tracking pulse sequence employing echo-dephased projections
along all three physical axes was used to localise this paramagnetic marker [149].
The drawback is that the susceptibility artefact due to the stainless steel marker
was reported relatively large (∅ = 20 mm) compared to the guidewire (∅ = 0.89
mm) and might mask relevant anatomy. Furthermore, off-resonances and other
field inhomogeneities in the body could potentially affect the robustness of this
device tracking approach and modifications to the pulse sequence are required if
different marker materials are employed [74].
2.4.5.2 Micro Receive Coils
Active tracking was initially proposed by Dumoulin et al. [146] and employs one or
several small receive coil(s) attached or incorporated into an interventional device.
Each micro coil requires an electrical connection to a receiver channel of the MRI
scanner. A dedicated tracking pulse sequence, employing one-dimensional (1D)
projection readouts, is used for localisation (X,Y,Z) of each micro coil in space.
A sharp peak corresponding to the position of a micro coil is measured along the
readout axis because the micro coil is sensitive to a very small region only. This
tracking technique allows for fast, reliable and highly accurate automated device
localisation [146]. Active tracking can furthermore be interleaved with imaging
sequences and be used to automatically update the scan geometry and coordinates
for the imaging sequence [157].
Standing waves along conducting cables, which approach the quarter wave-
length of the RF excitation field in tissue (λtissue
4
) are the primary source of device
heating in the MRI environment [75]. This can be a potential safety hazard for
active tracking [31, 33, 34] and temperature rises of more than 50 ◦C and sparks
have been reported [35] for elongated conductive structures [32, 33]. The regu-
latory hurdles in this context are significant because RF safety throughout the
procedure has to be guaranteed [36]. The International Electrotechnical Commis-
sion (IEC) issued the following limits for safe use of devices in human subjects
[141], which are also accepted by the ASTM [36]: The maximum temperature
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increase in normal scan mode is limited to ∆0.5 ◦C for the whole body and a
maximum localised temperature of 39 ◦C for the torso.
Various methods such as quarter-wavelength coaxial chokes [158] or integra-
tion of transformers into the transmission line [159] have been proposed to elim-
inate resonant RF heating in active tracking catheters. These have shown to
overcome the heating risks but would further increase challenges for the design
and production of these, mainly single use, catheters. Hence, widespread use of
active tracking in humans during iMRI is still limited due to the system complexity
and design challenges [149] to overcome safety hazards and achieve the required
mechanical properties (i.e. torque transmission and elasticity) for clinical devices.
Nevertheless, active tracking provides an accurate and reliable solution for
clinical applications where the patient and cable connections do not come in con-
tact e.g. for real-time position tracking of an ultrasound transducer during MRI-
guided focused ultrasound surgery (MRgFUS) [160].
2.4.5.3 Wireless Resonant Markers
Inductively coupling fiducial markers [145], in the following termed wirelessly con-
nected resonant circuits (wRC), provide an alternative positive contrast technique
and wRCs are readily identifiable against the background with standard imaging
pulse sequences [161]. wRCs are based on the principle of EM induction, where
an electric circuit is tuned to resonate at the Larmor frequency, determined by
the field strength of the imaging system (Equation 2.2). The circuit consists of a
capacitive element with capacitance C, an inductive element with inductance L
and a resistive element with resistance R. This circuit, contains two independent
energy storage elements L and C and can therefore resonate. Both, the inductive
and capacitive reactance, are frequency dependent and resonance occurs when
both reactances cancel. Therefore, a wRC has to be designed and tuned according
to Equation 2.19 to match the carrier frequency f1 of the MRI system.
fr =
ω0
2pi
=
1
2pi
√
LC
(2.19)
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The transmit coil of an MRI system produces an RF excitation pulse with
carrier frequency f1. This alternating field (B1) induces a current in the inductor of
the wRC via inductive coupling (see Figure 2.16). This generates a local magnetic
flux and causes an intense excitation of the spins in the direct surroundings of the
inductive element [145]. Hence, the local B1 field is amplified and locally increased
FAs are produced in close vicinity of the wRC.
A high quality factor Q(fr) of the wRC results in a significant amplification in
central flux and even RF pulses with low FA can result in a substantial rotation of
magnetisation in close vicinity of the inductive element [145]. The background, on
the contrary, will give relatively little signal compared to the amplified signal [75].
The quality factor Q is a dimensionless parameter that can be used to describe the
bandwidth of a resonator in relation to its resonance frequency [162]. Q is defined
as 2pi times the ratio of the energy that is stored divided by the energy that is
lost in a single cycle [163]. The quality factor can also be calculated according to
Equation 2.20 by measuring the cut-off frequencies fL and fH at -3 decibel (dB)
and the resonance frequency fr.
Q =
fr
fH − fL (2.20)
Generally, wRCs are designed for a specific MRI scanner configuration (ver-
tical or horizontal B0 field axis) and field strength [164] due to their dependence
on excitation frequency (see Equation 2.19) and orientation in regards to transmit
and receive coil [75]. The orientation of a device containing a wRC is important
in order to accomplish satisfactory coupling to the RF transmit and receive coil(s)
(see Figure 2.16). Finding the right coil design is essential for a particular device
and application.
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Figure 2.16: Schematics of inductive RF signal coupling between a single
loop receive coil and two different coil configurations to be used as wRC on the
tip of a catheter. Figure (a) illustrates a single loop coil in an orientation that
results in poor signal coupling and Figure (b) a single loop coil in an orientation
that that results in maximum signal coupling. During RF transmit mode (not
shown), a wRC on the catheter locally amplifies the B1 excitation field [145].
In RF receive mode, a wRC picks up the MR signal in its immediate vicinity,
resulting in a B1 field vector that inductively couples to the receive coil [75].
Note, this is a modification of Figure 1 found in [75].
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3.1 Introduction
Endovascular interventions require sequential and combined use of guidewires and
catheters, as well as device exchanges [122]. Due to the aforementioned safety
and technology challenges (see Section 1.2), there is still a shortage of MRI-safe
interventional instruments [27]. Thus, novel devices and materials are required to
enable interventional procedures using MRI guidance. Endovascular interventions
depend upon a distinct visualisation of catheters and guidewires with respect to
the vessels and anatomy of interest. Moreover, it is important to be able to identify
each device individually. This is the key reason why different device visualisation
approaches were employed in the context of this thesis. It is proposed to use
wRCs (Section 2.4.5.3) for catheter visualisation because no electrically conduc-
tive connection is required between the marker and the MRI system. This avoids
the risk of RF induced heating and reduces system complexity in terms of produc-
tion and eases procedure workflow [164]. Different optimised marker designs and
configurations (single wRC, multiple wRCs or one wRC and passive susceptibility
markers) were developed and adapted to the distal shape of a particular catheter
or MRI-safe guidewires.
Phantom and Thiel soft-embalmed human cadaver experiments have been
conducted to validate the capability of these novel guidewires and catheters for
MRI-guided endovascular interventions.
3.2 Materials and Methods
The following sections describe the design of interventional devices such as guidewires
and catheters including MRI visualisation methods and how these devices were ex-
amined in vitro and ex vivo.
3.2.1 Device Design
Various devices were developed or modified for iMRI and this section describes
the devices in detail.
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3.2.1.1 Design of MRI-Safe Guidewires
A polymer-based guidewire, specifically developed for MRI-guided interventions,
was manufactured by EPFlex Feinwerktechnik GmbH (Dettingen/Erms, Germany)
and refined in collaboration with our group1. This guidewire (Figure 3.1) consisted
of a high strength fibre (para-aramid synthetic fibre (Kevlar R©)) core, surrounded
by a bending resistant high performance polymer (Polyether ether ketone (PEEK))
and a hydrophilic coating. The tip section was conically tapered by EPFlex to
create an atraumatic tip. The guidewires were supplied with a ”J”-shaped or
straight tip, a diameter of 0.014” or 0.035” and a length of 150 cm or 180 cm.
Guidewires with a diameter of 0.035” were used during interventions on major
vessels (Chapter 5 and 6) and guidewires with a diameter of 0.014” were used in
smaller branches i.e. during neurovascular interventions (see Chapter 7).
Superparamagnetic nanoparticles (nPs) were applied in distinct locations at
the tip section (Figure 3.1c) for iMRI visualisation. The first nPs marker was posi-
tioned at the tip and additional markers were applied distally along the tip section.
EPFlex then coated the radio-opaque tip section with a copolymer (Polyether
Block Amide (PEBAX)) as illustrated in Figure 3.1.
Figure 3.1: Illustration of the CE marked MRI-safe PEEK-based guidewire
developed at EPFlex in collaboration with the author at IMSaT - (a) the hy-
drophilic coated surface of the guidewire, (b) cut through the guidewire il-
lustrating the polymeric components, (c) schematic representation of the tip
section with the nanoparticles (nPs) markers illustrated in red (spacing in mm)
and (d) a photograph of the tip section with a ”J”-shaped tip.
Two different nP types were selected and evaluated for passive iMRI visu-
alisation. Firstly, commercially available superparamagnetic iron oxide (SPIO)
nPs (Nano4imaging GmbH, Aachen, Germany) and secondly, superparamagnetic
1Guidewire samples were received from EPFlex during each development and production
stage.
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iron-platinum alloy (FePt) nPs in a polymeric matrix (FePt nPs). These FePt
nPs were developed at the University of St. Andrews as strong T2 MRI con-
trast agent with a large T2 relaxivity (r2) for biomedical applications [165]. In a
static magnetic field B0, superparamagnetic nPs are magnetised up to saturation
magnetisation, while each particle distorts the local magnetic field depending on
its magnetic susceptibility. Both employed nPs (FePt and SPIO) have a much
stronger paramagnetism than i.e. Gd [26] leading to a magnetic dipole-dipole in-
teraction between the nPs in such a manner that these are aligned following the
field lines of B0 [166] (see Section 2.4.5.1). Like other inhomogeneities in MRI,
these nPs cause an acceleration of the dephasing process of protons (leading to
a reduction in relaxation times T∗2, T2 and also T1). This inhomogeneity effects
extend over a volume many times larger than the actual particle [26]. Thus, very
low concentrations are sufficient for passive visualisation in MRI.
Various FePt nPs concentrations (2.5, 5, 20 mg/mL) in a polymeric matrix
were compared to commercially available SPIO nPs in order to discover the most
suitable material and concentration for marking guidewires to be used in MRI-
guided interventions. Thus, seven markers, each 10 µL FePt nPs and 3 mm in
length, were distributed over the tip section using a micro pipette (Genex Beta
720080GN, Genex Labratories, Torquay, UK).
3.2.1.2 Design of MRI-Safe Catheters
A set of commercially available non-braided MRI-compatible catheters2 (Table -
3.1) was prepared for MRI visualisation with wRCs. The wRCs were fabricated
either in saddle (Figure 3.2b) or planar rectangular spiral (PRS) coil configuration
(Figure 3.2c) using enamelled copper wire (2UEWF, Conrad, Hirschau, Germany)
and connected to a non-magnetic surface mounted capacitor (VJ0402, Vishay In-
tertechnology, Inc., Malvern, PA, US). Each wRC was then tuned to 63.8 MHz or
123.5 MHz (the proton Larmor frequency at 1.5 T and 2.9 T3, respectively) using a
24-F, 5-F, and where required 6-F catheters were selected because 4-F and 5-F are the most
frequently used flush and selective catheter sizes [132].
3Note, that the field strength of the MRI scanner (Magnetom Trio, Siemens Healthcare,
Erlangen, Germany) used for the experiments in this chapter was 2.9 T and not 3 T. However,
for simplicity, the commonly reported (rounded) value 3 T will be used during this thesis.
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spectrum analyser (HMS1000, HAMEG, Mainhausen, Germany), crimped around
a catheter and coated with medical grade heat shrink tubing (Advanced Polymers,
Salem, NH, US). It has previously been shown [75] that heat shrink tubing pro-
vides sufficient electrical insulation and limits tissue loading effects with associated
degradation of the quality factor.
Figure 3.2: Schematics of various coil designs for wRCs. (a) Exemplary part
drawing of a balloon (green) catheter with two grooves for attachment of two
wRCs, (b) wRC with saddle coil, (c) wRC with planar rectangular spiral (PRS)
coil, (d) wRC with single loop coil parallel to the catheter axis, (e) wRC with
solenoid coil with pitch with the central axis parallel to the catheter axis and
(f) wRC with single loop coil perpendicular to the catheter axis. Note, coil
designs (b), (c) and (f) (bottom row) are shown as planar coils and have to be
crimped to the catheter (see top row) before the final coating is applied.
Depending on the head shape of a particular catheter different marker con-
figurations were employed: Straight catheters were equipped with a single wRC
on the tip (Figure 3.3a - e). Balloon catheters were equipped with either one or
two wRC distal and/or proximal to the balloon (Figure 3.3f - j). Multiple markers
were applied to selective catheters to visualise the profile and orientation of the tip
section during MRI. Thus, the tip section was either marked with several wRCs
(Figure 3.3n) or a single wRC on the tip and several FePt nPs [165] markers along
the shaft (Figure 3.3l - m)). In contrast to all other catheters, one shaped catheter
(C1 - Table 3.1) was prepared to be used at a field strength of 3 T. Furthermore, a
custom made non-braided micro catheter (µC1 - Table 3.1) was prepared for small
vessels i.e. during neurovascular interventions. The current wRC design is limited
to devices with an outer diameter of 1 mm and above. Therefore, iron oxide (FeO)
particles (Goodfellow Cambridge Ltd., Huntingdon, UK) were incorporated into
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Figure 3.3: Photographs of catheters prepared for iMRI visualisation (for
details see Table 3.1). The green arrows illustrate wRCs and the white arrows
passive markers:
Straight catheters (a - e): (a) Catheter with one wRC (S1) before heat
shrink tubing was applied in (b), (c) catheter with one wRC (S2), (d) catheter
with one wRC (S3) and (e) catheter coated over the whole length to avoid
diameter changes.
Balloon catheters (f - j): (f) CAD drawing of a balloon catheter indicating
the two locations (grooves) for wRCs (1: location behind the tip, 2: location
behind the balloon indicated by ’+’), (g) photographs of a catheter (B1) with
a single wRC behind the balloon, (h) catheter (B2) with a single wRC behind
the balloon, and (i) a customised balloon catheter (B3, same model as B2) with
an extension to create space (black arrow) for a wRC (j) at the tip.
Shaped catheters (k - n): Cobra catheter (C1) with one wRC at the tip
before (k) and after (l) the FePt nPs markers were applied. (m) Sidewinder II
(SW2) with one wRC at the tip and 7 FePt nPs markers and (n) Sidewinder I
(SW1) with five wRCs applied at the tip section and along the shaft.
Micro catheter (o): Tip of µC1 with FeO particles tip marker (white arrow).
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the tip of this micro catheter. These FeO particles allow susceptibility-based vi-
sualisation, similar to what has been described in Sections 2.4.5.1 and 3.2.1.1 for
guidewires.
3.2.2 MRI Setup and Protocol
All experiments, except the experiments to assess the catheter (C1 - Table 3.1)
that was prepared for 3 T, were conducted at IMSaT in a clinical 1.5 T MRI scan-
ner (Signa HDx, Software release 15.0M4A, GE Healthcare, Waukesha, WI, USA)
(see Figure 3.4). Receive coils were selected for each device and study and are re-
ported in the particular sections. When applicable, a novel interventional coil suite
”DuoFlex” developed in collaboration with MR Instruments, Inc. (Minnetonka,
MN, USA) and GE Healthcare (Waukesha, WI, USA) was used for imaging. The
DuoFlex coil suite facilitates access for interventional procedures with different
combinations of coil elements (4ch paddle elements [24 cm x 24 cm], 4ch paddle
elements [10 cm x 10 cm], 1ch single loop element), which can be plugged into a
connector box. The coil suite also supports a lightweight single loop element for
interventions with a large opening and an exchangeable soft cover. This soft cover
can be covered by sterile drapes and disposed of when contaminated.
The standard GE console and the product rtMRI platform (i/Drive Pro Plus,
GE Healthcare, Waukesha, WI, USA) or RTHawk (Version 0.9.28, HeartVista,
Inc., Palo Alto, CA, USA) were utilised. The 3T experiments were conducted at
the Clinical Research Centre (NHS Tayside and University of Dundee, UK) using
a clinical 3 T MRI scanner (Magnetom Trio, Software Release Syngo MR B15,
Siemens Healthcare, Erlangen, Germany) with a 12ch head coil (Siemens Health-
care, Erlangen, Germany). A summary of the pulse sequences and parameters
for the guidewire and catheter experiments are shown in Table 3.2 and Table 3.3,
respectively.
3.2.3 In Vitro Experiments in Tissue Mimicking Phantoms
Basic bench testing was conducted in tissue mimicking phantoms to assess guidewire
and catheter performance. If not otherwise stated, the phantoms or vessels of a
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Table 3.1: Commercially available non-braided angiography catheters cus-
tomised and prepared for iMRI visualisation.
Ref.
#
Type / ∅ / Length
/ Lumen / Balloon
wRCs: # / Location /
Propertiesa
nPs Markers: # / Lo-
cation / Properties
Max.
∅
S1 Straightb / 5-F / 70
cm / 0.035” / -
1 / 5 mm from the tip,
PRS coil: wire ∅: 0.2
mm, l = 15 mm, N = 5,
C = 18 pF, Q ≈ 65
- 7-F
S2 Straightb / 5-F / 70
cm / 0.035” / -
1 / 5 mm from the tip,
PRS coil: wire ∅: 0.2
mm, l = 10 mm, N = 5,
C = 29.2 pF, Q ≈ 49
- 7-F
S3 Straightb / 5-F / 70
cm / 0.035” / -
1 / 5 mm from the tip,
PRS coil: wire ∅: 0.3
mm, l = 8 mm, N = 5,
C = 35.7 pF, Q ≈ 51
- 8-F
B1 PTA Balloonc / 5-F /
75 cm / 0.035” / 10
mm x 4 cm
1 / 5 mm behind balloon,
PRS coil: wire ∅: 0.3
mm, l = 15 mm, N = 5,
C = 22 pF, Q ≈ 68
- 7-F
B2 PTA Balloond / 5-F /
75 cm / 0.035” / 10
mm x 4 cm
1 / 5 mm behind balloon,
PRS coil: wire ∅: 0.3
mm, l = 15 mm, N = 5,
C = 27 pF, Q ≈ 61
- 7-F
B3 PTA Balloond / 5-F /
75 cm / 0.035” / 10
mm x 4 cm
2 / (1) 5 mm from the tip,
(2) 5 mm behind the bal-
loon, saddle coil: wire ∅:
0.2 mm, l = 8 mm, N =
2, C1 = 47 pF, C2 = 54
pF, Q1 ≈ 38, Q2 ≈ 30
- 7-F
M1 Multipurpose (MPA)e
/ 6-F / 90 cm / 0.035”
/ -
1 / 2 mm from the tip,
PRS coil: wire ∅: 0.3
mm, l = 10 mm, N = 5,
C = 27 pF, Q ≈ 50
1 / long marker along the
tip section (13 cm) / 3
µL/cm of 1.25 g/mL FePt
nPs
8-F
C1 Cobraf / 4-F / 65 cm
/ 0.035” / -
1 / 2 mm from the tip,
saddle coil: wire ∅: 0.2
mm, l = 11 mm, N = 2,
C = 16.9 pF, Q ≈ 28, f0
= 123.5 MHz
5 / increasingly spaced at
2 cm, 3 cm, 3 cm, 4 cm,
4 cm / each 7 µL of 1.25
g/mL FePt nPs, l = 5
mm
8-F
SW1 Sidewinder If / 5-F /
100 cm / 0.035” / -
5 / equally spaced every 2
cm, saddle coils: wire ∅:
0.2 mm, l = 10 mm, N =
2, C = 50 - 54 pF, Q ≈
30 - 37
- 8-F
SW2 Sidewinder IIf / 4-F /
100 cm / 0.035” / -
1 / 5 mm from the tip,
saddle coil: wire ∅: 0.2
mm, l = 11 mm, N = 2,
C = 51.9 pF, Q ≈ 32,
7 equally spaced every 2
cm / each 11 µL of 1.25
g/mL FePt nPs, l = 5
mm
7-F
µC1 Micro catheterg / 2.6-
F / 150 cm / 0.035” /
-
- 1 / at the tip - FeO parti-
cles (average size 1-6 µm)
/ L = 1 mm
2.7-
F
aDesign: wire ∅, length (l), number of windings (N), capacitance (C), quality factor (Q)
bBeacon Tip Royal Flush, Cook Inc., Bloomington, IN, US
cWorkhorse II, AngioDynamics, Latham, NY, US
dAdvance 35LP, Straight, Cook, Bloomington, IN, US
eMPA Soft-Vu, AngioDynamics, Latham, NY, US
fPro-tex HF, Somatex, Teltow, Germany
gPenumbra, Inc., Alameda, CA, USA
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(a) Photograph of the iMRI Setup (b) Floor-plan of the iMRI Setup
Figure 3.4: Multi-modality setup at the Institute for Medical Science and
Technology (IMSaT) in Dundee (first installation in the UK in 2009) - The
left room contains a digital subtraction angiographic unit (OEC 9900 Elite,
GE Healthcare Systems, Waukesha, WI, USA) and the right room is an RF
shielded enclosure with a clinical 1.5 T MRI scanner (Signa HDxt, GE Health-
care, Waukesha, WI, USA). The rooms are interconnected with sliding doors
(Imedco, Haegendorf, Switzerland), that shield RF and radiation and allow a
patient transfer on a mobile table with radiolucent sliding table top (MR 1050
surgical suite, GE Healthcare and Maquet, Rastatt, Germany). To further as-
sist interventions, a shielded 40” liquid crystal display (LCD) monitor (Multeos
401, NEC Corporation, Tokyo, Japan) was installed and connected to the scan
console via optical fibre cables (M1-1000, Opticis, Sungnam City, Korea).
phantom were filled with 0.9% saline solution4 in order to mimic the electrical
properties of blood.
3.2.3.1 In Vitro Evaluation of Guidewires
To date, no dedicated standards for assessing MRI visualisation properties of
guidewires are available. Hence, the current ASTM standard test method (F2119-
07) for evaluation of MR image artefacts from passive implants [30] was adopted
to assess the MRI visualisation properties of the PEEK-based guidewire. A plastic
container (l = 16 cm, w = 13 cm, h = 14 cm) was filled with 0.9% saline solution
and doped with Gd (1:500) to reduce T1 relaxation and to keep TR during imaging
at a reasonable level. The guidewire was then immersed in the phantom and po-
sitioned in an 8-channel (ch) brain coil (HD Braincoil, GE Healthcare, Waukesha,
WI, USA) for MRI according to Table 3.2.
4The following ingredients were used: 9 g of sodium chloride (NaCl) dissolved in one litre of
tap water. This resulted in the following relaxation times measured at 1.5 T and 20 ◦C: T1 ≈
1150 ms, T2 ≈ 130 ms.
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Table 3.2: Summary of the MRI parameters for the guidewire experiments
Parameter
Diagnostic rtMRI
SE GRE WMI
bSSFP
FSPGR FGRE WMI
edSSFP
TE / TR [ms] 20 / 500 15 / 200 2.4 / 4.8 10 / 100 1.6 / 5.4 4.0 / 8.0
FOV [cm x cm] 25 x 25 25 x 25 20 x 20 40 x 40 40 x 40 40 x 40
Matrix 256 x 256 256 x 256 256 x 256 256 x 256 256 x 256 256 x 256
FA [◦] - 30 80 60 40 50
Slice thickness [mm] 3 3 13 3 4 5
Pairs of images (SE, GRE) were acquired both with and without guidewire in
the phantom (as suggested in [30]). The DICOM images were processed and anal-
ysed with a commercially available software package (OsiriX Pro 1.04.010, Aycan,
Wuerzburg, Germany). The susceptibility artefacts were assessed by computing
the differences between guidewire and reference images. Marker sizes were mea-
sured according to Figure 3.5 in coronal and axial planes where the signal void of
a marker showed a maximum diameter along the long axis a (in parallel to B0).
Additionally, rtMRI pulse sequences (FGRE, FSPGR) were selected to evaluate
the visualisation performance for MRI-guided interventions.
Figure 3.5: Measurement of the signal void induced by a passive susceptibil-
ity marker: a denotes the long axis (in parallel to B0) and b the short axis
(perpendicular to B0). Note, b represents the size along the x-axis, which is
equivalent along the y-axis due to radial symmetry [72, 151].
While passive markers generally result in signal voids as the means for detec-
tion (negative contrast) [154], it can be beneficial i.e. for localisation, if these can
be visualised with positive contrast while the background signals are suppressed.
This phenomenon is commonly known as white marker imaging [151] (WMI). Two
different WMI techniques were implemented in this thesis for guidewire visuali-
sation. Firstly, WMI based off-resonance excitation [73] (WMI bSSFP), whereby
off-resonance excitation generates positive contrast of the susceptibility markers
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Table 3.3: Summary of the MRI parameters for the catheter experiments
Parameter
1.5 T (GE) 3 T (Siemens)
Diagnostic rtMRI Diagnostic rtMRI
GRE FGRE FIESTA SPGR FSE RT FGRE 3D FLASH RT FLASH
TE / TR [ms] 15 / 500 4.0 / 7.7 1.1 / 3.7 3.7 / 8240 14 / 425 1.5 / 5.3 3.4 / 8.8 3.4 / 8.8
FOV [cm x cm] 32 x 32 25 x 25 25 x 25 20 x 20 40 x 40 40 x 40 17 x 19 20 x 20
Matrix 256 x 224 256 x 256 256 x 256 256 x 256 256 x 256 256 x 256 256 x 224 256 x 224
FA [◦] / ETL 30 30 5 - 90 5 - 90 ETL = 4 20 14 12
Slice thickness [mm] 3 7 10 6 10 5 0.74 3
compared to their background [73]. Secondly, an echo-dephased steady state free
precession sequence (WMI edFFSP) [72] was implemented, which can achieve
complete background suppression while hyper intense signals in close vicinity of
passive susceptibility markers are preserved [72]. Note, the imaging parameters
are also presented in Table 3.2.
3.2.3.2 In Vitro Evaluation of Catheters
The modified catheters (Table - 3.1) were tested in plastic phantoms or arterial
vessel replica models (left lower extremities (LE): L-F-S-Left-003 or head model:
H+N-S-A-10, Elastrat, Geneva, Switzerland). Please note that all pulse sequences
and parameters are summarised in Table 3.3. Preceding experiments [167] have
demonstrated that quantitative predictions of the coupling properties and result-
ing signal enhancement of wRCs were found very challenging due to the aforemen-
tioned coil orientation (Figure 2.16) and imaging parameter dependence (Section
3.2.1.2). Therefore, a double angle method (DAM) [168] was implemented to eval-
uate the orientation dependence and the related coupling effects of wRC configu-
rations to be used on catheters. Pairs of MR images (SPGR) with FA2 = 2 · FA1
were acquired using an 8ch brain coil (HD Braincoil, GE Healthcare, Waukesha,
WI, USA). FA maps were then computed using a commercially available software
package (MATLAB 2009a, The Mathworks, Natick, MA, US) according to what
has been proposed by Cunningham and colleagues [168].
Catheters with a Single wRC: Straight and balloon catheters (S1 - S3, B1,
B2 - Table 3.1) with a single wRC were positioned in a plastic phantom (l = 18
cm, w = 10 cm, h = 10 cm). rtMRI (FGRE) was performed with the DuoFlex
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interventional coil prototype (see page 51) using a 4ch 24 cm element combined
with the single loop element with disposable cover.
Catheters with Multiple wRCs: Varying the excitation angle (FA) can affect
the visualisation of wRCs as previously described by Quick et al. [75]. Thus, a
balloon catheter (B2 - Table 3.1) with two wRCs, each with a different quality
factor (Q1 ≈ 37, Q1 ≈ 30) was therefore inserted in the LE vessel model for MRI.
The signals induced by each wRC in comparison to the background signals were
then investigated (FIESTA) as a function of the FA using a commercially available
software package (Osirix 32bit, version 5.5, Pixmeo Sarl, Geneva, Switzerland).
The contrast-to-noise ratio (CNR) was determined by the signal intensity (SI)
difference between wRC and background and normalised against the background
noise [75].
To evaluate multiple wRCs for catheter shaft visualisation, a sidewinder
catheter (SW1) equipped with five wRCs was positioned in a plastic phantom
(l = 24 cm, w = 24 cm, h = 10 cm) and evaluated using rtMRI (RT FGRE).
Catheters with one wRC on the Tip and Passive Markers Along the
Shaft: A sidewinder II catheter (SW2 - Table 3.1) was evaluated for iMRI at a
field strength of 1.5 T (i). Firstly, the susceptibility artefacts induced by the FePt
nPs markers were measured (GRE) (according to [30]). Secondly, the catheter was
navigated in the LE vessel model while rtMRI scans (RT FGRE) were obtained
to assess the navigation properties. As mentioned in Section 3.2.1.2, one shaped
catheter (C1 - Table 3.1) was also prepared to be used at a field strength of 3 T.
Therefore, high spatial resolution (3D FLASH) and rtMRI (RT FLASH) of the
catheter in a plastic phantom (l = 24 cm, w = 24 cm, h = 10 cm) was conducted
in a 3 T MRI scanner (ii).
Micro Catheter: The micro catheter (µC1 - Table 3.1) with a passive marker
on the tip was evaluated for iMRI. The size of the susceptibility artefact was
measured during MRI (GRE - Table 3.3) according to Figure 3.5. The catheter
was then navigated in an arterial head model while rtMRI scans (RT FGRE -
3.2. Materials and Methods 57 Chapter 3. MRI Devices
Table 3.3 and edSSFP - Table 3.2) were obtained with the DuoFlex interventional
coil prototype (see Section 3.2.2).
RF Induced Heating Experiments: RF induced heating was evaluated dur-
ing MRI according to the ASTM protocol (F2182-09), originally developed for RF
induced heating on or near passive implants [36]. To consider the worst-case sce-
nario, the catheter (S1 - Table 3.1) equipped with the wRC providing the highest
quality factor (Q ≈ 65) was assessed. The temperature was recorded with gal-
lium arsenide temperature sensors connected to a measurement unit (Fotemp4,
Optocon AG, Dresden, Germany) via optical fibre cables. The measurement unit
(temporal resolution: 4 seconds, overall measuring accuracy: ± 0.2 ◦C) was posi-
tioned outside of the Faraday cage and the optical fibre cables were fed through
the wave-guides in order to connect the temperature probes. Three probes were
then attached to the wRC (distal, medial, proximal) and one probe to the patient
table to be used as reference. The wRC was positioned in a head-torso phantom
(head: l = 27 cm, w = 15 cm, h = 9 cm / torso: l = 65 cm, w = 42 cm, h =
9 cm) filled with a tissue equivalent gel5 to prevent heat convection. Fast spin
echo [36] (FSE) imaging was performed in a 1.5 T MRI scanner (see Section 3.2.2)
using the integrated body coil (transmit/receive). This sequence was prescribed
for approximately 15 minutes and produced an averaged whole body SAR of 2
W/kg.
3.2.4 Ex Vivo Experiments in Thiel Embalmed Human
Cadavers
All human cadavers used in the context of this thesis were donated according to
standard procedures as set out in the Human Tissue (Scotland) Anatomy Act 2006,
and the Thiel Advisory Committee (University of Dundee, UK) has approved all
procedures involving human cadavers. The cadavers were embalmed according to
the Thiel soft-fix embalming method as currently in use at the Centre for Anatomy
5Ingredients according to [36]: H20, 1.32 g/L NaCl, 10 g/L poly-acrylic acid partial sodium
salt (PAA) (Sigma Aldrich Corp., Saint Louis, Missouri, USA), electrical conductivity: σ = 0.47
S/m ± 10% at f = 63.8 MHz
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and Human Identification (CAHID) in Dundee [169]. Two Thiel soft-embalmed
human cadavers (female, approximated age: 60 - 85, approximated weight: 65 - 85
kg) were prepared in the angiography suite and then transferred to the MRI suite
(Figure 3.4). Vascular access was established with 12-F introducer sheaths (Cook
Medical, Bloomington, IN, USA) placed into the right femoral vein and left femoral
artery. Please note, the large diameter sheaths were required to partially block off
the vessels for subsequent perfusion experiments. The vessels were then flushed
with Thiel moistening solution before the abdomen of a cadaver was positioned in
an 8ch body array coil (FullFOV, GE Healthcare, Waukesha, WI, USA).
3.2.4.1 Ex Vivo Evaluation of Guidewires
According to the results of the preceding phantom experiments the marker solvent
with 20 mg/mL FePt nPs was chosen and employed for the cadaver experiments.
The guidewires were inserted through the sheath and then navigated using rtMRI
guidance (FGRE). Two experienced interventional radiologists evaluated overall
guidewire visibility and mechanical performance (pushability, torque and gliding
properties) during navigation to the target vessel segment (vena cava).
3.2.4.2 Ex Vivo Evaluation of Catheters
In the first cadaver, a straight catheter (S2 - Table 3.1) equipped with one wRC
on the tip was inserted over a guidewire (Section 3.2.1.1) and positioned in the
left common iliac artery. In the second cadaver a balloon catheter (B3 - Table 3.1)
equipped with two wRCs was introduced over the MRI-compatible guidewire and
positioned in the left common iliac artery while diagnostic (FSPGR) and rtMRI
(FGRE) scans were obtained.
3.3 Results
The results for in vitro and ex vivo validation for the developed guidewires and
catheters are presented in the following:
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3.3.1 In Vitro Evaluation of Developed Devices
This section describes the results of the device validation in tissue mimicking phan-
toms. During these in vitro experiments, all devices with their applied markers
showed no macroscopic evidence of fracture or kinking and remained patent.
3.3.1.1 In Vitro Evaluation of Guidewires
Figure 3.6 illustrates MR images of the guidewire containing FePt nPs (20 mg/mL)
markers for visualisation. The signal voids were found dependent on various imag-
ing parameters and the orientation in the scanner. The artefact size was found
mainly dependent on the guidewire orientation in respect to B0 and was increasing
with TE. The long axis a of the susceptibility artefacts aligned with the field lines
of B0 (Figure 3.6). The measurements of the susceptibility artefacts resulting from
the different nPs markers on the guidewires are summarised in Table 3.4. This
table illustrates the induced artefact sizes during SE and GRE imaging accord-
ing to the ASTM protocol (F2119-07) [30] and during FSPGR imaging optimised
for subsequent cadaver experiments. Additionally, it was feasible to visualise the
markers on the guidewire with positive contrast. This is demonstrated in Figure
3.6b. The markers were visualised with high SIs while background suppression
was achieved using WMI (Figure 3.6).
3.3.1.2 In Vitro Evaluation of Catheters
Figure 3.7 illustrates FA maps, which were computed for different coil configura-
tions to be used as wRC on catheters. Both coil designs showed areas in close
vicinity of the wRC with significantly amplified FAs for all orientations but one.
In this particular orientation the FA amplification effect was less pronounced. For
the single loop coil the area of amplified FAs was minimal (FAmax = 54
◦) if the
coil was contained in the transverse plane Pxy (see the image in the middle of
Figure 3.7a). Saddle coils showed a weaker signal amplification if the main axis
was orientated in parallel to the transverse plane Pxy (see the image in the middle
of Figure 3.7b). However, this effect was less distinct for the saddle (FAmax = 57
◦)
than for the loop coil.
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(a) FSPGR - Coronal (b) WMI bSSFP - Coronal (c) MIP of the WMI bSSFP
dataset
(d) FSPGR - Axial (e) WMI edSSFP (2pi/voxel) -
Axial
(f) WMI edSSFP (4pi/voxel) -
Axial
Figure 3.6: Visualisation of the MRI-safe guidewire prototype (FePt nPs (20
mg/mL) markers): Images were obtained with FSPGR in (a) and (d) and
WMI bSSFP employing off-resonance excitation in (b). Figure (c) shows a
MIP of the WMI bSSFP dataset. Figures (e) and (f) were obtained with
echo-dephased steady state free precession (WMI edSSFP) imaging resulting in
incomplete background suppression in (e) (dephasing of 2pi/voxel in the readout
direction) and complete background suppression in (f) (dephasing of 4pi/voxel
in the readout direction). Note, the sequence parameters are summarised in
Table 3.2.
Catheters with a Single wRC: Figure 3.8 illustrates straight (a - c) and
balloon catheters (d, e) that were imaged in a phantom. The quality factor of each
wRC significantly affected the signal characteristics in MRI. A locally increased SI
was visible at the location of each wRC (Figure 3.8). Note, a comparative analysis
of how different quality factors affect the signal amplification is described in the
following paragraph.
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Table 3.4: Measurements (according to Figure 3.5) of the induced suscepti-
bility artefacts caused by nPs markers on the MRI-safe guidewire - The images
(SE, GRE) were obtained according to the standard protocol [30] and with a
pulse sequence optimised sequence for Thiel cadaver imaging (FSPGR). Note
the sequence parameters are summarised in Table 3.2).
Pulse Se-
quence
nPs Concentration
[mg/mL]
Size (a)
[mm]
Size (b)
[mm]
SE
FePt
2.5 2 - 3 2 - 3
5 2 - 4 2 - 3
20 3 - 6 3 - 5
SPIO n/a 7 - 8 6 - 8
GRE
FePt
2.5 3 - 5 2 - 4
5 4 - 7 4 - 6
20 7 - 13 6 - 11
SPIO n/a 12 - 16 13 - 15
FSPGR
FePt
2.5 5 - 8 3 - 6
5 6 - 9 4 - 8
20 12 - 15 9 - 13
SPIO n/a 13 - 15 10 - 12
(a) Single Loop Coil (b) Saddle Coil
Figure 3.7: Colour coded FA maps of wRCs with different coil configurations -
(a) Single loop coil (Figure 3.2f) and (b) saddle coil (Figure 3.2) configuration.
The wRCs were positioned in three different orientations in regards to B0. The
orientation is illustrated above each FA map and the magnitude image (FA =
FA1 = 10
◦). Note, the main axis of B0 (z-axis) is from bottom to top and the
x-axis from left to right.
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Figure 3.8: MR images (FGRE - Table 3.3, same window level) obtained for a
phantom and various catheters (Table 3.1) equipped with a single wRC. Figures
(a - c) show straight ((a): S3, (b):S2, (c):S1) and Figures (d - e) show balloon
catheters ((d): B2, (e):B1).
Catheters with Multiple wRCs: The quality factor of a wRC significantly
affects the signal characteristics in MRI (see Section 2.4.5.3). The phantom ex-
periments with the balloon catheter (Figure 3.9) demonstrate that during imaging
with low FA (≤ 5◦), signals were predominantly obtained from the two wRCs while
signals from the background were suppressed. Similar to what has been reported
by Quick and colleagues [75], imaging with intermediate FAs provided simulta-
neous wRC and anatomic visualisation, and high FAs provide solely anatomic
visualisation.
Figure 3.9: Two wRCs on a balloon catheter (B3 - Table 3.1) inserted in the
arterial vessel phantom. MR images were obtained (FGRE - Table 3.3) while
the FA was varied.
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The wRC with higher quality factor (Q1 ≈ 38) resulted in an area with higher
SIs in particular for low FAs with maximum SI and CNR at a FA of 10◦ (Figure
3.10). The wRC with the lower quality factor (Q2 ≈ 30) resulted in lower SIs
(compared to the wRC with Q1) with a maximum SI (Figure 3.10) and CNR if a
FA of 15◦ was used. For intermediate FAs, the wRC and the background tissues
were both visible. However, no signal increase (compared to the background) was
obtained using high FAs (Q2: CNR = 0 at FA = 48
◦ and Q1: CNR = 0 at FA =
73◦).
Figure 3.10: Investigation of wRC signal versus background signal as a func-
tion of the FA. The experiment was conducted with a FIESTA pulse sequence
(Table 3.3), similar to what has been proposed in [75].
For shaped catheters it is important to visualise the head shape and orien-
tation of the tip section. Figure 3.11 illustrates a MRI scan that shows the tip
profile of a sidewinder catheter (SW1) with multiple wRCs. The catheter tip
section, containing the wRCs, was visible over a length of 10 cm.
Figure 3.11: Sagittal MR image (FIESTA - Table 3.3) of a plastic phantom
containing the sidewinder I catheter (SW1 - Table 3.1) equipped with five wRCs.
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Catheters with one wRC on the Tip and Passive Markers Along the
Shaft: An alternative approach to provide visualisation of the catheter shape
and orientation is to employ a single wRC on the tip and susceptibility markers
along the catheter shaft. This is shown in Figures 3.12, 3.13 and 3.14.
(i) Imaging experiments at 1.5 Tesla
The susceptibility artefacts caused by the FePt nPs exhibited 3 - 6 mm sized signal
voids (axis a - see Figure 3.5) increasing with TE (Figure 3.12).
Figure 3.12: MR images (according to Table 3.3) of a sidewinder II catheter
(SW2 - Table 3.1) with a wRC on the tip and FePt nPs markers along the shaft
- Figure (a) was obtained (GRE) according to the ASTM protocol [30] with a
guidewire (without markers) in place. Figures (b - d) were obtained with a
rtMRI sequence (FGRE) and demonstrate how the artefact can be manipulated
by varying TE ((b) TE = 2.5 ms, (c) TE = 5 ms, (d) TE = 10 ms).
Figure 3.13a illustrates catheter navigation into the superficial femoral artery
while images were obtained in sagittal orientation. Figure 3.13 illustrates MR
images, which were obtained in sagittal (a) or coronal orientation (b - e) while
the same catheter was navigated into the lateral circumflex femoral artery. Note,
only one FePt nPs marker was visible in Figure 3.13c) but none in b) and d) as
these were not contained in the current rtMRI scan plane. It should also be noted
that the susceptibility artefacts resulting from the FePt nPs markers affected the
signal enhancement of a wRC if both markers were located close to each other.
Figure 3.13e illustrates such a situation where the catheter was bent and one
of the FePt nPs markers (white arrow) was positioned very close to the wRC on
the tip (green arrow) and thereby reducing the signal enhancing effect of the wRC.
(ii) Imaging experiments at 3 Tesla
The susceptibility artefacts (Figure 3.14a) caused by the FePt nPs exhibited 7 -
11 mm (measured according to Figure 3.5) sized signal voids along axis a (same
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Figure 3.13: rtMRI scans (FGRE - Table 3.3) while a sidewinder II catheter
(SW2 - Table 3.1) with wRC on the tip (green arrow) and seven FePt nPs mark-
ers (white arrows) along the shaft was navigated (downstream) in the LE vessel
replica model - Figure (a) illustrates catheter navigation into the superficial
femoral artery, Figures (b - d) (2x magnification) illustrate catheter navigation
into the lateral circumflex femoral artery. Figure (e) (7x magnification) illus-
trates how a FePt nPs marker affected the signal enhancement effect of a wRC
if both markers were positioned very close to each other.
imaging parameters as for the experiments at 1.5 T (Figure 3.12a). The wRC on
the tip (Figure 3.14) showed high device to background contrast during imaging
with low and intermediate FAs (FA < 45◦: high CNR, FA = 75◦: CNR = 0). The
wRC (Figure 3.14, green arrow) on the cobra catheter (C1 - Table 3.1) was clearly
visible while the passive susceptibility markers along the shaft were not detected
in the MIP (Figure 3.14b).
Figure 3.14: 3 T MRI (3D FSPGR - Table 3.3) of a phantom containing the
cobra catheter (C1 - Table 3.1) equipped with single wRC at the tip (green
arrow) and FePt nPs markers (white arrows) along the catheter shaft. Figure
(a) illustrates a sagittal slice and (b) a MIP of the 3D dataset.
Micro Catheter: MR images of the micro catheter during navigation in an
arterial vessel phantom are demonstrated in Figure 3.15. The FeO particle marker
on the micro catheter (µC1 - Table 3.1) exhibited 14 - 16 mm sized signal voids
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along the axis a and 11 - 13 mm along the axis b (measured according to Figure
3.5).
Figure 3.15: MR images (RT FGRE - Table 3.3) of the micro catheter (µC1
- Table 3.1) with a passive tip marker navigated in an arterial head phantom
- Figure (a) illustrates a coronal, (b) a sagittal and (c) an axial scan (differ-
ent catheter location). Note, air bubbles lead to susceptibility artefacts in the
background due to the degrading gel (on the forth day of experiments) (c).
Additionally, it was evaluated if the FeO marker on the micro catheter can
be visualised with positive contrast while the background signals are suppressed
(i.e. for localisation). Figure 3.16 demonstrates that WMI edSSFP imaging with
dephasing of 4pi/voxel in the readout direction resulted in complete suppression of
background signals while hyper intense signals in close vicinity of the FeO marker
were preserved.
RF Induced Heating Experiments for the wRC with the Highest Q:
The maximum local temperature (measured at three locations of the wRC) did not
exceed 0.6 ◦C during the entire RF induced temperature measurement [36]. Figure
3.17 shows four box plots that summarise the temperatures that were recorded
during MRI (FSE - Table 3.3) with high SAR exposure (2W/kg) over a period of
15 minutes.
3.3.2 Ex Vivo Evaluation of Developed Devices
The following paragraphs describe the ex vivo validation of the guidewires and
catheters that was performed using Thiel-Soft embalmed human cadavers.
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Figure 3.16: Complete background suppression was achieved with dephasing
by 4pi/voxel in the readout direction while exploiting positive contrast of a FeO
marker on the micro catheter (µC1 - Table 3.1) using a dedicated edSSFP pulse
sequence. The red arows indicate the FeO marker location in the FOV. The
main image (right) shows one frame during rtMRI (WMI edSSFP - Table 3.2).
The three scout images on the left (top to bottom - axial, sagittal, coronal)
indicate the orientation of the current rtMRI scan plane.
Figure 3.17: Box plots of the temperature measurements according to the
ASTM protocol (F2182-09) [36]. Three temperature probes were attached to a
wRC (probe 1: proximal, probe 2: distal and probe 3: medial) on the tip of a
catheter (S1 - Table 3.1) and one probe was attached to the MR table outside
of the bore and used as reference.
3.3.2.1 Ex Vivo Evaluation of the Guidewires
Two experienced interventional radiologists successfully navigated the guidewire
from the femoral vein into the targeted vessel segment (vena cava) of both cadavers,
solely using MRI-guidance (Figure 3.18a). Both radiologists rated the mechanical
performance (pushability, torque and gliding properties) for this task comparable
to standard guidewires used in X-Ray fluoroscopy. The susceptibility artefacts
induced by the FePt nPs markers enabled distinct rtMRI visualisation of the
guidewire (Figure 3.18a) with a mean marker size of 14 mm (axis a) and 12 mm
3.3. Results 68 Chapter 3. MRI Devices
(a) Coronal RT FGRE (b) Coronal FSPGR
Figure 3.18: MR images (according to Table 3.2) of the guidewire navigated
in the vena cava of a Thiel soft-embalmed human cadaver - Figure (a) shows a
rtMRI scan (FGRE) and (b) a diagnostic FSPGR scans.
(axis b). The susceptibility artefacts aligned with the field lines of B0. The FePt
nPs markers showed ball-shaped rather than dipole - dipole shaped artefacts as
during the idealised phantom experiments (see Figure 3.6).
3.3.2.2 Ex Vivo Evaluation of the Catheters
During our experiments, two different catheters, a straight (S2 - Table 3.1) (see
Figure 3.19) and a balloon catheter (B3 - Table 3.1) were inserted and successfully
navigated from the left femoral artery into the common left iliac artery of two
Thiel soft-embalmed human cadavers (Figure 3.20). The wRCs on both catheters
exhibited high device to background contrast during imaging with low and inter-
mediate FAs (<45◦). In the cadaver experiments the signal of each wRC was less
intense as compared to the phantom experiments. However, the bright spot ap-
peared similar in size and each wRCs (Figure 3.19 and 3.20) was visible during all
steps of a procedure (manual scan plane adjustments). For the straight catheter,
the area of increased SIs measured 9 - 11.5 mm along the main catheter axis and 4
- 6 mm perpendicular to the catheter axis. For both wRCs on the balloon catheter
10 - 12.5 mm and 6.5 - 8 mm were measured, respectively.
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(a) Sagittal - rtMRI Scan (b) Coronal - rtMRI Scan
Figure 3.19: MR images (according to Table 3.3) of a straight catheter (S2 -
Table 3.1) with single wRC (green arrow) positioned in the left common iliac of
Thiel soft-embalmed human cadaver (transfemoral access) - Figure (a) shows a
coronal and (b) a sagittal rtMRI scan (FGRE).
Figure 3.20: Balloon catheter (B3 - Table 3.1) with two wRCs navigated
into the right common iliac artery of a Thiel soft-embalmed cadaver - The MR
images were obtained (FSPGR - Table 3.3) during catheter navigation. Figure
(a) shows the passive markers while the MRI-safe guidewire was advanced into
the aorta, Figure (b) shows a coronal scan plane with both wRCs and (c) two
axial scan planes that contain a wRC each (green arrows). Note, the significantly
improved RF penetration resulting in a higher SNR during MRI as compared
to the cadaver in Figure 3.19.
3.4 Discussion
Endovascular interventions require distinct visualisation of the shape and position
of a device as well as its location in regards to the vessel wall [78]. Importantly,
all device visualisation techniques that were employed in this chapter did not
require a connection between the device and the MRI scanner, thereby simplify-
ing instrument handling and avoiding elongated electrically conductive structures.
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Such structures can potentially act as an RF antenna and thus accumulate en-
ergy, which constitutes a significant safety risk for the patient [32, 36] (see also
Section 2.4.5). The main benefit of wRCs is that these markers are technically
simpler compared to active tracking coils [146] and have the potential for integra-
tion into the commercial production of endovascular devices [164] as no physical
wire connection to the MRI scanner is required. Susceptibility-based visualisation
of devices is generally more difficult to depict on MRI as passive markers cause
signal voids while wRCs cause signal intensity increases. However, the coil and
capacitor dimensions, which are required to achieve a sufficient Q (greater than
15), limit the use of wRCs for devices with a small outer diameter (below 1 mm).
At present, this restricts the use of this technology to guidewires with an outer
diameter of 0.038” or less.
3.4.0.3 MRI-Safe Guidewire Design
The PEEK-based guidewire does not contain any metallic structures besides the
nPs markers, which can be realised on micro metre scale. In addition, it has
previously been demonstrated that no relevant heating could be detected during
imaging with fast GRE-based sequences [134]. The phantom and cadaver experi-
ments demonstrated that this guidewire enabled rtMRI-guided interventions while
multiple contrast mechanisms (including WMI) can be achieved. The induced sus-
ceptibility artefacts, resulting from the FePt and SPIO nPs, have been optimised
for experimental use but can be manipulated by changing imaging parameters
(mainly TE) or the concentration and material of the nPs. iMRI pulse sequences,
however, require high frame rates and therefore short TE and TR. Thus, the
manipulation of the induced artefacts solely by changing imaging parameters is
limited. The two lower FePt nPs concentrations (2.5 and 5 mg/mL) were found
useful in idealised phantom conditions but generally hard to identify during the
ex vivo experiments. The induced artefact size was too small in particular during
imaging with very short TE. Hence, the passive marker solvent with 20 mg/mL
FePt nPs or the SPIO nPs were found most useful for localizing guidewires during
MRI-guided interventions.
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Passive visualisation was found to be sufficient for guidewire navigation during
all experiments in this chapter. However, in small vessels or next to air-filled
cavities (which also result in signal voids), a more precise visualisation method
(i.e. active tracking with multiple micro receive coils) could improve localisation
and visualisation of the shape and orientation of a device, in particular in small
branching vessels. A possible solution is to use WMI (see Figure 3.6) to localise the
passive markers and then manually update the scan plane or overlay the marker
locations i.e on a 3D MRA roadmap (similar to what has previously been proposed
[27]). However, this would not allow automated tracking and be at the expense of
significantly increased scanning time.
The FePt nPs were synthesised in-house, while the SPIO nPs were commer-
cially available. It has been reported that these FePt nPs [165] provide a six-fold
increase in FePt-based T2 contrast properties compared to those of commercially
available iron oxide nPs for clinical use. However, this had a minor impact for the
application on guidewires, as both nPs marker (FePt and SPIO) can be realised
on micro metre scale and therefore do not compromise the design of the guidewire.
The radiologists furthermore considered the mechanical performance (i.e. torque,
pushability, elasticity) similar, for the particular task, as commercially available
guidewires for X-Ray fluoroscopy. However, further studies are required to fully
assess the mechanical performance of this novel MRI-safe in particular during more
challenging tasks and complex device manipulations.
3.4.0.4 MRI-Safe Catheter Design
As illustrated in Figure 3.7, the computed FA maps correspond well with existing
literature [164] that loop coil (including single loop and PRS coils with an axis
perpendicular to B0) or saddle coil designs (Figure 3.7b) provide the best coupling
properties for long and thin devices if the axis is mainly orientated in parallel to
B0. This is the case for most catheters that are designed for interventions in
cylindrical bore magnets (horizontal B0 field). Alternatively, it has previously
been shown that this orientation dependence can be overcome i.e. by using two
decoupled perpendicular coils [170, 171].
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The results of this study also demonstrate that the shape and orientation
of catheters can be visualised in MRI using either multiple wRCs or a wRC on
the tip and passive markers such as FePt nPs along the shaft. The phantom
experiments showed that combining FePt nPs and a wRC provided a suitable
and reliable device localisation technique for both field strengths, 1.5 T and 3 T.
Small wRCs that inductively couple to the MRI transmit and receive coils of MRI
systems do not require elongated electrical conductors. The RF induced heating
experiments according to the ASTM protocol [36] demonstrated that no significant
heating (<0.6 ◦C) was detected for the catheter (S1 - Table 3.1) equipped with the
wRC providing the highest quality factor (Q ≈ 65). This protocol constitutes the
worst-case scenario (for 1.5 T) while no blood flow cooling effects were considered.
This maximum local temperature rise was found to be well within the limits for
localised heating in human subjects [141].
A limitation of the catheters that were used in this study is that wRCs were
applied to the surface of the catheters and therefore increased the outer diame-
ter and stiffness of the device. This would necessitate arterial access of a larger
calibre than would normally be performed and potentially limits the use of these
catheters to interventions in larger vessels. Thus, passive visualisation was em-
ployed for micro catheters, which created additional challenges to differentiate
between micro catheter and guidewires because both devices employed passive
visualisation. Please note that the increased stiffness and outer diameter are tem-
porary problems relating to manually fabricated wRCs. Recently, micro systems-
based technologies for producing wRCs have been validated [172], which would
allow for complete integration under the final coating of catheters. The exper-
iments in this study demonstrate that the quality factor of a wRC significantly
affected the signal characteristics in MRI in terms of locally increased SIs and
CNR threshold. In this regard, micro system-based manufacturing technologies
are currently evaluated6 to understand if sufficient quality factors can be achieved
for iMRI.
6M. Kaiser, M. Detert, M. A. Rube, A. El-Tahir, O. J. Elle, A. Melzer, B. Schmidt, G. H.
Rose. ”Resonant marker design and fabrication for device visualization during interventional
magnetic resonance imaging”. Biomed Tech (Berl) (accepted with revisions).
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3.4.0.5 Thiel Soft-Embalmed Cadavers as Ex-Vivo Model
In the cadaver experiments the SNR was significantly poorer than in idealised in
vitro conditions, which also affected the signal amplification of the wRCs (less
intense but similar in size). However, it has previously been shown that MRI of
Thiel soft-embalmed tissue is constrained and living organisms provide better RF
penetration [67] (see also Section 1.3). It is foreseen that device visualisation and
discrimination between device and surrounding tissues will improve in animal and
patient studies. To further evaluate the device visualisation techniques, which
were presented in this chapter, pre-clinical validation studies were conducted to
assess the device performance for specific interventions in vitro, ex vivo and in
vivo (large animal models). These studies are described in Chapters 6 and 7.
3.5 Concluding Remarks
In this chapter a number of interesting device visualisation strategies were demon-
strated for interventional MRI. A major shortcoming for the past three decades
in the field of MRI-guided endovascular interventions was the lack of MRI-safe
guidewires with regulatory approval. Thus, the novel PEEK-based guidewire could
enable many MRI-guided procedures in future. Despite the encouraging in vitro
and ex vivo results, the author is aware that further design optimisations are re-
quired before the presented interventional devices can be used in a similar fashion
as state of the art devices for X-Ray fluoroscopy. The next steps in research
should involve a completely integrated design of wRCs into the device material or
outer coating of the finished device. Future research should furthermore focus on
a comprehensive assessment of the mechanical performance of the guidewires and
catheters.
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Chapter 4
Mobile Technology to Improve
iMRI Workflow
Major parts of this chapter have been submitted for publication as:
M. A. Rube, A. B. Holbrook, B. F. Cox, R. Buciuc, A. Melzer, ”Wireless mobile technology
to improve workflow and feasibility of MRI-guided percutaneous interventions”, Int J Comput
Assist Radiol Surg [in press].
Experimental contributions:
(i) B. F. Cox prepared the Thiel-embalmed cadavers and gel phantoms for the experiments.
(ii) A. B. Holbrook assisted in developing the front-end of the browser-based user interface (see
also [173]). (iii) B. Cox, A. Melzer and R. Buciuc validated the developments from a clinical
perspective.
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4.1 Introduction
MRI provides true multi-planar imaging with arbitrary slice orientation and con-
sequently allows aligning the scan plane interactively according to an instrument
trajectory [105] to target challenging lesions. MRI can furthermore be utilised to
characterise lesions before, after and during a procedure [24]. To date, most scan-
ner manufacturers provide moderately interactive real-time User Interfaces (UI)
that are adequate for diagnostic MRI or available as work in progress packages
[43, 44] for off label use only. In addition a very limited number of display and
input devices, such as tableside controls, are available. However, to date no intu-
itive scanner interaction has been achieved that accommodates dynamic changes
to the scan acquisition that are frequently required during iMRI.
A substantial hurdle for MRI in the context of percutaneous interventions is
the lack of a dedicated and adequate workflow [19] that i.e. omits the need for
leaving the scan room during interventions for viewing images and communicating
with the radiographer. High acoustic noise levels during scanner operation, ranging
between 70 and 110 dB [20], add a substantial health and safety risk, in particular,
for fast GRE-based sequences [20] that are frequently used for iMRI [24, 105]
applications. Hence, noise protection is required and special solutions for audio
communication [51] between interventionist, radiographer and patient. Guettler et
al. proposed a wireless Bluetooth (BT)-based communication system that can be
used during MRI scanner operation [52]. This concept was adopted for this study
and extended for multi-user communication between physician, assisting staff and
scanner operator using tablet personal computers (tablet PCs).
Wireless input devices such as tablet PCs are also promising candidates to
be used at the patient side as interactive image display and for interactive MRI
control. The display resolution of such tablet PCs is continuously improving such
that modern tablet devices meet or exceed display resolution of desktop Liquid-
Crystal Display (LCD) monitors in terms of dots per inch (DPI). The FDA has
recently approved a tablet PC (iPad, Apple, Cupertino, CA, USA) and associated
applications (apps) for radiologists to read diagnostic images (K123082). Recent
studies have evaluated the image quality and diagnostic performance of tablet PCs
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in comparison to diagnostic LCD monitors for emergency brain CT scans [174] and
for mobile on-call radiology in CT and MRI studies [175]. Holbrook et al. have
proposed to use a tablet device for controlling or monitoring of MRI-guided high
intensity focused ultrasound (HIFU) procedures [176] and for collaborative iMRI
[177].
The overall objective of this study was to improve percutaneous iMRI, through
easy to use and inexpensive mobile tablet devices. The implementation consisted
of selected wireless tablet PCs, a multi-user communication system and a plat-
form independent web-based UI optimised for interactive iMRI. This setup was
validated for iMRI during percutaneous biopsies on phantoms and Thiel soft-
embalmed human cadavers employing the MRI-guided freehand approach [105].
4.2 Materials and Methods
This section describes the implementations, the setup and the modifications as
well as their assessment in regards to MRI safety and performance in vitro and ex
vivo.
4.2.1 Interventional MRI Setup and Modifications
The setup for validation is a dedicated imaging suite for MRI-guided interventions
and surgery (see Figure 4.1) and consists of a clinical 1.5 T MRI scanner (Signa
HDx, Software release 15.0M4A, GE Healthcare, Waukesha, WI, USA) connected
to a surgical suite (1050, Maquet, Rastatt, Germany). In this study, the DuoFlex
interventional coil prototype (see Section 3.2.2) was used with a 4ch 24 cm element
combined with the single loop element with disposable cover (Figure 4.3).
Two-way data communication between the MRI scanner (MR Host) and an
external Linux (Ubuntu 11.10 64bit) workstation (16-CPU, 32 GB memory, z820,
Hewlett-Packard, Palo Alto, CA) (RT PC) was accomplished via Gigabit Ethernet
(IEEE 802.3z). Next to the magnet, a 23-inch LCD monitor (SW2309W, Dell,
Austin, TEX, USA) was installed on a flexible swivel arm. A second, shielded 40-
inch LCD monitor (Multeos 401, NEC Corporation, Tokyo, Japan) was mounted
4.2. Materials and Methods 78 Chapter 4. Mobile Technology for iMRI
Figure 4.1: 2D floor plan with wireless control and communication setup -
”1” and ”2” represent the mounting positions of the tablet PC. The position
can be changed according to the preference of the physician in terms performing
interventions from the left or the right side of the patient table or on the other
side of the bore. Please note that Figure 3.4 on page 53 illustrates the same
facility without modifications.
to the opposite wall. The integrity of galvanic isolation between the MRI control
room and scan room was retained by using optical fibre cables and optical-to-
electrical as well as electrical-to-optical converters that keep RF noise outside
of the Faraday cage. Both monitors were connected with an optical fibre cable
(M1-1000, Opticis, Sungnam City, Korea) to the RT PC and used simultaneously
to display the iMRI-UI. This allowed interventions to be performed from both
sides of the patient table while either the interventionist or the assisting nurse
monitored the 23 or 40-inch screen, respectively. A Wireless Local Area Network
(WLAN) was implemented for wireless data transfer within the scan room as
illustrated in Figure 4.1. The WLAN (2.4 GHz, IEEE 802.11) connection was
established with a modified router (DIR615, D-Link, Taipei, Taiwan) where one
antenna was positioned in the magnet room and the other one outside the Faraday
cage providing the same local network Service Set Identifier (SSID) throughout
both areas.
Interactive MRI pulse sequences with different contrast mechanisms were de-
veloped and implemented in the RTHawk [45] software framework (Version 0.9.28,
HeartVista, Inc., Palo Alto, CA, USA). Three interactive MRI pulse sequences
were implemented that allow different contrast weightings (T1, T2
∗, T2/T1) for
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lesion detection and can be switched and also be interleaved on the fly: A FSPGR
providing rapid T1-weighted imaging [86, 178], a bSSFP sequence providing T2/T1
contrast [95, 96], in particular useful for blood vessel visualisation employing high
flip-angles [97] and a reversed fast steady state precession (PSIF) sequence pro-
viding fast T2
∗-weighted imaging for iMRI [179].
Figure 4.2: Screenshot of the web-based user interface for iMRI running on a
workstation (Ubuntu 11.10) - Up to three real-time imaging planes can be se-
lected that are frequently updated according to the user selected geometry, scan
parameter and pulse sequence choice. MR images of a spherical phantom are
shown exemplary that were obtained with a FSPGR sequence in an interleaved
manner. The pulse sequence can be selected from dropdown list located on
the top left corner of the screen under the browser address bar. The geometry
control is activated for the left window and the scan plane selection can also be
operated via a tablet PC using multi-touch gestures.
A dedicated multi-device iMRI-UI (Figure 4.2) was developed and integrated
into RTHawk. This UI allows scanner interaction through an Internet browser,
across multiple operating systems and platforms such as PCs, tablet PCs or mo-
bile phones [173]. MRI controls were integrated into a backend developed in C++.
These were then attached to a locally hosted node.js server hosting the UI over
a secure sockets layer (SSL), using a mongoDB database for authentication. The
interface was developed exclusively with Hyper Text Markup Language (HTML),
Cascading Style Sheets (CSS), and JavaScript, using the following open source
libraries: Enyo 2.0 for the interface, Flot.js for plotting, and Three.js for HTML5
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canvas and webGL rendering. The iMRI-UI was employed for image display and
interactive scan and parameter control and it was designed to image up to three
independent slices. The user was able to select and interleave different pulse se-
quences. The UI also supported 3D volume rendering of scan planes and included a
thermometry module that has been described elsewhere [173]. A Virtual Network
Computing (VNC) connection was established between the MRI scanner running
a VNC server and the MRI input device running a VNC client application to com-
pare the developed iMRI-UI to the standard real-time interface (GE i/Drive Pro
Plus, GE Healthcare, Waukesha, WI), which is provided by the scanner manufac-
turer. The implemented web interface was also tested on various computers and
mobile devices with different Internet browsers: Mozilla Firefox (Ubuntu 11.10,
OSX Snow Leopard), Google Chrome (Ubuntu 11.10, OSX Snow Leopard, MS
Windows 7), and Apple Safari (OSX Snow Leopard) and Mobile Safari.
Two mobile tablet PCs have been selected (iPad 1 and 3, Apple, Cupertino,
US) with a 9.7 inch (diagonal) multi-touch display and a resolution of 1024 x 768
and 2048 x 1536 pixels, respectively. Each tablet PC was inserted into a plastic
cover to simulate sterile equipment and mounted to a customised MRI-safe in-
travascular pole (GE Healthcare, Waukesha, WI, USA) with modified car mounts
for tablet PCs (Matek Trading Co., Ltd, Hanoi, Vietnam). Two-way communi-
cation between the scanner operator, the operating physician, and the assisting
nurse was established using Voice-over-Internet-Protocol (VoIP) technology and
wireless mobile BT headsets (Calisto B70, Plantronics, Santa Cruz, CA, USA)
integrated into modified earmuffs (RS Components Ltd, Corby, UK). Two-way
communication was also established with two tablet PCs in the scan room and a
PC in the control room using a VoIP software application (Skype, Luxembourg
City, Luxemburg).
4.2.2 Acceptance Testing
Primary interactions between the MR system and the additional components in
the MRI scan room were evaluated with the test method proposed by ASTM. The
magnetically induced displacement force was assessed according to the standard
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test method (ASTM F2052-06) [129] for measurement of magnetically induced
displacement force on medical devices in the MRI environment. Each device was
suspended from a string attached to the 0◦ indicator on the intravascular pole
to measure the deflection angle α. The displacement force Fm can be calculated
[129] based on the deflection angle, the mass m of the device, and the gravitational
factor g according to Equation 4.1.
Fm = m · g tan(α) (4.1)
Moreover, potential RF interference was evaluated on a phantom with a co-
herent noise test (GRE, TE / TR= 13 / 32 ms, FOV = 20 cm x 20 cm, Matrix
= 512 x 256, FA = 10◦, Slice thickness = 5 mm, Bandwidth = 122.7 Hz/pixel)
with an 8ch HD brain coil as well as a white pixel test (SE EPI, TE / TR = 36.1
/ 6000 ms, FOV = 9.9 cm x 9.9 cm, Matrix = 128 x 64, Slice thickness = 10 mm,
Bandwidth = 3906.25 Hz/pixel) employing the integrated body coil. Both tests
were available from the service browser on the MRI scanner to evaluate image
quality.
4.2.3 Techniques for MRI-Guided Interventions
An experienced interventional radiologist (10 years experience - ”expert”) and one
physician in training (no interventional experience - ”novice”) performed all pro-
cedures. A carbon fibre composite puncture needle with Nitinol mandrin (21G /
150 mm, Radimed, Bochum, Germany) was used during MRI-guided needle punc-
tures. Tissue samples (in case of artificial targets) were obtained for verification
with an MRI-safe biopsy needle (MR Biopsy-Handy, 16G, 15cm, Somatex, Teltow,
Germany). Passive, susceptibility-based visualisation (see Section 2.4.5.1) of the
needles [22, 29] was applied for needle guidance.
Initially, a planning dataset with high spatial resolution (FSPGR, TE / TR =
10 / 80 ms, FA = 60◦, FOV = 25 cm x 25 cm, Matrix = 384 x 384, Slice thickness
= 2 mm) was acquired and the target and skin entry points were selected. The
target point was defined as a sphere (∅ = 8 mm). The patient table was then
moved out of the bore and the physical entry point was marked on the skin/surface
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by calculating the distance offset (in x and z direction) from the laser crosshair. A
small incision was then performed using a non-ferro magnetic disposable titanium
scalpel (# 11 blade) at the entry point and the needle was positioned.
The physician then requested the scanner operator to remotely move the
patient table back into the MRI scanner while the physician kept his finger at the
skin entry point to mark-up the location on the subsequent MRI images. The
FSPGR rtMRI acquisition was then initiated on request of the physician and
two perpendicular scan planes were setup containing both the entry and target
point. Once the physician was satisfied with the location of the skin entry point
and scan plane orientation, the needle was inserted under rtMRI guidance. During
rtMRI the physician was able to adjust the pulse sequence (bSSFP, FSPGR, PSIF),
geometry and parameters via the tablet PC or communicate the adjustments to
the scanner operator. The physician terminated rtMRI via the tablet PC once the
needle was positioned in the lesion. A second high-resolution dataset (the same
sequence and parameters as during planning) was then acquired with the needle
still in place to verify the needle position. Note, the imaging pulse sequences and
parameters were optimised for MRI of Thiel soft-embalmed cadavers [67].
An intervention was rated successful if the needle tip was positioned within
the predefined target region and clearly identified on multiple rtMRI planes and in
the high-resolution dataset. In the case of targeting Gd-doped target, visual checks
were additionally conducted to ensure that the desired targeting was achieved. The
root-mean-square (RMS) 3D error was calculated based on the high-resolution
dataset for the discrepancy between the actual needle tip and the target point
position (3D coordinates of the planned target point).
4.2.4 In Vitro Evaluation in Tissue Mimicking Phantoms
The in vitro experiments were conducted in a muscle tissue-mimicking, ballis-
tic gelatine phantom with 10% w/w gelatine powder (G8-500, Fisher Scientific,
Hampton, NH, USA) [180]. A range of targets (∅ 20 mm), mimicking lesions and
consisting of gelatine, agar (A360-500, Fisher Scientific, Hampton, NH, USA), fat
and food colouring (Dr. Oetker, Bielefeld, Germany) for visual confirmation were
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positioned within the gelatine matrix. A layer of boiled spaghetti (Buitoni, Sanse-
polcro, Italy) in gelatine was added to the phantom to mimic blood vessels that
should be avoided during targeting.
Each physician performed ten double (trajectory lengths ranged from 80 - 160
mm) and ten single oblique interventions (trajectory lengths ranged from 100 - 160
mm). The times for needle targeting and the total intervention were recorded.
4.2.5 Ex Vivo Evaluation in Thiel Embalmed Human Ca-
davers
The human cadavers used in this study were donated according to standard proce-
dures as set out in the Human Tissue (Scotland) Act 2006 and the Thiel Advisory
Committee (University of Dundee, UK) has approved all procedures in this study.
Three Thiel soft-embalmed cadavers (sex: 1 female and 2 male, age: 50 - 75 years,
weight: 65 - 80 kg) were prepared in the angio suite (the room on the left side in
Figure 4.1) and then transferred to the MRI suite (Figure 4.3). The peripheral
cannulation and tumour phantom implant was performed through a pre-existing
median laparotomy. Gd-doped targets (agar/fat, ∅ = 25 mm) were implanted to
mimic liver lesions that appear bright in T1-weighted images for targeting. Alter-
natively target choice was predetermined during the procedure planning stages on
a MRI distinctive area within the liver parenchyma (one cadaver). An MRI com-
patible anaesthetic ventilator (ventiPAC, PneuPAC Ltd., Luton, UK) was used
for mechanical ventilation (Inspiration time TI = 2 s, Expiration time TE = 4 s,
and tidal volume VT = 750 ml) with tracheal intubation to simulate hepatic mo-
tion throughout the procedure. The expert and the novice performed four double
oblique interventions (trajectory lengths ranged from 60 - 120 mm) in each human
cadaver.
4.3 Results
The findings of the acceptance testing as well as the in vitro and ex vivo validation
are presented in this section.
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Figure 4.3: Photograph of a Thiel soft-embalmed human cadaver positioned
in front of the MRI scanner. The single loop element with disposable cover was
positioned anterior for easy percutaneous access to the liver while the 4ch 24cm
element of the DuoFlex interventional coil was positioned posterior. The black
strap was used for compression of the chest to improve hepatic access.
4.3.1 Acceptance Testing
According to the standard test method (ASTM F2052-06) [129], a mean deflection
angle (α) of 34◦ was measured for the employed tablet PC and a mean deflection
angle of 29◦ while attached to the custom made holder. Furthermore a mean de-
flection angle of 42◦ was measured for the BT headset and a mean deflection angle
of 6◦ was measured while the BT headset was incorporated in the ear defenders.
This results in a magnetically induced deflection force Fm = 4.90 N for the tablet
device (Fm = 5.59 N for the tablet PC attached to the holder) and Fm = 0.16
N for the BT headset (Fm = 0.24 N for the BT headset incorporated in the ear
defenders). No displacement force was present for the custom made holder itself
or the ear defenders without the BT headset, even if positioned in the bore. No
displacement force was present for the tablet PC at a distance greater or equal to
50 cm (4-10 mT) from the end of the bore.
It was verified that the tablet devices (Figure 4.4) that were used in this
study can be operated with gloves while covered in drape as illustrated in Figure
4.4c. Audio communication via VoIP was possible throughout all interventions
with a stable BT connection. However, during scanner operation the acoustic
noise level was high, which led to imperfect sound quality, which was still rated
suitable for communication. No degraded image quality or RF interference could
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be detected on any MR image, the white pixel, or on the coherent noise test
while the devices were set up in the scan room and the WLAN connection was
established. The WLAN supplied by the modified router provided a stable and
fast connection, facilitating rapid image update rates without noticeable delay for
the rtMRI feed into the scan room. Using the VNC connection provided a feasible
connection with the scanner manufacturers UI but the performing physicians rated
the latency (ranging between 0.2 - 1.3 seconds) between actual image acquisition
and display not acceptable for interventions. On the contrary, the node.js server
showed no noticeable lags or time delays serving the MR images to the clients
(Figure 4.4c). Multiple connections were established (i.e. via multiple browsers
on one PC and across several tablet devices), all able to access and visualise the
data individually as desired, or controlling or monitoring the procedure via the
iMRI-UI as allowed by each user’s login permissions.
4.3.2 In Vitro Studies in Tissue Mimicking Phantoms
All phantom biopsies (n = 40) were technically successful (the needle tip was
positioned within the predefined target region). The mean 3D RMS error between
the planned target point and the needle tip was 2.8 ± 1.0 mm, with further details
given in Table 4.1. The mean targeting time was 5 minutes and 21 seconds and
the mean procedure time was 15 minutes and 46 seconds (range 10 - 19 minutes)
for the expert. The mean targeting time was 6 minutes and 35 seconds and the
mean procedure time was 17 minutes and 31 seconds (range 12 - 22 minutes) for
the novice.
The in-room interactive tablet PCs provided the operator with images in near
real-time and the ability to self-select important parameters or switch between
pulse sequences on the fly (one click on the touch screen and no delay). Parameter
control and slice repositioning from inside the scan room was achieved, facilitating
fast navigation to the puncture target. The close proximity of the touch device
allowed for zooming (Figure 4.4c and d) and precise target acquisition during
simulated interventions. The interventional workflow for a freehand needle biopsy
illustrated in Figure 4.5.
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Table 4.1: Needle Targeting Accuracy
User Total 3D RMS error (mm)
In Vitro - Single Oblique
Expert n = 10 1.5 (± 0.5)
Novice n = 10 2.5 (± 0.6)
In Vitro - Double Oblique
Expert n = 10 2.5 (± 0.8)
Novice n =10 4.0 (± 1.2)
In Vitro - All
All Paths n = 40 2.8 (± 1.0)
Ex Vivo - Double Oblique
Expert n = 12 2.9 (± 0.8)
Novice n = 12 4.1 (± 0.9)
Figure 4.4: Wireless scanner interaction from within the magnet room with
a tablet PC. The multi-touch mobile tablet PCs were mounted on an MRI
compatible intravascular pole (a), whereas, one tablet was used to display the
iMRI-UI while the other tablet was used for communication in combination with
BT headsets. A successful needle puncture in the phantom is demonstrated (b).
The physician (wearing gloves) was also able to zoom into relevant anatomical
areas on the tablet PC. This is illustrated during a needle biopsy in a Thiel
soft-embalmed human cadaver in Figure (c).
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Figure 4.5: Simplified needle biopsy for a single oblique trajectory using the
freehand approach and near real-time MRI guidance (FSPGR, TE/TR = 4.0 /
8.3 ms, Matrix = 256 x 256, FOV = 33 cm x 33 cm, FA = 60◦, Slice thickness
= 7 mm). The target lesion is shown in Figure (a). The needle entry point was
identified (b) by finger pointing and the real-time scan plane was then updated
to contain the skin entry and target point. The needle was then advanced
towards the intended target (c) and the lesion punctured (d).
4.3.3 Ex Vivo Studies in Thiel Embalmed Human Cadav-
ers
All cadaver biopsies (n = 24) were technically successful (needle tip was positioned
within the predefined target region) under simulated free breathing conditions.
The mean RMS 3D error between the planned target point and the needle tip was
2.9 ± 0.8 mm for the expert and 4.1 ± 0.9 mm for the novice, with further details
given in Table 4.1.
The variations between individual cadavers (surgical history, post mortem
training procedures, the shelf time, pre-existing or artificial lesions) were found
to be significant. Detailed recording of procedure times (ranging from 20 - 55
minutes) was abandoned for the Thiel soft-embalmed cadaver experiments due
to the influence of confounding variations and problems, which are not present
in living patients. These included trapped air (green arrow in Figure 4.6e) in the
abdominal cavity, decreased liver dimensions due to dehydration, varying quality of
preserved tissues, and pre-existing damage due to previous training events. Note,
the substantial difference in image quality between Figures 4.6 and 4.7 along with
the absence of air in the cadaver in Figure 4.7.
A screenshot of a successful needle puncture with a double oblique trajectory
is shown in Figure 4.6 and Figure 4.7. The screenshot of the iMRI-UI (Figure
4.6d) contains three near real-time MR images that were frequently updated with
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Figure 4.6: MRI-guided liver biopsy in a Thiel soft-embalmed human cadaver
performed with the freehand technique and under simulated free-breathing con-
ditions. The implanted targets (blue arrows) are shown in the planning images
(a - c) acquired with a diagnostic FSPGR that was optimised for Thiel cadaver
imaging (FSPGR, TE / TR = 1.8 / 70 ms, FA = 60◦, Matrix = 256 x 256, FOV
= 30 cm x 30 cm, Slice thickness = 5 mm, NEX = 2). The planning images in
Figures (a and b represent sagittal images and (c) an axial oblique image. A
deep target was successfully punctured with the biopsy gun during near real-
time MRI in an axial oblique plane (d) and a shallow target was punctured in an
axial plane (e). The orange arrow indicates the needle tip that can be detected
(signal void). Note, targeting was constrained because of trapped air (green ar-
row) in the abdominal cavity of this particular cadaver. Also note, most vessels
and organs (including the liver) in Thiel soft-embalmed cadavers are collapsed
due to the absence of perfusion and tissue dehydration. Additionally, it should
be noted that the cadavers were used in previous training procedures, which
affected usability in particular due to preformed incisions and trapped air.
a T1-weighted pulse sequence in three different slice orientations. The needle was
advanced during continuous MRI with a temporal resolution of 1 frame per sec-
ond. A correct needle placement was then confirmed with a high spatial resolution
dataset (Figure 4.8). Trapped air (green arrow in Figure 4.6e) in the abdominal
cavity of the cadaver, decreased liver dimensions (compared to a liver in a liv-
ing human) and a short needle that was required for the 60 cm bore diameter
constrained the choice of potential needle paths.
4.4 Discussion
A substantial hurdle for MRI-guided percutaneous interventions is the lack of a
dedicated and efficient workflow [19] that is required for effective procedures in the
complex MR environment. In this chapter a wireless system for communication
and interactive remote control of a clinical whole body MRI scanner was therefore
developed and validated to facilitate iMRI. The magnetically induced deflection
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Figure 4.7: Screenshot acquired on the tablet PC during needle placement
with interactive rtMRI guidance (FSPGR, TE / TR = 2.8 / 6.6 ms, FA = 60◦,
Matrix = 256 x 256, FOV = 30 cm x 30 cm, Slice thickness = 8). An axial
oblique plane (left) and a sagittal oblique plane were updated in an interleaved
manner for targeting a predefined and existing target area with double oblique
needle trajectory.
Figure 4.8: Verification of correct needle placements (coronal, axial, sagittal)
in the target (dark) area of the liver a Thiel soft-embalmed cadaver (FSPGR,
TE / TR = 3.1 / 70 ms, FA = 60◦, Matrix = 384 x 224, FOV = 36 cm x 36
cm, Slice thickness = 4 mm, NEX = 4). The blue arrow indicates the needle
(signal void).
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angle was measured to be less than 45◦ for all components, which means the de-
flection force induced by the field of the 1.5 T MRI scanner was less than the force
on the device due to gravity [129]. While these results are a good indication for
MRI safety, the test method for magnetically induced displacement force alone is
not sufficient for ultimately determining the device safety in the MRI environment
and further testing may be required before clinical application [129] and regulatory
approval.
4.4.1 Interventional MRI Workflow
Challenging but important technical tasks during MRI-guided needle interventions
are selecting the correct MRI scan planes and maintaining an appropriate angula-
tion during needle placement [105]. Slice re-alignments typically require significant
intra-procedure communication [19] and time. The close proximity of the touch
screen improved the scanner interaction considerably both during phantom and
cadaver experiments.
To use a VNC connection for remote control of the MRI scanner is attractive
because this connection can give multiple users access to centralised resources, in
this case the MRI scanner host PC, through conventional or consumer devices
[181]. However, the presented results demonstrate that the latency for the imag-
ing feed was unacceptable for iMRI. In comparison to this setup, the standard
commercially available real-time UI that was available on our scanner (i/Drive
Plus, GE Healthcare, Waukesha, WI, USA) provided only limited features and
can only be used with a single pulse sequence (FGRE - RF spoiled or unspoiled)
and one interactive imaging plane at a time. The proposed browser-based iMRI-
UI allowed flexible and intuitive scan plane adjustments in real-time. Different
contrast mechanisms (T1, T2, T2/T1) can interactively be selected on the fly and
also be interleaved. The availability of various contrast mechanisms is in particular
useful where a sequence with only a single contrast weighting may not simulta-
neously generate contrast among tumours, lesions and normal soft tissues, which
compromises lesion assessment and MRI guidance [179].
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In the course of a procedure, the device trajectory, the pulse sequence and scan
parameters could be adjusted dynamically. This decreased needle passage, which
is associated with trauma and bleeding and also results in workflow interruptions
[19, 105]. It should be noted that the three planes were a design choice based on
user feedback and not a capability limitation.
The two interventional radiologists concluded that the described setup resem-
bles a suitable hybrid approach combining the workflow from CT with real-time
needle guidance capability that they are familiar with from ultrasound while MRI
provides superior soft tissue. The proposed image guidance arrangements were
also found satisfactory in terms of decreasing interruptions i.e. caused by moving
clinical staff in and out of the scan room, moving the patient in and out of the bore
as well as scan interruptions for sequence and parameter updates. The established
multi-user communication with a wireless setup that can potentially be produced
at a low cost (the cost of the additional components was approximately US$ 3000),
clearly improved our iMRI workflow compared to previous experiments. This ben-
efit, however, has to be quantified in further studies. Additional acoustic or digital
noise filtering could also enhance the communication [52].
Controlling an MRI scanner and guiding interventional procedures from a web
browser presents many interesting solutions for device integration. The web-based
model allows easy access to data and the experimental controls, whether on a
tablet in the magnet room, a desktop in the control room, or a device potentially
anywhere. This could enable an intuitive and collaborative multi-user approach for
MRI-guided interventions, and facilitate educational demonstrations or collabora-
tive treatment planning. In theory, MRI-guided interventions including thermal
treatments could be assisted, guided and monitored remotely. However, with in-
creasing distance and network traffic, compared to a local network, the latency
between transmitter and receiver would also increase and compromise procedure
safety.
4.4. Discussion 92 Chapter 4. Mobile Technology for iMRI
4.4.2 In Vitro and Ex Vivo Studies
All experiments in this study were performed in a closed bore MRI scanner with
60 cm bore diameter. This limited the selection of individual cadavers and the
choice of needle trajectories and achievable target depth because only short needles
could be used in the narrow bore. A short and wide bore scanner could significantly
improve patient access and device placements [19, 24, 105, 182]. It should be noted
that the proposed scanner control via mobile tablet PCs in combination with auto-
land marking [183] could furthermore facilitate interventions on the other side of
the bore where patients might be more accessible (no patient table mount) but
generally no MRI controls are located (i.e. current wide bore MRI scanners).
Targeting accuracy is essential for image-guided interventions and an in-plane
error of 5 mm is acceptable in most clinical situations according to Rothgang
and colleagues [19]. The 3D RMS error was found to be below this value in the
phantom and the cadaver experiments performed by the expert and novice. Our
targeting accuracy results (Table 4.1) are equivalent to the targeting errors that
have previously been reported (Stattaus et al. [182] - in vivo: 3.4 mm median
lateral deviation, Fischer et al. [131] - 5.2 mm mean in-plane error, Rothgang et
al. [19] - in vitro / in vivo: 1.8 mm / 2.9 mean targeting error in all directions) for
MRI-guided percutaneous interventions employing the freehand technique. The
mean puncture times (novice: 6 minutes and 35 seconds / expert: 5 minutes and 21
seconds) and mean procedure times (novice: 17 minutes and 31 seconds / expert:
15 minutes and 46 seconds) are reasonable in comparison to what previous freehand
liver biopsy studies have reported (Stattaus et al. [182] - in vivo: 19 minutes mean
puncture time, Das et al. [104] - in vivo: 20 - 25 minutes mean intervention time,
Fischbach et al. [25] - in vivo: 18 minutes mean intervention time).
The variation between individual cadavers, i.e. time of death to embalming,
the shelf time (which affects the MRI properties [67]), the surgical history (causing
air trapped within the abdominal and thoracic cavities, displaced and shrunken
liver, lack of blood supply and unusual liver motion), and whether or not pre-
existing (one cadaver) or artificial lesions were employed, influenced procedure
times. Due to the influence of these cadaver specific variations, which are not
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found during clinical procedures, detailed recording of procedure times was not
applied during the Thiel soft-embalmed cadaver experiments. Further experience
with the cadaver model, vascular re-perfusion [61] and adaptation of technique
should solve most of these problems in the future so that the benefit of the real
human anatomy [61] can be fully explored for the development and training of
iMRI procedures.
4.5 Concluding Remarks
MRI has unique potential for guiding percutaneous interventions specifically for
procedures that cannot be performed safely or satisfactorily using other guidance
modalities due to lack of tissue contrast, imaging interference (e.g. ribs or air
filled bowel during ultrasound), vascular imaging [24] or ionising radiation, which
is most relevant e.g. for young patients [59, 119]. The presented components and
techniques can improve the workflow of percutaneous interventions using MRI
guidance by providing interactive, versatile and intuitive MRI acquisition control
at the patient table as well as scanner operator - physician - assistant communi-
cation. Future research should involve acoustic or digital noise filtering for audio
communication, a full MRI safety assessment of all incorporated components, in-
tegration of optimised fast pulse sequences into the web UI and a protocol for
pre-clinical trials (i.e. using large animals). It should be noted that the methods
presented in this chapter were designed for percutaneous needle interventions but
can be translated with limited effort to other MRI-guided applications. A final
word of caution is warranted in reproducing the described setup and each solution
and component should be tested individually on site and approved by the local
MRI safety authorities.
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Wireless Tracking of
Interventional Devices
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5.1 Introduction
During iMRI, operator/physician interaction is required for acquiring and display-
ing images according to the position and orientation of the interventional device.
This is particularly important for endovascular procedures, where blood flow and
respiratory motion are present during device manipulation. Interactions with the
MRI system, in terms of device localisation and change of acquisition parameters,
are challenging [157] in comparison to conventional X-Ray guided procedures and
represent a major hurdle for an efficient workflow [19, 184].
Safe, reliable, and easy to use tracking and visualisation of moving devices
are key elements for successful clinical implementation of iMRI [6]. Over the past
decades, several device visualisation and tracking methods have been developed
for iMRI as outlined in Section 2.4.5. This chapter presents an application of MR-
tracking, based on the well-known method introduced by Dumoulin and colleagues
[146], which was dramatically improved in his publication in 2010 [185] in which
phase-field dithering was added to the tracking pulse sequence. Phase-dithering
removed issues encountered when working with situations where signal dephasing
occurs due to pulsatile flow, issues resulting from the proximity of imaging coils
(i.e. B1 effects), as well as due to complex susceptibility artefacts.
In contrast to the aforementioned MR-tracking sequence by Dumoulin et al.,
this tracking implementation was applied to wRCs that inductively couple [145] to
the surface receiver coils of an MRI system (see Section 2.4.5.3). Device tracking
based on wRCs presents a promising solution for iMRI because no electrically
conductive connection between the device tip and the MRI scanner is required.
This avoids the risk of RF induced tissue heating [31, 33, 35, 186] and reduces
system complexity in terms of engineering and procedure workflow. This MR
tip-tracking sequence was also interleaved with various fast, user-selectable pulse
sequences that generated different contrast mechanisms with potentially different
temporal resolutions. Each imaging sequence received a frequent geometry update
from the tracking kernel. The coil position was also mapped to a pre-acquired 3D
angiographic roadmap.
This work serves as a feasibility study of wireless device tracking to be used
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during iMRI and was demonstrated on a clinical 1.5 T MRI scanner by means
of arterial flow phantom and Thiel soft-embalmed human cadaver [62, 67, 169]
experiments.
5.2 Theory
As described in Section 2.4.5.3, wRCs are based on the principle of electromag-
netic induction, where an electric circuit is tuned to resonate at the proton Lar-
mor frequency (f0) of the imaging system according to Equation 2.19. It has been
proposed [145, 187] to use a small object containing a solution with very short
T1 within the coil of the wRC to enhance the signal amplification effect. How-
ever, this is not applicable for the described purposes, as endovascular procedures
are performed according to Seldinger [122], whereby catheters are placed over a
guidewire, and essentially no MR signal-carrying lumen can be used to contribute
to the signal amplification.
Weiss et al. [188] suggested using low FA RF excitation pulses and projection
readouts to localise a wRC during iMRI. This concept was adopted and integrated
into a dedicated non-imaging MR pulse sequence proposed by Dumoulin and col-
leagues [185]. This pulse sequence had been originally developed for improved
active catheter tracking in low SNR conditions and for active tracking of micro
coils that were inductively coupled to the receive coil.
The proposed tracking pulse sequence (Figure 5.1) employs non spatially-
selective or weakly spatially-selective RF excitation pulses with very low FA. MR
signal is detected in the presence of a frequency-encoding gradient applied along
all three axes (Gx, Gy, Gz) while intentionally no phase-encoding gradient pulse is
present. This 1D projection sequence is repeated four times while the gradient
polarities are alternated in a Hadamard modulated readout (HR) scheme [146]
to compensate for off-resonance effects. The position (X,Y,Z) of the wRC with
respect to the applied magnetic field gradient pulse is determined by FFT (see
Section 2.2.4) and is computed according to Equation 5.1 by finding the peak
position (Pi) for each of the four excitations as previously described by Dumoulin
and colleagues [146].
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X = −P1 + P2 + P3 − P4
Y = −P1 + P2 − P3 + P4
Z = −P1 − P2 + P3 + P4
(5.1)
Phase-dithering is employed to improve the peak-to-noise ratio (PNR), simi-
lar to the method that has been described in [185]. Therefore, additional dephas-
ing magnetic field gradient pulses (illustrated as (A) in Figure 5.1a) are applied
orthogonal to the subsequent frequency encoding gradient pulses to suppress back-
ground signals while preserving the intensified signal around the wRC. A magnetic
field gradient applied perpendicular to the frequency encoding direction causes de-
phasing of the tissue signal and leads to a reduction of overall background signal.
Ideally, a one-cycle (2pi radians) dephasing gradient is applied across the excited
slab, resulting in complete background cancellation [189, 190]. The same dephas-
ing gradient does not affect the signal of the wRC significantly, because the coil
is relatively small (less than 15 mm) compared to the excited background tissue
slab [190], thus the enhanced signal caused by the wRC is preserved.
The direction and amplitude of an efficient dephasing gradient is highly de-
pendent [185] on the object within the FOV and the orientation of the wRC in
regards to the RF transmission coil. To avoid imperfect dephasing, a series of
readouts with N different dephasing gradient directions is acquired. The can-
didate with the highest PNR for each HR is then selected automatically. The
dephasing gradient direction (Figure 5.1b) is chosen to be always in a plane (P )
that is perpendicular to the direction of the frequency encoding gradient pulse.
An arbitrary choice has to be made for the first direction [185] because an infinite
number of orthogonal directions exist. The dephasing gradient is then rotated by
2pi/N for each sequential acquisition [185]. This implementation requires N x 4
repetitions to compute the most accurate position of the wRC. Spoiling gradients
are applied at the end of each repetition to dephase the magnetization, and thus
(for low FA excitations) reduce phase coherences.
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Figure 5.1: Pulse Sequence diagram for detecting the position of the wRC -
(a) A weakly selective RF excitation pulse with very low FA excites all spins
within the active slab. The spins in the close vicinity of the wRC experience
an amplified FA because a current is induced within the coil of the wRC. The
frequency encoding gradient pulse (B) is multiplexed with a Hadamard scheme
as described by Dumoulin et al. [146]. Before the frequency encoding read-
out a phase-field dithering (A) is applied [185]. The direction of the dephasing
gradient (A) is chosen to be in a plane P perpendicular to the direction of the
frequency encoding gradient pulse (B) as indicated in (b). An arbitrary choice
is made for the first direction and the gradient direction is then rotated in the
plane P by 2pi/N for the next repetition. This tracking scheme requires N rep-
etitions for the different dephasing directions multiplied by the four different
Hadamard multiplexed frequency encoding gradient pulse directions. The po-
larity [Gx, Gy, Gz] of the gradient (B) for the four readouts is B1 = [+,+,+],
B2 = [−,−,+], B3 = [−,+,−], B4 = [+,−,+].
5.3 Materials and Methods
This section describes the implementation of the MR-tracking and the imaging
pulse sequences in detail. In addition, the iMRI, the phantom and cadaver setup
and protocols are outlined.
5.3.1 Tracking Pulse Sequence
The tracking pulse sequence diagram is shown in Figure 5.1. The HR scheme pro-
vides three dimensions of positional information within four excitations. Therefore,
this tracking implementation requires four times the number of different dephasing
gradient directions (N x 4 x TR) to compute the most accurate position of the
wRC.
It should be noted, that ideally the coil of the wRC should have had all
dimensions matching the readout resolution. This would have resulted in a very
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sharp peak in the presence of magnetic field gradients and hence spatially very
accurate tracking results. However, for the described (non-ideal) wRC designs
(see Figure 3.3 and Section 3.4.0.4) it was essential to use the centre of mass for
the peak detection algorithm and not the maximum signal intensity value, as the
broad peak represents a relatively large area of spins with amplified FA in close
vicinity of the wRC.
The tracking sequence was implemented with standard multiple receiver imag-
ing coils and no limitation of receiver channels. Therefore, the PNR was taken
into account for each coil element. The coil element with the highest PNR (for
a given phase-field dithering direction) was selected because this represents the
coil element that inductively couples best to the wRC. The catheter tip position
was then computed in the MRI coordinate system after a gradient warp correction
for gradient non-linearities. The tracking pulse sequence parameters were used
as follows: TE/TR = 1.52/2.18 ms, FA = 0.3◦, FOV = 48 cm along the readout
direction, Isotropic tracking resolution = 1.8 mm, Slice thickness = 300 mm.
5.3.2 Interleaved Imaging Pulse Sequences
The tracking sequence was interleaved with one or more user-selectable rapid imag-
ing sequences in a closed loop manner. This is illustrated in Figure 5.2. Generally
the tracking pulse sequence can be interleaved with any imaging pulse sequence
that accepts a position update from the tracking sequence and does not inter-
fere with its low FA excitation. For instance, remaining magnetisation has to
be eliminated before a subsequent tracking cycle. The position of the tip of the
interventional device was detected by the tracking sequence and then used to au-
tomatically adjust the scan plane of the following imaging slice. Spoiling gradients
were applied at the end of the imaging sequence to dephase the magnetisation, and
thus reduce phase coherences before a subsequent low FA excitation was employed
in the tracking sequence.
Three different imaging sequences were implemented that received a scan
plane update from the tracking sequence. First, a bSSFP sequence using a Carte-
sian k-space data acquisition scheme and generating T2/T1 contrast [95, 96] was
5.3. Materials and Methods 101 Chapter 5. Device Tracking
Figure 5.2: The block diagram of the interleaved tracking and imaging pulse
sequence with automated scan plane updates. The wRC position is determined
by the tracking kernel, which then automatically emits a coordinate update.
The imaging sequence receives this new coordinate and geometry update and
is executed after a steady state stabilisation interval. The imaging sequence
can be repeated for a number of user selected exclusive runs before it receives a
new coordinate update. Finally, spoiling gradients are applied to reduce phase
coherences before a subsequent low FA excitation.
Table 5.1: MRI pulse sequences and parameters for the tracking study
Parameter
Diagnostic MRI Interactive rtMRI
2D SPGR TOF bSSFP FSPGR spGRE
TE / TR [ms] 2.3 / 18.0 2.5 / 5.0 2.8 / 5.6 3.5 / 20.4
FOV [cm x cm] 20 x 20 30 x 30 30 x 30 24 x 24
Matrix / Resolution 256 x 256 320 x 192 256 x 128 0.9 mm
FA [◦] 30 70 30 70
Slice thickness [mm] 2 / 20% gap 7 7 8
realised. Second, a FSPGR sequence with Cartesian k-space acquisition scheme
generating high spatial resolution and T1 contrast [191] was integrated. Third,
a GRE-based sequence with spiral k-space data acquisition scheme (spGRE) was
designed to achieve a high temporal resolution. Therefore, five 10.65 ms spiral
readouts were used to cover k-space for a FOV of 24 cm to achieve an in-plane res-
olution of 0.9 mm and a temporal resolution of 10 frames per second (fps) for the
spGRE sequence. The operator was able to select each imaging sequence through
the control console on the fly. All imaging parameters for the tracking study are
summarised in Table 5.1.
Figure 5.2 illustrates how each imaging sequence received a coordinate and
geometry update and was executed after a steady state stabilisation interval. As
previously proposed [192], a non-linear ramp-up with eight consecutive RF pulses
(β = 3) was used to transfer the initial longitudinal magnetisation toward its
steady state prior to bSSFP data acquisition. Alternatively, a stabilisation in-
terval (similar to what has been described in Figure 2.12) employing 40 dummy
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repetitions [193] was used prior to FSPGR data acquisition. The catheter tip po-
sition was also used in a previously acquired static 3D MRA roadmap for catheter
guidance. As proof of principle a bright blood ToF [194] sequence (2D SPGR
ToF) was integrated into the iMRI interface producing a 2D stack of non-contrast
enhanced MRA (nonCE-MRA) images.
5.3.3 Real-Time MRI Implementation
All experiments in this study were performed in the iMRI suite at IMSaT, which
was described in Section 3.2.2, and with the modifications that were outlined in
Section 4.2 (except the browser-based iMRI UI that was designed for percutaneous
interventions). All MRI experiments were conducted in the 1.5 T MRI scanner
(Signa HDx, Software Release 15.0M4A, GE Healthcare, Waukesha, WI, USA)
with the DuoFlex coil prototype (see Section 3.2.2) consisting of a single loop
element with disposable cover (posterior) and a 4ch 24 cm element (anterior).
All pulse sequences were designed in a graphical pulse sequence environment
(SpinBench, Version 1.3.2, HeartVista, Inc., Palo Alto, CA, USA) and imple-
mented in RTHawk [45] (RTHawk, Version 0.9.28, HeartVista, Inc., Palo Alto,
CA, USA), running on the external workstation. A real-time visualisation appli-
cation [57] (Vurtigo, Version 2-1b, Sunnybrook Health Sciences Centre, Toronto,
Canada) embedded in RTHawk, was used to render the tip position, the cur-
rent scan plane, and optionally a 3D MRA dataset. This allowed the operating
physician to view the real-time catheter tip position connected to the rtMRI scan
plane and also to monitor the catheter movement overlaid to a MIP of the nonCE-
MRA dataset. The performance of the tracking kernel for reliable detection of the
catheter was optimised and evaluated by moving a straight catheter (S1 - Table
3.1) through the imaging volume along known reference points.
5.3.4 In Vitro Experiments in Perfused Arterial Phantoms
In vitro experiments (20 repetitions) were conducted by two experienced interven-
tional radiologists in an arterial vessel phantom consisting of an above the knee
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lower extremities (LE), an abdominal and a thoracic module (L-F-S-Left-003, A-S-
N-001, T-R-N-020, Elastrat, Geneva, Switzerland). The phantom was connected
to a modified heart lung machine (HL-30, Maquet, Rastatt, Germany) and per-
fused with 0.9% saline solution to mimic the electrical and relaxation properties of
blood (T1 ≈ 1150 ms, T2 ≈ 130 ms at 1.5 T and 20 ◦C). The pump was positioned
outside the scan room and set to a flow rate of 4.8 L/min, a heart rate of 85 beats
per minute and a systolic/diastolic pressure of approximately 130 / 70 mmHg.
The containers of the vessel phantom were backfilled with a 10% gelatinous
solution to mimic muscle tissue (T1 ≈ 846 ms, T2 ≈ 51 ms at 1.5 T and 20 ◦C).
Vascular access was established with a 12-F introducer sheath (Check-Flo, Cook
Inc., Bloomington, IN, US) in the right femoral LE. A straight (S1 - Table 3.1) and
a balloon catheter (B1 - Table 3.1) were inserted over a 0.035” MRI-safe polymer
guidewire (Section 3.2.1.1). The balloon catheter was inflated with a 1:100 Gd-
DOTA (Dotarem; Guerbet, RoissyCDG Cedex, France) doped solution to allow
positioning verification and to monitor the dilatation process.
Figure 5.3: Balloon angioplasty performed in a clinical whole body 1.5 T MRI
scanner (Signa HDx, GE Healthcare, Waukesha, WI, USA). The catheter was
manipulated in front of the bore while the catheter was tracked and the scan
plane updated and displayed accordingly. The pictures were taken from three
wireless IP cameras (M1031W, Axis, Lund, Sweden) that were installed in the
scan room. All three images were acquired at the same point in time on (a) the
left camera, (b) the right camera and (c) the camera behind the bore with a
10x zoom lens. The interventional radiologist was able to monitor the procedure
on a 40” in-room monitor NEC (Multeos 401, NEC Corporation, Tokyo, Japan)
and adjust the scan acquisition on demand or with a wireless input device as
described in Chapter 4 (not shown on the photographs).
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5.3.5 Ex Vivo Experiments in Thiel Embalmed Human
Cadavers
The human cadavers used in this study were donated according to standard proce-
dures as set out in the Human Tissue (Scotland) Anatomy Act 2006, and the Thiel
Advisory Committee (University of Dundee, UK) has approved all procedures in
this study involving human cadavers. Three Thiel soft-embalmed cadavers (sex:
2 male and 1 female, age: 50 - 70 years, weight: 65 - 80 kg) were prepared in the
angio-suite and then each cadaver was transferred to the MRI for the experiments
(the setup is illustrated in Figure 3.4). Vascular access was established with a
12-F introducer sheath (Check-Flo, Cook Inc., Bloomington, IN, US) in the left
femoral artery. The femoral artery was then flushed with 0.9% saline solution to
mimic the electrical properties of blood.
Two experienced interventional radiologists evaluated the proposed methods
by navigating the straight catheter over the MRI-safe guidewire into the femoral
artery. No 3D roadmap was acquired for the cadaver experiments due to the
absence of perfusion (at the time of experiments, venous return was not be estab-
lished in the Thiel cadaver model and extravasation permitted perfusion of longer
vascular segments).
5.4 Results
All catheters with wRCs remained functional throughout the flow phantom and
cadaver experiments. The wRCs resulted in an increase in mechanical stiffness
and an outer diameter of 2.4 mm (7-F) of both catheters. This prohibited their
use in vessels with an inner diameter of 3 mm or less.
5.4.1 In Vitro Evaluation in Perfused Arterial Phantoms
Figure 5.4 illustrates the signal after FFT for four different receive coil channels.
Each coil element was receiving MR signals during a tracking cycle with phase-field
dithering (N = 3) while the straight catheter was navigated through the phantom.
The coil element with the highest PNR averaged over the 4 HR is plotted in Figure
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5.5 (same phase-field dithering cycle as in Figure 5.4), which was automatically
selected by the peak detection algorithm. Without phase-field dithering, catheter
positions were not adequately resolved due to high background noise.
Figure 5.4: Signal plots post fast Fourier transform (FFT) while each of
the four plus one different coil channels were receiving MR-tracking signals
during a tracking cycle with phase-field dithering (N = 3). The catheter coil
peaks in the four Hadamard modulated readouts (HR) can be distinguished
from the background noise for each coil element. The catheter position was
computed from the coil element with the highest peak-to-noise ratio (PNR)
averaged over the 4 HR. This coil element is displayed separately in Figure
5.5. The pulse sequence then emitted a new geometry if the PNR was above a
user-defined threshold. The PNR was found to exceed a value of 15 along all
readout directions (data not shown) during catheter navigation in the perfused
phantom.
Figure 5.5: MR-tracking signals post fast Fourier transformation (FFT) from
a phase-field dithering cycle (N = 3) using the 5-French straight catheter in the
perfused arterial phantom. The plot displays the coil element with the highest
peak-to-noise ratio (PNR) averaged over the 4 Hadamard modulated readouts
(HR). The catheter coil peaks / locations in the four HR can be distinguished
from the background noise. Note, if the wRC and the MR environment were
ideal, each HR would have shown a single narrow peak.
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An area with enhanced FA was clearly visible at the tip of the catheter,
once the wRC was located in the imaging slice, after a coordinate update (Figure
5.7a and b). The tracking kernel provided up to 38 catheter position updates
per second. The tracking sequence delivered very low SAR compared to standard
imaging pulse sequences because of the low FA excitation.
Distance errors were measured as the difference between the tracking position
and the centre of gravity of the catheter tip (Xc, Yc, Zc) as displayed in Figure 5.6a.
The centre of gravity is depicted as sphere in Figure 5.6a. All tracking points were
found to be inside the area of enhanced signal resulting from the wRC on the
catheter tip. The statistical summary for the distance error is displayed in Figure
5.6b. The volume root mean square (RMS) distance error was 2.81 mm, the mean
distance error in 3D was 2.49 mm and the standard deviation was 1.31 mm.
Figure 5.6: Distance errors (mm) represented as a frequency histogram - The
error (E) represents the distance between the tracking position and the centre
of gravity of the wRC on the catheter (Xc, Yc, Zc). The centre of gravity is
indicated as red sphere in (a). The green points in (a) show the tracking point
history (n = 1000) for one fixed catheter position in the vessel phantom. The
statistical summary for the distance error is displayed in (b). As demonstrated
in the graph, all points were found to be inside the area with enhanced signal
intensity caused by the wRC on the catheter tip
Two interventional radiologists concluded that both catheters could be steered
through the target vasculature with adequate visualisation of the catheter tip in
addition to the surrounding anatomy (Figure 5.7). The small FA of the tracking
excitation followed by spoiling and a steady state preparation interval did not
noticeably affect the quality of the rtMRI images. The imaging pulse sequences
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received a frequent geometry update from the tracking kernel and the coil position
was also mapped to a pre-acquired 3D roadmap. Figure 5.7 illustrates the ability to
switch between different sequences during a procedure with each sequence tailored
to the particular task at hand. The tracking position was stable while navigating
through the femoral artery, iliac artery (Figure 5.7b) and the aorta. The position
remained adequate during balloon inflation in the right iliac artery (Figure 5.7c).
The operator was able to switch back and forth between different pulse sequences
(one mouse click, no time delay) while each sequence was receiving an adequate
coordinate update.
Figure 5.7: MRI-guided balloon angioplasty of the right iliac artery in the
perfused arterial phantom. The rtMRI sequence received a tracking update
from the tracking pulse sequence and the pulse sequence and parameters were
switched on the fly over the user interface - bright blood imaging (a) with
bSSFP (TE/TR = 2.5/5.0 ms, FA = 70◦, FOV = 30 cm, Matrix 256 x 256, Slice
thickness = 2.5 mm). The straight catheter (wRC is illustrated as arrow) was
advanced (b) while the FA is reduced in the bSSFP to FA = 30◦. The catheter
was then exchanged with a balloon (wRC is illustrated as arrow) catheter and
inflated (c) with a 1:100 Gadolinium doped solution and once the catheter
was in position, a balloon inflation (arrowhead) was performed using FSPGR
imaging (TE/TR = 2.8/7.0 ms, FA = 70◦, FOV = 30 cm, Matrix 256 x 256,
Slice thickness = 7 mm).
A 2D spGRE plane was fused to a 3D nonCE-MRA roadmap (Figure 5.8a).
Then a catheter was inserted and advanced while the imaging plane was continu-
ously re-aligned to the updated tracking position of the catheter (Figure 5.8b). A
2D view of a FSPGR sequence while the slice was updated to the current catheter
position (red sphere pointed out by arrow) is demonstrated in Figure 5.8c. The
catheter position was also mapped to the roadmap (Figure 5.8b) according to the
preference of the physician and was optionally used to realign the scan plane to
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the current catheter position. Figures 5.8d and e demonstrate how the catheter
was moved inside the 3D roadmap while the 2D spGRE scan plane (arrowhead)
was automatically realigned to the current catheter position (red sphere pointed
out by arrow).
Figure 5.8: Wireless device tracking in 2D and 3D. Figure (a) A (2D) spGRE
plane was fused to a short section of a previously acquired maximum intensity
projection (MIP) of a non-contrast-enhanced MR 3D angiogram while no device
was present. Note the image, obtained with the spGRE (TE / TR = 3.5 / 20.4
ms, FA = 30◦, FOV = 24 cm, 5 interleaves, Slice thickness = 8 mm) and a
frame rate of 10 images per second, shows a black area right before the aortic
bifurcation due to the present turbulence. The catheter was inserted and the
tracking position was rendered to the dataset. Then the imaging plane (b) was
automatically re-aligned based on the tracking position of the wRC (red sphere
pointed out by arrow). According to the preference of the interventional radi-
ologist, the tracking position of the wRC was rendered to a previously acquired
MIP of a non-contrast-enhanced MR angiogram (3D) while the scan 2D plane
was not updated (c). Images (d - e) demonstrate how the catheter was moved
inside the roadmap while the 2D spGRE (TE / TR = 3.5 / 20.4 ms, FA = 7◦,
FOV = 24 cm, 5 interleaves, Slice thickness = 8 mm) scan plane (arrowhead)
was automatically realigned to the current catheter position.
5.4.2 Ex Vivo Evaluation in Thiel Embalmed Human Ca-
davers
During ex vivo experiments, two interventional radiologists successfully inserted
and navigated the straight catheter (5-F) through the femoral artery of three
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Thiel soft embalmed cadavers. Figure 5.9 illustrates the signal after FFT for four
different receive coil channels, similar to what was described for the phantom ex-
periments. Each coil element was receiving MR-tracking signals during a tracking
cycle with phase-field dithering (N = 3). The PNR was calculated for each HR
and is displayed in Figure 5.9 above each peak. During catheter navigation and
continuous movement the PNR was found to exceed a value of 10 along all readout
directions (data not shown). The sequence parameters required optimisation for
the Thiel embalmed human cadaver. Hence, a FA of 1.5◦ and smoothing of the
curve were applied to improve the PNR.
Figure 5.9: MR-tracking signals post fast Fourier transformation (FFT) from
a phase-field dithering cycle (N = 3) while the 5-French straight catheter was
positioned in the femoral artery of a Thiel soft-embalmed human cadaver. The
plot displays the coil element with the highest peak-to-noise ratio (PNR) aver-
aged over the 4 Hadamard modulated readouts (HR). The catheter coil peaks /
locations in the four HR can be distinguished from the background noise. Note,
smoothing of the curve and a FA of 1.5◦ were applied to improve the PNR for
the tracking pulse sequence for the cadaver experiments.
During catheter navigation an area with enhanced FA was clearly visible
(Figure 5.10) at the tip of the catheter after a coordinate update was received and
executed. Figure 5.10 illustrates interactive switching between different pulse se-
quences during the catheterisation of the femoral artery of a Thiel soft embalmed
cadaver. This was enabled on request of the operating physician, depending on
his preference of high spatial or temporal resolution. Figure 5.10e illustrates the
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tracking positions that were found for 1000 repetitions of the tracking pulse se-
quence with phase-field dithering (N = 3) while the catheter was maintained in
the same position.
Figure 5.10: MRI-guided catheter navigation in the left femoral artery of a
Thiel soft embalmed human cadaver. The arrow indicates the wRC that ap-
pears very bright compared to the background tissue. An axial FGRE (TE/TR
= 5/11.8 ms, FA = 20◦, FOV = 21 cm, Matrix 256 x 256, Slice thickness =
5 mm) localiser slice (a) that contains the wRC is displayed. The rtMRI se-
quence received a tracking update from the tracking pulse sequence and the
pulse sequence and parameters were switched on the fly with the user interface.
Images obtained with (b) a FSPGR sequence (TE/TR = 2.8/7.0 ms, FA =
70◦, FOV = 25 cm, Matrix 256 x 256, Slice thickness = 7 mm), (c) a bSSFP
sequence (TE/TR = 2.5/5.0 ms, FA = 70◦, FOV = 30 cm, Matrix 256 x 256,
Slice thickness = 2.5 mm) and (d) a spGRE sequence (TE / TR = 3.5 / 20.4
ms, FA = 30◦, FOV = 24 cm, 16 interleaves, Slice thickness = 8 mm). On the
right (e) the history of 1000 tracking points (arrowhead) for a fixed catheter
position was overlaid on a magnitude image of the cadaver.
5.5 Discussion
A wireless tracking sequence employing phase-field dithering and projection re-
construction was developed and interleaved with various user-selectable fast pulse
sequences to facilitate cardiovascular interventions in clinical whole body MRI
scanners. RTHawk is a flexible research real time MRI software framework [45]
and allows generating new pulse sequences and dynamically changing major as-
pects of data acquisition such as gradient waveforms, excitations and scan planes
on the fly. A dedicated real-time visualization application for guiding interven-
tions called Vurtigo [57], developed at the Sunnybrook Health Sciences Centre and
embedded in RTHawk, was used to render the tip tracking position, the current
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scan plane, and optionally a 3D MRA dataset. The proposed tracking and imag-
ing methods do not require hardware modifications of the MRI scanner setup and
address the key issue of robust MR tracking.
On the other hand, active tracking based on physically connected micro coils
mounted at catheter distal ends has widely been used [34, 103, 146, 185, 195] and
provides an excellent, reliable and very robust form of MR tracking. However,
these micro receive coils of the catheter have to be connected to the MRI system
in a similar fashion as imaging coils. This constitutes significant design challenges
[149], potential cable loops [196] and the risk of instrument heating [31–33] leading
to increased cost of producing these catheters (see also Section 2.4.5.2). The
proposed technique is based on small resonant circuits that inductively couple to
the MRI transmit and receive coils and does not utilise long electrical conductors
[75] and did not show significant heating (less than 0.6◦C) during RF induced
heating experiments, which were described in Section 3.3.1.2.
Phase-dithering, similar as described by Dumoulin et al. for active tracking
[185], has significantly improved the tracking accuracy and the peaks in the MR
tracking were adequately resolved. The accuracy of the proposed tracking method
was found to be similar to methods that were proposed for active catheter tracking
and cited an overall accuracy in the range of +/- 2 - 4 mm [195, 197, 198]. Similarly,
the time that was required for a positional update was approximately 26 ms, which
is comparable to active tracking methods ranging between 20 ms [185] and 24 ms
[34]. Further improvement for this tracking pulse sequence is possible by averaging
over multiple tracking cycles, at the expense of increased scanning time. The
results of the phantom and cadaver experiments successfully demonstrate that
fast and reliable detection of wRCs is feasible and may successfully be employed
for iMRI applications. The PNR of the cadaver experiments (Figure 5.9) was
lower compared to the idealised phantom experiments (Figure 5.5). However, MR
imaging of Thiel soft-embalmed cadavers is constrained [67] and constitutes the
worst case as living organisms provide better RF penetration [67] and it is foreseen
that imaging and tracking will improve in animal and patient studies.
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Additionally, it would be desirable for complex catheter shapes and challeng-
ing vascular navigation to obtain more than one tracking position on catheters
to determine the tip orientation in particular where the tip can fold on itself (i.e.
create a loop of the shaft near the tip), which cannot be detected with a single coil.
Therefore, it was proposed to use multiple independent micro receive coils for ac-
tive catheter tracking [34, 57, 146]. In the presented implementation, if more than
one wRC is used, multiple signals would couple to the receive coils resulting in
multiple peaks per projection readout. These peaks would correspond to a range
of possible 3D position candidates after computation of the Hadamard encoded
readouts. To overcome this problem, an algorithm for fast 3D localisation of sev-
eral wRCs has been proposed [187] and applied in prostate biopsies (using three
wRCs containing a MR signal-carrying lumen each). This method [187] could po-
tentially also be adapted for MR tracking of multiple wRCs on catheters (SW1 -
Table 3.1) employing phase-field dithering, which has to be investigated in further
studies.
Another interesting approach to address this problem is to combine a single
wRC on the tip of the catheter and passive susceptibility markers along the shaft
(SW2 or M1 - Table 3.1). These catheters could also be used with this tip tracking
implementation (no modifications required) while the wRC on the tip is used for
position tracking (and scan plane updates) and the passive markers for catheter
shaft visualisation.
The presented implementations offer reliable catheter tip localisation and scan
position updates in combination with the ability to switch between high- and low-
resolution as well as different contrast mechanisms. Despite the fact that the re-
sults with bSSFP or FSPGR imaging were obtained with approximately one fps,
higher frame rates could easily be achieved by utilizing parallel imaging [39, 40]
or other acceleration techniques while not affecting the tracking robustness. The
presented spGRE achieved frame rates up to ten fps and was found useful for
imaging of dynamic processes e.g. for blood flow proximal and distal to an oc-
cluded vessel pre and post treatment. Higher frame rates utilizing spGRE may be
possible; however this would compromise image quality. While the 2D display was
5.6. Concluding Remarks 113 Chapter 5. Device Tracking
the preferred guidance method, the operating interventional radiologists rated the
real-time tip tracking position displayed in the 3D roadmap very useful, particu-
larly during the initial steps of an intervention. This was also preferred when exact
positioning under rtMRI guidance was not essential or in anatomical structures
with complex vasculature that could not be imaged within a single 2D plane. The
tracking position displayed in the roadmap can be particularly useful when low
SAR exposure is a key requirement.
In this study, two different (straight/balloon) catheters were used to demon-
strate fast sequence and device interchange ability during a procedure. However,
a major hurdle to clinical evaluation is the integration of wRCs with a sufficient
quality factor into the catheter design [164, 167, 199]. Ideally, the coil design (see
Figure 3.3a) should have had all dimensions matching the readout resolution but
with current manufacturing technologies, we were not able to achieve a sufficient
Q for the given catheter dimensions. Alternatively, a higher Q could have been
achieved by increasing the diameter of the copper wire. However, this was dis-
carded because a larger outer diameter would necessitate arterial access of a larger
caliber and limits the use to interventions in larger vessels only. As already dis-
cussed in Section 3.4.0.4, the stiffness and increased outer diameter is a temporary
problem of manually wound wRCs and recently micro systems based technolo-
gies for production of wRCs have been validated [164, 200, 201]. In the future,
these optimised and miniaturised wRCs, will enhance the tracking accuracy and
alleviate negative catheter changes (e.g. increased diameter, stiffness and glide).
However, these manufacturing technologies have to be evaluated to understand if
sufficient quality factors [164, 167, 199] can be achieved for MR-tracking.
5.6 Concluding Remarks
A feasible concept for fast and robust wireless device tracking was presented that
is not limited to catheters and can in principle be used on any device (e.g. a
guidewire or cannula) with a wRC. The wireless tracking can be combined with
various pulse sequences and does not require any changes to the MRI scanner
hardware. This implementation reduces complexity, minimises user interaction
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with the MRI system and provides the interventional radiologist with a flexible
and intuitive tool to perform interventions under rtMRI guidance. Future research
should aim to fully integrate wRCs into the device material and to enable tracking
of multiple catheter positions, which is a requirement for complex endovascular
navigation. Alternatively, the concept from Chapter 3 could be augmented and one
wRC could be used for catheter tip tracking and passive markers for visualisation
of the catheter profile.
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Chapter 6
Applications to Specific
Interventions: Pre-clinical Iliac
Angioplasty
Major parts of this chapter have been submitted for publication as:
M. A. Rube, F. Fernandez-Guttierez, B. F. Cox, J. G. Houston, R. D. White, H. McLeod,
M. Fatahi, A. Melzer, ”Preclinical Feasibility of a Technology Framework for MRI-guided Iliac
Angioplasty”, Int J Comput Assist Radiol Surg [in press].
Experimental contributions:
(i) B. F. Cox prepared the phantoms and the flow pump. (ii) F. Fernandez-Guttierez provided the
interventional workflow design and recorded all procedure times. (iii) B. F. Cox, R. D. White, and
J. G. Houston performed the clinical part (intervention) during the phantom experiments. (iv)
M. Fatahi and H. McLeod assisted during the experiments (i.e. as study nurse). (v) A. Theissen
assisted with the ethical approval and also prepared and supervised the animal experiments. (vi)
A. Melzer and S. Zangos prepared the ethical approval and performed the interventions during
the animal experiments.
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6.1 Rational for Cardiovascular iMRI
Cardiovascular applications of iMRI have substantial clinical potential but face a
number of challenges before clinical routine implementation [120]. As outlined in
Chapter 1 (page 3) there are still several tasks that have not been fully addressed
in the past: Real-time guidance; interactive MRI remote control; in-room com-
munication; safe, robust and versatile device visualisation and tracking as well as
workflow optimisation and training. As a consequence, MRI has not gained an
important role for guiding interventions with broad clinical acceptance [59] and is
primarily limited to research centres [19].
The objective of this chapter was to validate an improved framework of tech-
nologies to address these obstacles and to validate safe, fast and efficient solely
MRI-guided angioplasty of the iliac arteries in vitro (perfused vascular phantom)
and in vivo (porcine model).
6.2 Materials and Methods
This section describes the materials and methods for this angioplasty study and
includes many cross-references to related content described elsewhere in this thesis
as the devices and the technologies have been introduced in the preceding chapters.
6.2.1 Interventional Devices
The devices for this study were selected according to MRI compatibility and were
modified or developed in-house as described in Chapter 3. Passive markers (SPIO
nPs) were employed for guidewire visualisation (see Section 3.2.1.1) and wRCs
were used for catheter visualisation (see Section 3.2.1.2).
6.2.1.1 Guidewires
For X-Ray-guided interventions, commercially available 0.035” guidewires (Stan-
dard Glidewire, Terumo, Somerset, NJ, USA) were used. For MRI-guided inter-
ventions, MRI-safe guidewires were used with SPIO nPs markers incorporated into
the tip material, as described in Section 3.2.1.1.
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Figure 6.1: Multi-modality setup at IMSaT including modifications for rtMRI
image display, in-room MRI remote control, communication and the heart-lung
machine (HL-30, Maquet, Rastatt, Germany) for vascular perfusion. Note, a
photograph of the initial setup without modifications is displayed in Figure 3.4.
6.2.1.2 Catheters
The following catheters were used for the MRI-guided interventions: 5-F straight
catheters (S1, S2, S3 - Table 3.1), a 5-F MPA catheter (M1 - Table 3.1) and 5-F
PTA balloon catheters (B1, B2 - Table 3.1). For X-Ray-guided interventions, the
same (commercially available) type and manufacturer were used without wRCs.
6.2.2 In Vitro Studies in Perfused Arterial Phantoms
All experiments were conducted at the Institute for Medical Science and Technol-
ogy, Dundee, UK, in a multi-modality setup (Figure 6.1) consisting of a digital
subtraction angiographic (DSA) unit (OEC 9900 Elite, software release 7.0.31, GE
Healthcare, Waukesha, WI, USA) and a 1.5 T MRI unit (Signa HDx, software re-
lease 15.0M4A, GE Healthcare, Waukesha, WI, USA). The units were located in
two adjoining rooms, interconnected with shielded sliding doors that allow patient
transfer between the units on a mobile table with radiolucent sliding table top
(MR 1050 surgical suite, GE Healthcare and Maquet, Rastatt, Germany).
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6.2.2.1 MRI Remote Control and Communication
A wireless inroom operator control system based on a mobile tablet device (iPad
1, Apple, Cupertino, CA, USA) was implemented to provide the vast majority
of control in the procedure room (see Figure 6.2). The main components of the
setup were described in Section 4.2. A tablet PC, mounted on a modified MRI-safe
intravenous (IV) fluid-holder pole, enabled the physician to interact directly with
the MRI scanner and/or the rtMRI system (RTHawk, Version 0.9.28, HeartVista,
Inc., Los Altos, CA, USA). Communication between the tablet PC and Linux
workstation was established via VNC. This setup allowed the physician and op-
erator to make real-time changes to the scan sequence parameters to follow the
manipulation of devices on the fly. A second tablet PC (iPad 3, Apple, Cupertino,
CA, USA) provided wireless audiovisual communication, which has been described
in Section 4.2. Each tablet device was inserted into a plastic cover to simulate ster-
ile conditions, while the physician was still able to operate the touch screen with
latex gloves.
Figure 6.2: In-room iMRI display and control setup - Photographs taken
during a MRI-guided iliac angioplasty procedure demonstrating the in-room
iMRI display and control setup. The pictures were taken from two wireless
IP cameras (M1031W, Axis, Lund, Sweden) that were installed in the scanner
room. These IP cameras are designed to deliver live video through the WLAN
(see Section 4.3.2) to a web browser or recording application. The picture (a)
was acquired from the back and picture (b) from the front. The mobile tablet
PC was mounted on an IV pole. The screen of the tablet shows the same rtMRI
scene as the 40” in-room monitor. Note, the physician was able to zoom into
the region of interest on the touchscreen (a).
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6.2.2.2 Experimental Phantoms
In vitro experiments were conducted on an arterial vessel phantom consisting of
linked femoral, abdominal and thoracic modules (L-F-S-Left-003, A-S-N-001, T-R-
N-020, Elastrat, Geneva, Switzerland). A neonatal blood pressure cuff (SoftCheck
Neonatals, Statcorp Medical, Jacksonville, FL, USA) was secured to the right
common iliac artery (with electrical tape and rubber sheet). The pressure cuff
(arrowhead in Figure 6.3) was inflated with water to occlude the artery. The re-
sistance was optimised in order to allow passive deflation with angioplasty balloon
expansion.
The phantoms were placed in the supine position on the MRI-safe sliding
tabletop. A heart-lung machine (HL-30, Maquet, Rastatt, Germany) was then
connected to the arterial model. One HL-30 D150 pump was customised to work
with a single roller head in order to mimic (pulsatile) physiologic flow. The model
was connected to the pump as demonstrated in Figure 6.3. Inflow was connected
to the models cardiac chamber (arrow) and outflow was achieved with dual upper
(neck and arm) and lower (everywhere else) systems. System pressure was con-
trolled using a non-operational D150 pump occlusion knob on the lower system
outflow tube in order to mimic systolic / diastolic pressures. The master arterial
flow pump was set to a flow rate of approximately 5.5 litres per minute, a heart
rate of 85 - 95 BPM and a blood pressure of approximately 130 / 70 mmHg.
Vascular access was established with a 12-F introducer sheath (Check-Flo, Cook
Inc., Bloomington, IN, USA) (indicated by a ’+’ in Figure 6.3), inserted into the
right femoral artery. All vessels, tubing and the pump reservoir were filled with
0.9% saline solution to mimic the electrical properties of blood. Furthermore, each
container of the vessel phantom modules was backfilled with a 10% gelatinous solu-
tion to improve the MRI vascular visualisation (for details about tissue mimicking
materials see Section 3.2.3). The heart-lung machine was positioned in the X-Ray
angiography suite (see Figure 6.1) to prevent interference with the MRI system.
For MRI experiments, however, the phantom was connected to the vessel model
via tubing (see Figures 6.1 and 6.3), passing the Faraday cage through the waveg-
uides. Silicon tubing (PT 12.7x3.2, Silex, Bordon, UK), with an inner diameter
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of 16 mm and length of 5 m, was utilised for the inflow as well as the outflow, for
both the X-Ray and MRI experiments.
Figure 6.3: Arterial phantom setup for cardiovascular iMRI - the vessels were
perfused with food colouring for optimised visualisation and demonstration: The
model consisted of three connected modules: a leg model (a) - full left leg and
a simplified right leg, an abdominal model (b) and a rigid thoracic phantom
(c) (L-F-S-Left-003, A-S-N-001, T-R-N-020, Elastrat, Geneva, Switzerland).
The master arterial pump of the heart lung machine (HL-30, Maquet, Rastatt,
Germany) was connected to cardiac chamber of the thoracic phantom and the
arrow indicates the inflow. The ’+’ indicates the 12-F introducer sheath for vas-
cular access and the arrowhead indicates the neonatal pressure cuff (SoftCheck
Neonatals, Statcorp Medical, Jacksonville, FL, USA) that was attached to the
right common iliac artery to mimic a stenosis.
6.2.2.3 Study Protocol
Percutaneous balloon angioplasty is a technique widely used to treat iliac artery
stenosis or occlusion. In this study, two trained interventional radiologists (one
consultant and one final year trainee (SpR / Registrar)) and one physician in
training performed 39 procedures in 6 sessions. A detailed analysis of the equiv-
alent workflow from the X-Ray angiography suite was conducted1 and applied.
All procedures were performed according to the protocol described in Figure 6.4
and the time for each step was recorded. The clinical protocol employed for X-
Ray-guided common iliac angioplasty is displayed in Figure 6.4a. With increasing
experience the DSA protocol was adapted to the MRI environment and the steps
were adjusted to the final MRI protocol, which is demonstrated in Figure 6.4b. At
the beginning of each session, a set of X-Ray-guided procedures was performed as
1Please note, the workflow analysis was not scope of this thesis but will be published in the
associated Ph.D thesis ”Workflow analysis, modelling and simulation for improving conventional
and MRI-guided vascular interventions” by F. Fernandez-Gutierrez.
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a reference for the subsequent experiments. Each person in the room was wear-
ing lead aprons for radiation protection. The phantom was then transferred into
the MRI room. During MRI-guided interventions, a trained MRI technologist or
researcher operated the scanner. In addition the physician, who had visual and
audio contact with the operator, was able to make the required adjustments with
the tablet PC.
(a) X-Ray Protocol (b) MRI Protocol
Figure 6.4: Flow diagram of the common iliac angioplasty protocol - (a)
Standard protocol applied in the interventional radiology department of the
local hospital (Ninewells Hospital, Dundee, UK) for X-Ray-guided balloon an-
gioplasties and (b) the adapted protocol for MRI guided-interventions. Note,
stenting was not considered in the current study.
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X-Ray Imaging: X-Ray-guided common iliac angioplasty procedures were per-
formed using the OEC 9900 C-Arm (GE Healthcare, Waukesha, WI, USA) accord-
ing to the standard protocol applied in the interventional radiology department of
the local hospital (Ninewells Hospital, Dundee, UK), at which the two interven-
tional radiologists worked (see Figure 6.4a). X-Ray contrast agent (Omnipaque,
GE Healthcare, Princeton, NJ, USA) diluted in 0.9% saline solution (50:50) was
injected into the balloon catheter for visualisation and to verify correct placement.
After the balloon catheter was removed, a straight catheter was inserted and DSA
was performed with a bolus of contrast agent to evaluate the results.
MR Imaging: All MR images were obtained with the DuoFlex coil suite (see
Section 3.2.2).. For this study, a 4ch 24 cm element was used, which was positioned
posteriorly and a single loop element with disposable cover, which was positioned
anteriorly. The imaging parameters are summarised in Tables 6.1 and 6.2 and were
acquired without breath hold or cardiac triggering. After the pre-interventional
diagnostic scan sequence, an interactive rtMRI sequence was used during device
manipulation. During the intervention, diagnostic images were only acquired on
request of the physician. At first the interventions were performed using the prod-
uct rtMRI protocol and later on with the developed rtMRI protocol, both with
communication between operator and physician.
MR Imaging - Product Protocol
Diagnostic imaging, based on high-resolution FSPGR and ToF MRA, was per-
formed for pre-interventional assessment and procedure planning. During the in-
tervention, interactive FGRE or FSPGR images were acquired using the product
rtMRI interface (i/Drive Pro Plus, GE Healthcare, Waukesha, WI, USA). For vi-
sualisation of the expanded endovascular balloon, a 0.9% saline solution doped
(1:100) with a Gd-based MRI contrast agent (Magnevist, Beyer-Schering Pharma
AG, Berlin, Germany) was injected into the catheter. This enabled us to depict the
balloon in a T1-weighted FSPGR sequence. After the procedure, a high-resolution
FSPGR and a ToF MRA sequence were acquired to verify the technical success,
while the guidewire was kept in place. All pulse sequences and imaging parameters
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Table 6.1: Summary of the MR imaging parameters for the product protocol
Parameter
Diagnostic MRI Interactive rtMRI
FSPGR 2D ToF FGRE FSPGR
TE / TR [ms] 2.0 / 4.5 2.6 / 7.5 1.7 / 4.8 1.8 / 5.9
FOV [cm x cm] 40 x 40 35 x 35 40 x 40 40 x 40
Matrix 256 x 256 320 x 192 256 x 128 256 x 128
FA [◦] 70 70 30 70
Slice thickness [mm] 7 7 7 7
are displayed in Table 6.1.
MR Imaging - Research Protocol
All pulse sequences for the research protocol were developed and inplemented
in RTHawk [45] (Version 0.9.28, HeartVista, Inc., Los Altos, CA, USA). The
following sequences were implemented: A high-resolution FSPGR for diagnostic
imaging, a real-time flow analysis (rtFLOW) with bipolar velocity-encoding gra-
dients and a spiral k-space acquisition scheme for pre-interventional assessment,
procedure planning and stenosis assessment. In consensus with the interventional
radiologists, we increased the spatial resolution for the sequences with a Cartesian
readout scheme and reduced the k-space coverage in the phase encoding direction
(ky = 62%) and employed zero filling [202] (see Section 2.4 on page 32) to decrease
scan time.
During an intervention the operation physician was able to switch on the fly
between various pulse sequences including the rtFLOW sequence: A bSSFP se-
quence with either Cartesian or spiral readout scheme was used for bright blood
visualisation, a FGRE (Cartesian) sequence for guidewire and catheter visualisa-
tion; and a (T1-weighted) FSPGR (Cartesian) sequence for visualisation of the
inflated balloon. The 0.9% saline solution doped with Gd-based contrast agent,
which was used for injection into the balloon catheter was the same as used with
the product protocol. The FA was varied (15 - 60◦) depending on which device
would be advanced and anatomical location examined. It was set to 30◦ or lower
for catheter visualisation and to 60◦ for T1-weighting for visualisation of the in-
flated balloon catheter. At the end of each procedure the outcome was assessed,
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Table 6.2: Summary of the MR imaging parameters for the research protocol
Parameter
Diagnostic MRI Interactive rtMRI
FSPGR Spiral
bSSFP
(MRA)
rtFLOW bSSFP Spiral
bSSFP
FGRE
TE / TR [ms] 2.0 / 4.5 3.5 / 21.5 4.9 / 23.5 4.8 / 6.9 3.5 / 20.0 3.0 / 7.4
FOV [cm] 40 24 24 40 40 24
Matrix or Resolution 256 x 256 1.76 mm 1.76 mm 256 x 256 1.76 256 x 256
FA [◦] 70 70 30 70 70 ≤30 / 60
Slice thickness [mm] 3 7 5 5 7 5
Interleaves - 16 5 - 6 -
with a similar protocol as during the planning stage, with flow analysis in the tar-
get section and high-resolution diagnostic imaging. All employed pulse sequences
and imaging parameters are reported in Table 6.2.
6.2.3 In Vivo Validation in a Porcine Model
Animal experiments in living pigs were performed in the department of diagnos-
tic and interventional radiology in the Goethe University hospital in Frankfurt,
Germany. The protocol2 for animal experiments was approved by the local In-
stitutional Review Board (IRB). Three living pigs (40 - 50 kg) were prepared at
the animal laboratory and transferred to the imaging facility with manual ven-
tilation (Ambu bag, Glostrup, Denmark). All imaging and procedures were per-
formed under general anaesthesia. Following substances were injected intravas-
cular: Heparing 5000 (2.5 ml), Propophol (20ml/st 2% solution) and Phentanyl
(0.5 µm/ml every 30 min). Vascular access was established with 12-F introducer
sheaths (Check-Flo, Cook Inc., Bloomington, IN, US), which were inserted into
the left and right femoral artery. The pigs were also monitored via standard ECG
(heart bit frequency) and detection of blood oxygenation and CO2 level using an
MRI compatible mobile monitoring device (SpO2 Invivo, Cambridge, MA, USA).
The animals were sacrificed at the end of the study.
2This protocol consisted of a series of experiments, all to be performed in each individual
animal if no complications occurred. Following experiments were part of the protocol: (i) General
device visualisation and navigation, (ii) percutaneous transluminal angioplasties of the iliac
arteries or veins, common carotid arteries or veins, (iii) stenting of the iliac or common carotid
arteries, (iv) deployment of implants including inferior vena cava filters, patent foramen ovale
occluders and heart valves.
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MRI (no cardiac triggering) was performed in a short and wide bore 1.5T MRI
scanner (Magnetom Espree, Software Version: Syngo MR B17, Siemens Health-
care, Erlangen, Germany) (see Figure 6.5) using the 8ch body matrix coil com-
bined with eight elements of the integrated spine matrix coil. All MR images
were displayed on a 18.1” in-room console (Conraq / Siemens, Erlangen, Ger-
many). During MRI-guided procedures, the X-Ray system was still available for
preparation, backup or emergencies.
Figure 6.5: Multi-modality setup at the department of diagnostic and inter-
ventional radiology in the Goethe University hospital in Frankfurt, Germany.
The right room (a) contains a digital subtraction angiographic unit (Axiom Ar-
tis dTA, Siemens, Erlangen, Germany) and the left room (b) is an RF shielded
enclosure with a clinical short and wide bore 1.5T MRI scanner (Magnetom
Espree, Siemens Healthcare, Erlangen, Germany). The rooms are intercon-
nected with sliding doors, that shield RF and radiation and allow a patient
transfer. The red arrow in Figure (b) illustrates the in-room console (Conraq
/ Siemens, Erlangen, Germany) for rtMRI display.
No major modifications to the MRI setup or adding research pulse sequences
were allowed because this imaging facility was in a clinical centre. However, a
Wireless Personal Area Network (WPAN) based on Bluetooth was established us-
ing an optical fibre USB cable (M2-100, Opticis, Sungnam City, Korea) and a
USB WLAN dongle (Belkin, Playa Vista, CA, USA) for in-room audio commu-
nication with a mobile tablet device (iPad 3, Apple, Cupertino, CA, USA) and a
wireless headset (Calisto B70, Plantronics, Santa Cruz, CA, USA). Moreover, a
second optical fibre cable was fed through the waveguides and connected to the
MRI scanner host PC to be able to adjust the rtMRI acquisition from within
the magnet room. Therefore, a wireless optical mouse (M185, Logitech, Morges,
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Table 6.3: Summary of the MR imaging parameters for the animal experi-
ments
Parameter
Diagnostic MRI Interactive rtMRI
HASTE Radial
VIBE
Radial true-
FISP
Radial
FLASH
TE / TR [ms] 86 / 900 1.6 / 22.4 1.9 / 3.8 1.9 / 3.8
FOV [cm] 33 x 45 35 x 35 35.6 x 35.6 25.5 x 25.5
Matrix 256 x 192 160 x 160 240 x 240 240 x 240
FA [◦] - 40 20 20
Slice thickness [mm] 5 7 8 8
Radial Views - 995 500 505
Switzerland) was modified (the standard AA batteries were replaced commercially
available Lithium-ion battery packs in a plastic housing) and sealed.
6.2.3.1 Study Protocol
In this study, one trained interventional radiologist (certified board member with
more than 10 years experience) performed 6 procedures in 3 sessions while a re-
searcher operated the MRI scanner. All procedures were performed according to
the protocol described in Figure 6.4b (Section 6.2.2.3). Additionally, each device
was positioned in the aorta to perform a second balloon angioplasty for demonstra-
tion purposes. A pre-interventional 3D planning sequence (radial VIBE 3 [203]) for
enhanced vessel visualisation without contrast material was acquired along with
a half Fourier acquisition single shot SE (HASTE) acquisition. Then interactive
rtMRI was performed with an RF spoiled or a trueFISP radial sequence [204, 205]
providing an image update rate of 384 ms. All MR pulse sequences and imaging
parameters are summarised in Table 6.3. For visualisation of the expanded en-
dovascular balloon, a saline solution doped with a Gd-based MRI contrast agent
(MAGNEVIST, Schering AG, Berlin, Germany) was injected into the catheter.
This enabled depicting the balloon during rtMRI.
3The conventional (non-radial) volumetric interpolated breath-hold examination (VIBE) is a
T1-weighted 3D FLASH sequence with fat-selective RF pre-pulses and partial k-space acquisition.
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6.3 Results
This section describes the detailed findings of the in vitro and in vivo common
iliac angioplasty studies.
6.3.1 In Vitro Studies in Perfused Arterial Phantoms
A total of 39 common iliac angioplasty procedures were performed in the perfused
vascular phantom. Nine X-Ray-guided procedures were used as references for the
30 procedures that were successfully and solely performed using MRI guidance.
In the present study, guidewire positioning was feasible, as was selective catheter-
isation of the common iliac artery, with the proposed visualisation techniques.
Over-the-wire positioning of the catheters was possible, as were consecutive bal-
loon angioplasties after removal of the guidewire (n = 39 out of 39). The average
procedure times and the range per operating physician are shown in Figure 6.6.
Figure 6.6: Average procedure times and range (illustrated as bars) for com-
mon iliac angioplasty categorised by setup and protocol. The vertical axis dis-
plays the average time in minutes, from the first localiser until the phantom
was taken off the MRI patient table. The three columns separate the operat-
ing physicians. The first set of columns shows the mean time for the X-Ray-
guided procedure that were performed as reference. Each physician performed
three independent X-Ray-guided iliac angioplasties. The second and third set of
columns show the MRI-guided interventions. The second set of columns shows
the average procedure time for the product protocol (n = 5 per physician) and
the last set of columns shows the MRI-guided iliac angioplasties performed with
the developed research protocol (n = 5 per physician).
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6.3.1.1 X-Ray - Guided Interventions
The mean procedure time (see Figure 6.6) for all X-Ray guided interventions (n
= 9) was 8 minutes and 42 seconds (ranging from 6 minutes and 32 seconds to
10 minutes and 51 seconds). The accumulated average X-Ray radiation dose for
all three procedures per radiologist was: 0.131 mGym2 (trained interventional
radiologist consultant level); 0.147 mGym2 (trained interventional radiologist -
SpR/Registrar); and 0.139 mGym2 (physician in training).
6.3.1.2 MRI - Guided Interventions
During guidewire positioning in the aorta, the rtMRI FGRE sequence was used
with a FA of 30◦ for improved visualisation of the passive markers. During catheter
insertion, the resonant coil led to high local signal increase during interactive
FGRE imaging with a FA of 15◦. This allowed for fast placement of the catheter
in the targeted vessel segment. Signal enhancements during imaging with low FAs
were more pronounced than with equivalent sequences with higher FAs. Figure
6.7 demonstrates device navigation during various steps of the balloon angioplasty
with the standard GE console (Figure 6.7a) and the product rtMRI interface
(i/Drive Pro Plus, GE Healthcare, Waukesha, WI, USA) (Figure 6.7b - d) and
Figure 6.8 shows the steps using the advanced research protocol. Figure 6.7a
shows a MIP of a 2D ToF MRA obtained in axial slice orientation without any
device present. Figure 6.7b displays the tip section of the MRI-safe guidewire (the
arrow illustrates the guidewire tip) positioned in the abdominal aorta. The wRC
(arrowhead) on the straight catheter can be identified in Figure 6.7c as a white
spot high up in the right common iliac artery. Figure 6.7d displays the inflated
balloon (indicated by a ’+’) (1:100 Gd-doped saline solution) that had been placed
just above the common iliac artery and required re-positioning.
Figure 6.8a shows the guidewire, visualised with the passive markers (the ar-
row illustrates the passive marker on the guidewire tip), which had been advanced
through the iliac arteries and positioned in the abdominal aorta during imaging
with the advanced research protocol. The image also shows a turbulent flow pat-
tern secondary to the connector distal to the renal arteries. Figure 6.8b shows
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Figure 6.7: MR images of the devices positioned in the common iliac artery
obtained with the product rtMRI interface (i/Drive Pro Plus, GE Healthcare,
Waukesha, WI, USA) - (a) Pre-interventional MIP of the 2D ToF MRA showing
the abdominal aorta and the iliac arteries without any device present, (b) shows
the tip section of the MRI-safe guidewire (the arrow indicates the tip) that was
positioned in the aorta, (c) the white spot (arrowhead) at the level beginning of
the iliac arteries shows is the wRC on the straight catheter, (d) inflated balloon
(’+’) catheter (with 1:100 Gd-doped saline solution) that was moved just above
the common iliac artery and required re-positioning.
the wRC (arrowhead) on the straight catheter, advanced over the guidewire and
positioned at the level of the simulated stenosis in the common iliac artery.
Figure 6.8c shows a high FA image with the expanded Gd-filled balloon (’+’)
catheter at the stenosed section of the common iliac artery. The signal enhance-
ment of the wRC on the balloon catheter allowed for fast positioning of the balloon
catheter in the target area. Inflating the balloon with a Gd-doped saline solution
and changing the FA to 60◦ to achieve T1-weighting enabled good intra-arterial
balloon position verification. Figure 6.8d shows a MIP of a 2D ToF MRA after
the stenosis has been treated. A drastic decrease in velocity (peak velocities of 20
- 25 cm/s pre-treatment and 10 - 12 cm/s post-treatment) was observed with the
rtFLOW assessment after treatment of the stenosis, as illustrated in Figure 6.9.
The catheters and guidewires along with their applied markers showed no
macroscopic evidence of fracture or kinking and the catheters remained patent.
The operators and physicians agreed that the catheter and guidewire position in
the MR images was identified easily and reliably on all occasions (n = 30 out of
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Figure 6.8: MR images of device placements in the common iliac artery ob-
tained with the developed real-time interface and customised interventional pro-
tocol - image (a) shows the tip section of the MRI-safe guidewire (the arrow in-
dicates the tip) with the susceptibility artefacts of each distinct passive marker.
Image (b) displays the straight catheter with the resonant tip marker (arrow-
head) at the level of the iliac arteries. On image (c) the inflated balloon catheter
(’+’) with 1:100 Gd-doped saline solution, positioned in the right common iliac
artery, can be depicted. Image (d) demonstrates a post-interventional MIP of
a 2D ToF MRA with treated stenosis in the right common iliac artery.
Figure 6.9: Flow/velocity examination performed in real-time and at various
segments of the common iliac artery. The flow study at the level of the stenosis is
shown exemplarily before (a) and after the stenosis treatment (b). The arrows
in the MIP dataset (2D ToF) indicate the orientation of the flow-encoded axial
images that are shown in the frame in the lower right corner of both MIP
datasets. The flow patterns below the two MIP datasets are also obtained with
real-time phase contrast (rtFLOW) MRI and demonstrate the velocity profile
averaged over a ROI, which was positioned within the vessel segment of interest
(ROI not shown for simplicity).
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30). The averaged procedure time per radiologist and the range (illustrated as
bars) are presented in Figure 6.6. The mean procedure time for all MRI-guided
interventions with the product protocol (n = 5 per radiologist) was 19 minutes
and 58 seconds (range 13 minutes and 32 seconds to 28 minutes and 34 seconds).
The mean procedure time with the research protocol (n = 5 per radiologist) was 9
minutes 2 seconds (range 6 minutes and 33 seconds to 11 minutes and 23 seconds)
with the research protocol (n = 5 per radiologist). Moreover, the physicians rated
the ergonomics for endovascular device placement during MRI scanning as being
tolerable.
6.3.2 In Vivo Validation in a Porcine Model
All in vivo procedures were successfully performed using MRI guidance. Over the
guidewire positioning of straight and balloon catheters was possible, as were the
consecutive balloon angioplasties after removal of the guidewire. The catheters
and guidewires along with their applied markers showed no macroscopic evidence
of fracture or kinking and the catheters remained patent. A successful balloon
angioplasty of the right common iliac artery is demonstrated in Figure 6.10. The
mean procedure time for the balloon angioplasties of the right common iliac artery
was 25 minutes and 42 seconds.
Figure 6.11 shows a balloon angioplasty while the balloon catheter was moved
into the aorta with a radial FLASH sequence. Each wRC led to locally increased
signal intensities in particular during interactive rtMRI with low FA. This allowed
for fast placement of the catheter in the targeted vessel segment (iliac artery -
Figure 6.10 and aorta - Figure 6.11). Imaging with a FA of 20◦ allowed satisfactory
visualisation of the guidewire (iliac artery - Figure 6.10a and aorta - Figure 6.10b),
the wRC (iliac artery - Figure 6.10c - e) and aorta - Figure 6.11) and also the
balloon, which was inflated with 1:100 Gd-doped saline solution (iliac artery -
Figure 6.10d and e and aorta - Figure 6.11c - e). The operator and physician agreed
that the catheter position in the MR images was identified easily and reliably on
all occasions (n = 6 out of 6). Guidewire visualisation was more difficult and time
consuming compared to the phantom experiments due to enclosed air and other
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Figure 6.10: MR images obtained with an interactive radial FLASH sequence
illustrating device placements in the aorta of a pig - Figure (a) shows the
tip section of the MRI-safe guidewire with the susceptibility artefacts of each
distinct passive marker (arrow). Figure (b) shows the tip section of the MRI-
safe guidewire positioned in the aorta. Image (c) displays the balloon catheter
with wRC (arrowhead) at the level of the iliac arteries. Figures (d) and (e) show
two images during balloon inflation (’+’) with 1:100 Gd-doped saline solution,
while the catheter was positioned in the right common iliac artery. Note, severe
banding artefacts close to the end of the receive coil and susceptibility artefacts
occurred during imaging with the interactive radial trueFISP sequence.
susceptibility artefacts in the abdomen of the pigs (in particular during imaging
with the trueFISP sequence).
6.4 Discussion
Although MRI has been previously used for guiding and monitoring a variety
of interventions, most cardiovascular studies focus on challenging procedures in-
cluding stenting [123], cardiac electrophysiology mapping during catheterisation
[56, 57] and heart valve repairs and replacements [58]. However, it is also impor-
tant to ensure familiarity with conventional endovascular procedures using MRI
guidance before approaching more complex cardiovascular techniques. This work
demonstrates the pre-clinical feasibility and efficiency of common endovascular in-
terventions (such as balloon angioplasty of the common iliac artery) using MRI
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Figure 6.11: MR images obtained with an interactive radial FLASH sequence
during device navigation in the aorta of a pig - Figures (a) (coronal) and (b)
(sagittal) show the wRC on the balloon catheter (arrowhead). Figures (c)
(coronal) and (b) (sagittal) show the inflated (1:100 Gd-doped saline solution)
balloon (’+’) with wRC (arrowhead). Figure (e) is a MIP of a MRA dataset
obtained with a Radial VIBE sequence. Note, the two signal voids within the
balloon (’+’) in (e) are susceptibility artefacts caused by the X-Ray markers,
which are generally invisible if the balloon is deflated.
guidance. A combination of optimised workflow, suitable technologies for commu-
nication, in-room visualisation and remote control of the MRI scanner, and safe
and readily visualised endovascular devices, enabled satisfactory and effective in-
terventions. This may be a first step towards standardisation to facilitate training
of MRI-guided techniques.
6.4.1 Interventional Devices
Endovascular interventions require iterative use of guidewires and catheters, as
well as device exchanges with one or the other in place. Both device visualisation
techniques employed in this study did not require a connection between the device
and the MRI scanner, thereby simplifying instrument handling as well as avoiding
unintended RF coupling effects. For this study, non-braided angiographic catheters
(see Chapter 3) were selected, which are MRI-safe but have little torque and lim-
ited navigation characteristics. This was not an issue for balloon angioplasty of
the common iliac artery (phantom and animal model) or the aorta (animal model)
but could be problematic for more challenging interventions. The passive mark-
ers on the guidewire were found to be sufficient for device navigation during all
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interventions performed in the current study. However, the animal experiments
demonstrated that in small vessels and next to air-filled cavities (which also give
signal voids), a more versatile contrast method would improve device localisation.
During MRI-guided interventions, the MRI-safe guidewire was considered satisfac-
tory for the outlined tasks, with a similar performance to commercially available
guidewires for X-Ray fluoroscopy, as validated by the interventional radiologists.
Further studies are needed to fully assess the mechanical performance of this new
MRI-safe guidewire.
6.4.2 iMRI Setup
The limited patient access in closed-bore magnets provides a significant challenge
for MRI-guided interventions, particularly if the physician has to reach into the
iso-centre of the MRI scanner e.g. for needle insertion [19, 24]. For endovas-
cular interventions, however, the access site is mainly via the common femoral
artery and only the treatment area is positioned in the centre of the bore. This
allows the physician to be situated in front of the MRI scanner while inserting
endovascular devices (see Figure 6.2). In this study, all physicians agreed that
this position was tolerable throughout the procedures and the scanner display and
control within arm reach was considered to be useful as demonstrated in the phan-
tom experiments. Moreover, the ergonomic component and access to the patient
was significantly improved by using longer introducer sheaths and a short and
wide bore MRI scanner for the animal experiments. However, a detailed study is
required to evaluate these modifications as well as long-term ergonomic effects.
Another hurdle to be overcome is the need to simplify receive coil positioning
while a sterile iMRI environment is maintained. The interventional coil prototype
facilitated fast and reliable coil positioning during the phantom experiments while
enabling suitable quality interventional imaging for a relatively large FOV. Imaging
and positioning of standard imaging coils, such as an 8ch body array coil (animal
experiments), was found to be time-consuming and could also prove challenging
in terms of maintaining sterility around the puncture site. This problem has been
addressed with a new interventional coil design (DuoFlex Coil Suite - see Section
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3.2.2) that employs an exchangeable soft cover, which can be covered by sterile
drapes and disposed of after a procedure.
6.4.3 Protocol and Workflow
Clinical MRI-guided endovascular procedures require suitable patient access within
the scanner, a good compromise between high-speed imaging, spatial resolution
and image quality, as well as intuitive interaction with the scanner. In this study,
all scan plane adjustments were performed manually i.e. to follow an interventional
device that was moved out of the current scan plane. In Chapter 5, a concept for
robust wireless tracking of catheters equipped with wRC was proposed. Integrat-
ing this concept into the proposed framework could further improve and simplify
the interventional workflow, which needs to be quantitatively assessed in further
studies.
6.4.3.1 In Vitro Studies
MRI-guided common iliac angioplasty procedures were conducted and assessed
with a newly developed iMRI framework regarding time and efficacy. In this
context, a product platform (i/Drive Pro Plus, GE Healthcare, Waukesha, USA)
with CE mark and FDA approval was compared to a research rtMRI platform
(RTHawk, HeartVista Inc., Palo Alto, CA, USA), approved only for investigative
use and not to be used with patients.
The integration of mobile touchscreen tablet devices and wireless communi-
cation was investigated as part of the interventional workflow. This enabled the
radiologist to have control of the MRI scanner at the procedural table (see Fig-
ure 6.2). This obviated the need for scan interruptions or verbal and gestural
commands to the MR technician, which were found to be a major challenge in
preceding experiments. The use of a research platform enabled us to design a
specific protocol and interface tailored to MRI-guided endovascular interventions.
This tailored rtMRI interface, in combination with the mobile touchscreen device,
led to a significant decrease in both complexity and the need for technician-driven
scan adjustments. Furthermore, the ability to select the rtFLOW visualisation on
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the fly (similar to Doppler ultrasound) was considered to be useful for pre- and
post-interventional assessment.
These implementations improved the interventional workflow and also re-
duced the required mean patient table time to 9 minutes and 2 seconds, which is
comparable to the X-Ray guided interventions (8 minutes and 42 seconds) that
were performed according to the protocol from the local hospital. The length of
time taken to perform the MRI-guided procedures was reduced (minimum proce-
dure time: 6 minutes and 33 seconds) as our experience with the setup increased.
Further experience and training with this developed framework of technologies
could potentially lead to shorter procedure times in future [59]. MRI-guided pro-
cedures were also successful with the commercially available rtMRI interface. How-
ever, workflow interruptions, caused by e.g. stopping the scanner, oﬄine adjust-
ments to pulse sequence parameters and re-starting the scan acquisition, resulted
in delays and the mean procedure time was more than double (19 minutes and
58 seconds) than either the X-Ray-guided or MRI-guided procedures with the
research protocol.
6.4.3.2 In Vivo Studies
MRI-guided common iliac angioplasty procedures were conducted in three pigs
using an open and short bore scanner. Because this imaging facility was in a
clinical centre, no major or permanent modifications to the MRI setup our pulse
sequences were allowed. MRI-guided procedures were also successful with this
setup demonstrating the feasibility of MRI-guided angioplasty in vivo. However,
the workflow and procedure times (mean: 25 minutes and 42 seconds) were in-
fluenced by more challenging device localisation, a compromised protocol (limited
availability of suitable rtMRI pulse sequences), numerous manual scan plane ad-
justments, which were found more time consuming than the phantom experiments
(vasculature around the iliac arteries cannot be scanned in a single plane) and the
need for oﬄine adjustments to the pulse sequence.
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6.5 Conclusions
In conclusion, the results of this study illustrate that endovascular interventions
such as common iliac angioplasty, solely with MRI, are experimentally feasible
with this novel framework of technologies (real-time guidance, interactive MRI re-
mote control, in-room communication and device visualisation). Dedicated equip-
ment designed for interventions and streamlined workflow improved the procedu-
ral efficacy. Developing an interactive protocol allowed switching between pulse
sequences without interruption of imaging. This provided real-time device ma-
nipulation and instant evaluation of technical procedural success, along with ad-
justments to the treatment protocol on the fly. Accordingly, with this protocol
the implications and response of the treatment to the downstream vasculature can
also be evaluated. In particular the rtFLOW visualisation was found to be helpful
for pre- and post-interventional assessment. Although the initial in vitro results
(partially verified in vivo) are encouraging, this novel framework was applied in
idealised phantom conditions only and needs to be repeated in vivo. The next
research steps should validate the rtFLOW measurement accuracy and compare
it to Doppler ultrasound and laser Doppler flowmetry. Future work is planned to
investigate the entire framework of technologies including wireless device tracking
in further animal studies before the translation into clinical studies.
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Experimental contributions:
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cadavers were embalmed and provided by CAHID). (ii) B. F. Cox and R. Buciuc performed the
clinical part (intervention) of the in vitro and ex vivo experiments. (iii) A. Theissen prepared
and supervised the in vivo experiments. (vi) R. Buciuc, A. Melzer and S. Zangos performed the
clinical part (intervention) of the in vivo experiments.
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7.1 Motivation
Stroke remains the third most common cause of death in the industrialized nations
and the single most common cause of serious long-term disability [206, 207]. The
time period after stroke onset is very critical because acute ischemic stroke is treat-
able and a significant portion of threatened brain is potentially salvageable [207]
with immediate treatment. Advances in imaging technology [207] and reperfusion
therapy have improved the clinical management of acute stroke patients. Pa-
tient management is largely dependent on the time period after stroke onset [208];
within the three-hour window intravenous (IV) thrombolysis [208–210] and within
the six-hour window intra-arterial (IA) thrombolytic therapy are clinically effective
options [208, 211]. Despite the fact that randomised clinical trials have suggested
both treatment options to be beneficial for acute stroke [209, 210, 212, 213] only
a small patient group receives IV (<10%) [76] and IA thrombolytic therapy [78].
Endovascular treatment has emerged as a key option for patients who ei-
ther have a contraindication to thrombolytics, are beyond the time window or
incomplete recanalisation has been achieved with thrombolysis treatment [207].
Moreover, endovascular therapy is increasingly used after administration of IV
thrombolytics in patients with moderate-to-severe acute ischemic stroke [76]. The
major drawback of endovascular treatment, is the delay in initiating treatment
[76] in consequence of preparation, patient handling and transfer times between
imaging modalities [207].
Although the Interventional Management of Stroke (IMS) pilot trials (IMS I
and II) have demonstrated [214, 215] that IV thrombolysis followed by IA throm-
bolysis therapy may be more effective than IV thrombolytic therapy alone [216],
the recent phase 3 trial (IMS III) was stopped early because no significant clinical
benefit of endovascular therapy after IV thrombolysis could be shown [58]. The
pilot trials (IMS I and II) demonstrate a direct link between clinical outcome and
time from stroke onset to revascularization [76, 217, 218]. The IMS III investiga-
tors concluded that a delay in initiating treatment (30 minute) compared to IMS
I could be a key reason for the lack of clinical benefit in the IMS III trial and rec-
ommended that future trials should attempt to minimize delays to the initiation
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of endovascular therapy [76].
Over the past decade, MRI has gained a significant impact on imaging of
stroke [219] and in many hospitals has become an integral part of early stroke
diagnosis and assessment of affected brain tissues. Diffusion-weighted imaging
(DWI) can rapidly detect ischemic brain lesions, and perfusion-weighted imaging
(PWI) can identify blood flow abnormalities [220] and the penumbra at risk. MRA
can identify vessel occlusion [219], detect chronic, small brain haemorrhages and
may predict patients that respond unfavourably to thrombolytic therapies [220].
Diagnosis and treatment in the same modality could also reduce patient han-
dling, streamline the procedure workflow and save crucial time that is required for
the transfer between diagnostic and treatment facilities [78]. Early MRI scans may
provide significant advantages (compared to CT) for identification of patients who
are likely to benefit from thrombolytic therapy, even beyond 3 hours after stroke
onset [220]. Using MRI for diagnosis and also treatment could accommodate imag-
ing and assessment of arterial and venous blood flow [221], the state of vessel walls
[42], brain diffusion and perfusion, tissue metabolism, tissue cell death and brain
function. MRI avoids ionising radiation and nephrotoxic and allergenic iodine-
based contrast media [77] and is the only imaging modality that can visualise the
blood vessels and the state of the brain parenchyma. Thus, iMRI could facilitate
critical decision making during a procedure as the viability of brain tissues can be
evaluated and tissues at risk for irreversible infarction can be detected [78].
This work serves as a pre-clinical study of MRI-guided endovascular mechan-
ical thrombolysis (clot retrieval) and was demonstrated by means of MRI-guided
vascular phantom and Thiel soft-embalmed human cadaver experiments. To val-
idate the developed devices for mechanical clot retrieval and the applied MRI
visualization in vivo, preliminary experiments were conducted in a porcine model.
All in vivo procedures were performed in one animal, which was also used for the
experiments described in Chapter 6. However, the arterial route of blood supply to
the brain differs between species and also between mammals. For instance in ox,
sheep and also pig the proximal segment of the internal carotid artery is absent.
Instead, branches of the internal maxillary and/or the external carotid artery feed
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into an arterial rete (a complex of arteries and veins located very close to each
other) [222]. A major drawback of the porcine model is the arterial rete, which
prevents catheterisation of the intracerebral arteries [60].
As alternative, the carotid arterial territory was selected for catheterisation
in vivo, which is also significantly associated with ischemic stroke [223].
7.2 Materials and Methods
The following subsections describe the materials and methods for this study and
include cross-references to related content described elsewhere in this thesis as
many of the methods have been introduced in the preceding chapters.
7.2.1 Interventional Devices
MRI-safe guidewires (see Section 3.2.1.1) with a length of 180 cm and a diameter of
0.035” and custom made micro guidewires (EPFlex, Dettingen/Erms, Germany)
with a length of 150 cm and a diameter of 0.014” were used for this study. A
conventional non-braided 5-F MPA catheter (M1 - Table 3.1) was prepared for
the initial steps of the procedure. Subsequently a custom made non-braided 2.6-F
micro catheter (µC1 - Table 3.1) was employed for navigation. In addition, the
first prototypes of the EPFlex 3-F Basketriever where used as clot retriever.
7.2.2 In Vitro Studies in Perfused Arterial Phantoms
In vitro experiments were conducted in an arterial vessel phantom consisting of a
linked femoral, an abdominal, a thoracic and a head and intracranial module (L-F-
S-Left-003, A-S-N-001, T-R-N-020, H+N-S-A-10, Elastrat Sarl, Geneva, Switzer-
land). Artificial blood clots made of fibrin sealant (TISSEEL, Baxter Healthcare,
Deerfield, IL, USA) were inserted into the M1 and M2 segments of the middle
cerebral artery (MCA). For the first series of experiments (n = 3) a clot was in-
serted into the left MCA (M1), for the second series of experiments (n = 3) into
the right MCA (M1) and for the third for series of experiments (n = 3) into the
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left MCA (M2). The phantoms were connected to the Maquet heart lung ma-
chine (see Section 6.2.2.2) and positioned in the supine position on the MR safe
sliding table top. Pump perfusion parameters were set to a flowrate of 5.5 litres
per minute, which translated into a heart rate of 110 beats per minute and the
systolic/diastolic pressure was maintained at approximately 120/80 mmHg.
(a) Intracranial module (b) Linked arterial phantom
Figure 7.1: Photographs of the phantom-setup for the MRI-guided endovas-
cular mechanical thrombolysis experiments - Figure (a) shows the intracranial
module of the phantom (without gel) and (b) shows the linked arterial phan-
toms in front of the 1.5T MRI scanner.
7.2.2.1 Imaging Protocol and Workflow
The setup for MRI-guided interventions has already been described in Section
6.2.2.1. The vascular phantom studies were conducted with the DuoFlex interven-
tional coil suite (see Section 3.2.2 for details) consisting of a single loop element
with disposable cover (posterior) and a 4ch paddle element (anterior). All rtMRI
implementations were developed in RTHawk in conjunction with the embedded
Vurtigo plugin (see Sections 5.3 and 6.2). Wireless device tracking and a dedi-
cated UI were used for this study as outlined in Chapter 5. The device position
was therefore rendered to the current 2D rtMRI scan plane and/or a 3D MRA
roadmap. The following paragraphs describe the modifications compared to the
preceding chapters:
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Table 7.1: MRI parameters for the in vitro and ex vivo MRI-guided endovas-
cular mechanical thrombolysis experiments
Parameter
Diagnostic MRA Interactive rtMRI
3D SPGR ToF FSPGR FGRE spGRE
TE / TR [ms] 2.8 / 23 2.0 / 4.5 2.82 / 7.04 3.5 / 20.4
FOV [cm x cm] 16 x 16 24 x 24 24 x 24 24 x 24
Matrix or Resolution 320 x 224 256 x 256 256 x 256 1.76 mm
FA [◦] 20 14 60 30
Slice thickness [mm] 1.4 6 10 8
Interleaves - - - 16
Non-braided customised 8-F vascular sheaths (Penumbra, Inc., Alameda, CA,
USA) were placed in the target carotid arteries via femoral access (see Figure 7.1)
using rtMRI guidance. Automated device tracking was only performed with the
MPA catheter until the internal carotid artery was reached then the catheter was
exchanged over the 0.035” guidewire to the micro catheter. The micro catheter
was used for upstream navigation in combination with either the 0.035” or 0.014”
guidewire. All pulse sequences and imaging parameters are summarized in Table
7.1. An intervention was rated successful once the devices were navigated into the
targeted vessel segment and mechanical blood clot removal was verified with 3D
ToF MRA. Another major differences was that a much smaller FOV (compared
to the preceding chapters) was required to accommodate experiments with the
cranial model.
7.2.3 Ex Vivo Studies in Thiel Embalmed Human Cadav-
ers
Initially, a series of T2-weighted baseline scans (FSE, TE/TR = 103.9 / 3000
ms, ETL = 16, FOV = 22 cm x 17.6 cm, Matrix 256 x 192, Slice thickness =
3 mm) was acquired to investigate if the brain of an individual cadaver was still
suitable for interventional procedures and MRI. If a cadaver was rated suitable, the
cadaver was prepared in the angio suite in the supine position and then transferred
to the MRI suite (similar setup as in Figure 6.1). Percutaneous vascular access
7.2. Materials and Methods 145 Chapter 7. MRI-Guided Clot Retrieval
was established bilaterally with a 12-F introducer sheath (Check-Flo, Cook Inc.,
Bloomington, IN, US), which was inserted in each femoral artery.
Initially, perfusion experiments were performed with the same pump setup as
described for the phantom experiments. However, MRA revealed that perfusion
resulted in significant extravasation and perfusion with the pump was abandoned.
To mimic perfusion for MRA, 10 ml Gd-doped solution (1:100) were slowly injected
through the vascular sheath in the carotid artery. This allowed for 3D roadmaps
of the vascular tree that were used in the subsequent rtMRI-guided interventions.
Then the same protocol as outlined for the phantom experiments (Section 7.2.2.1)
was followed, except that no artificial blood clots were deployed because substances
with human or animal origin (contained in fibrin sealant) were explicitly excluded
in the approved cadaver protocol. Device navigation in front of the bore was
evaluated in three different sets of experiments: Left MCA (M1) (n = 3), right
MCA (M1) (n = 3) and right MCA (M2) (n = 3). An intervention was rated
successful once the devices were navigated into the targeted vessel segment (n =
10).
7.2.4 Preliminary In Vivo Validation in a Porcine Model
The animal experiments in this study were scope of the approved animal proto-
col described in Chapter 6 (see Section 6.2.3 for details). All experiments were
performed under general anesthesia by an experienced neuro-interventional radi-
ologist (board certified in general diagnostic radiology and neuroradiology) in a
short and wide bore 1.5 T scanner (Magnetom Espree, Siemens Healthcare, Er-
langen, Germany) similar to what has been outlined in Section 6.2.3. To reduce
animal use, one of the pigs (50 kg) that was used in the iliac angioplasty experi-
ments described in Chapter 6, was also used for this study. The pig was prepared
for iMRI and positioned (supine) on the MRI table. The 12-F introducer sheath
(Check-Flo, Cook Inc., Bloomington, IN, US) was maintained in the right femoral
artery for percutaneous vascular access. The same scan protocol (Table 6.3) as
for the in vivo angioplasty experiments of the iliac artery, (see Section 6.2.3.1)
was applied to balloon angioplasty of the right common carotid artery (n = 2).
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An intervention was rated successful once the devices were navigated into the tar-
geted vessel segment and correct balloon dilatation was verified with a high spatial
resolution 3D radial VIBE dataset (see Table 6.3 for details).
7.3 Results
The following subsections describe the findings of the in vitro, ex vivo and in vivo
experiments of this pre-clinical pilot study of MRI-guided endovascular mechanical
thrombolysis.
7.3.1 In Vitro Studies in Perfused Arterial Phantoms
Artificial blood clots were successfully removed in three series of in vitro experi-
ments (1. left MCA (M1) (n = 3/3), 2. right MCA (M1) (n = 3/3), 3. left MCA
(M2) (n = 3/3)) by an experienced interventional neuro-radiologist and within 15
minutes. The workflow of a blood clot removal at the left MCA (M1) is demon-
strated in Figures 7.2 and 7.3. It should be noted that the Basketriever were tested
during initial phantom experiments but did not provide sufficient MRI visualisa-
tion, in particular for the expanded basket that was supposed to retrieve blood
clots. Thus, all subsequent experiments were performed without Basketriever and
artificial clots were removed with guidewire and catheter manipulation.
For the first series of experiments (n = 3), a 3D MRA dataset was obtained
and used as 3D roadmap (see Figures 7.2a and b). A perfusion defect (’+’) was
clearly visible in the left MCA due to the artificial blood clot in the M1 segment.
The same 3D roadmap was subsequently used for device navigation. This is illus-
trated in Figure 7.2c where a 2D rtMRI plane was rendered to the MIP dataset.
The position of the tip of the MPA catheter (arrow) was computed by the tracking
implementation and rendered to the 3D roadmap. This is shown in Figure 7.2c.
Automated tracking of the MPA catheter tip was feasible until the vessel diameter
of the internal carotid artery (C4 segment) prohibited the catheter with wRC to
pass and an exchange to the micro catheter (µC1 - Table 3.1) was required.
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Figure 7.2: Device navigation in an intra-cranial arterial vessel replica model
prior to treatment of an occlusion caused by an artificial blood clot in the M1
segment of the left MCA: A 3D ToF MRA dataset was acquired (a) as first
step and the MIP was then used as 3D roadmap (Figures (a) - (c)). The ’+’
indicates the lack of perfusion due to the artificial blood clot in the left MCA
(M1). As second step, a 2D rtMRI plane (FSPGR - Table 7.1) was rendered to
the roadmap (d) while the guidewire was inserted (arrow). As third step, the
MPA catheter was navigated while the rtMRI and the tracking pulse sequences
were interleaved (e). The red sphere (arrowhead) indicates the catheter tip
tracking position that was computed by the wireless tracking pulse sequence.
Figure 7.3 demonstrates how the guidewire (the white arrow indicates the
tip) and the micro catheter (the green arrow indicates the tip) were advanced into
the left MCA (M1) in order to remove the blood clot using rtMRI guidance. The
scan plane was then manually adjusted further upstream as per request of the
operating physician. Alternatively the physician was able to request that the 2D
rtMRI plane was fused to the 3D roadmap, tilted according to his preference and
the opacity adjusted to accommodate device navigation (Figure 7.3d and e). The
second and third series of experiments were successfully performed similar to what
was outlined for the first set of experiments in Figures 7.2 and 7.3.
7.3. Results 148 Chapter 7. MRI-Guided Clot Retrieval
Figure 7.3: Micro catheter navigation in the intra-cranial model - Figures (a
- c) show rtMRI (FGRE - Table 7.1) frames while the guidewire and micro
catheter were advanced into the left MCA to manipulate and remove a blood
clot in the M1 segment. The arrow indicates the tip of the guidewire and the
arrowhead the tip of the micro catheter. The inteventional neuro-radiologist was
also able to see a 2D rtMRI scan plane (red arrow) rendered to the 3D roadmap
(d) of the arterial intracranial model while the opacity could be adjusted (e)
on demand.
7.3.2 Ex Vivo Studies in Thiel Embalmed Human Cadav-
ers
The initial T2-weighted baseline brain scans (Figures 7.4a - c) revealed that two
(one male and one female, age range 50 - 70, weight 65 - 85 kg) out of four cadav-
ers were suitable for brain imaging and neurovascular interventions. Figure 7.4d
illustrates a MIP (black and white inverted) roadmap, obtained with 3D MRA
after a slow injection (0.5 mL/sec) of 10 ml Gd-doped solution (1:100). In one
cadaver a pre-existing flow defect (most likely caused by trapped air) was discov-
ered, which was employed as target for navigation. This flow defect in the left
MCA (M1) (white arrow) can be perceived as significantly reduced perfusion/ab-
sence of Gd-doped fluid. The Gd-doped solution allowed a distinct visualisation
of the neuro-vasculature (see Figure 7.5) during rtMRI. Device navigation (Figure
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7.5) was successfully performed in three different sets of experiments (1. left MCA
(M1) (n = 3/3), 2. right MCA (M1) (n = 3/3), 3. left MCA (M2) (n = 1/3)) by an
experienced neuro-interventional radiologist and within 25 minutes. Automated
device tracking was feasible until reaching the C4 segment of the internal carotid
artery where the vessel diameter prohibited the MPA catheter to pass. The poor
torque transition of the micro guidewire prototypes prevented (n = 2/3) to access
the M2 segment of the left MCA.
(a) Axial Baseline (b) Sagittal Baseline (c) Coronal Baseline (d) MIP - 3D ToF SPGR
Figure 7.4: MR images of a Thiel cadaver that was found suitable for iMRI
T2-weighted baseline scans ((a) axial, (b) sagittal, (c) coronal) to assess suit-
ability of a cadaveric brain. Figure (d) shows a MIP (black and white inverted)
of a 3D MRA dataset (Table 7.1). The white arrow illustrates the absence
of Gd-doped fluid due to pre-existing flow defect (most likely due to trapped
air) in the left MCA (M1). Note, the extensive amount of air and fluid in the
intracranial space in Figures (a) and (b).
7.3.3 Preliminary In Vivo Validation Experiments
Passive device visualisation enabled placement of the balloon catheter within 10
minutes after the first insertion of the guidewire at the femoral artery access site.
Balloon dilatation of the right carotid artery was successfully performed (n = 2/2).
Figure 7.6 illustrates sequential MR images (radial trueFISP) during device posi-
tioning of the guidewire (the white arrow illustrates the tip), the micro catheter
(the arrowhead illustrates the tip) and the wRC on the balloon catheter (red ar-
row). The susceptibility artefact induced by the FeO marker allowed adequate
localisation of the guidewire tip but was occasionally masking relevant anatomy,
in particular during navigation into or close to small branches. Manual scan plane
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Figure 7.5: Device navigation in the brain of a Thiel soft-embalmed human
cadaver - Figure (a) shows the tip tracking position (purple sphere) of the MPA
catheter rendered to a 3D roadmap and 2D rtMRI (FSPGR - Table 7.1) scan
plane while the MPA catheter with a wRC was navigated into the left internal
carotid artery (C4 segment). Figures (b - e) illustrate the navigation of a micro
guidewire into the right MCA with rtMRI guidance (FSPGR) while the 2D scan
plane was rendered to a 3D roadmap (d - e). The red arrows illustrate the tip
of the micro guidewire.
adjustments, in order to locate devices in the current scan plane, were found feasi-
ble but generally time consuming (compared to automated tracking), in particular
for the micro guidewires.
Once the balloon catheter was adequately positioned, the pulse sequence was
stopped and a radial FLASH was initiated to monitor the balloon dilatation pro-
cess (inflation with 1:100 Gd-doped saline solution). Figure 7.7 illustrates sequen-
tial images during the inflation process in the right common carotid artery. The
position of the inflated balloon was then verified and evaluated with a 3D radial
VIBE sequence (Figure 7.8).
7.4 Discussion
Generally, it is important that imaging methods are selected based on the condition
of the patient, the anatomical regions and structures involved, the time since
stroke onset, the logistical constraints of using one or the other modality, and the
capability of a facility to perform advanced therapy such as IA thrombolysis [207].
Possible limitations of iMRI-guided stroke therapy include a restricted access to
the patient and that MRI scans are more challenging to obtain (as compared to
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Figure 7.6: in vivo imaging during device navigation using rtMRI guidance
(radial trueFISP - Table 6.3) to position a balloon in the right common carotid
artery for angioplasty - Figures (a - e) illustrate how the balloon catheter
(wRC pointed out by red arrows) was initially advanced in combination with the
guidewire (markers pointed out by white arrows). Figures (f - j) illustrate how
the guidewire was advanced and positioned distally to the right carotid artery.
Figure (k) shows the tip marker of the micro catheter (arrowhead) that was
advanced over the guidewire and placed into the carotid artery (balloon catheter
has been withdrawn). The guidewire was then advanced into the carotid artery
and the micro catheter exchanged to the balloon catheter in Figure (l). Figures
(m - o) illustrate how the balloon catheter was advanced and positioned for
subsequent balloon dilatation (see Figure 7.7).
Figure 7.7: In vivo rtMRI (radial FLASH - Table 6.3) during balloon inflation
(arrowhead shows balloon filled with 1:100 Gd-doped saline solution) in the right
common carotid artery of a pig. The red arrow indicates the wRC behind the
balloon.
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Figure 7.8: Assessment of an in vivo balloon dilatation in the right carotid
artery. Figure (a) shows the images obtained with a 3D radial VIBE (Table 6.3)
slice by slice in axial orientation. Figure (b) shows a MIP of the 3D dataset.
Red arrows indicate the wRC on the balloon catheter and white arrowheads
show the inflated balloon (with 1:100 Gd-doped saline solution).
i.e. CT), in particular in acutely ill or uncooperative patients [220]. Additionally,
contraindications to MRI (such as ferromagnetic foreign bodies [224] and passive
or active implants [22, 225]) are challenging to identify in the acute stroke setting
[220] and can exclude a significant population of patients. Other drawbacks related
to MRI are the increased scan time that is required for both diagnostic (compared
to CT) and interventional (compared to X-Ray fluoroscopy) imaging, the need for
MRI-safe equipment (including anaesthesia equipment) and the learning curve to
perform these procedures.
This chapter presents a pre-clinical pilot trial to evaluate the feasibility of
MRI-guided mechanical clot retrieval. These in vitro experiments demonstrate
that recanalisation of occluded vessel segments (M1, M2) of the MCA, were feasi-
ble and practical using the developed framework of technologies and interventional
devices. This was also validated by means of ex vivo experiments using Thiel soft-
embalmed human cadavers. The initial ex vivo experiments were performed with
pulsatile flow (driven by a heart lung machine) because perfusion is a prerequi-
site for achieving vessel patency for guidewire movement and visualization. To
the authors’ knowledge, this is the first report that brain reperfusion has been
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established in a Thiel soft-fixed cadaver. However, this artificial perfusion of ca-
daveric brains resulted in considerable extravasation and thus loss of discernible
brain structure. Thus, optimizations of the perfusion setup and the protocol are
required for future studies. In addition, in vivo experiments were conducted in
a porcine model to further validate the developed devices and their visualization
in order to assess their future potential for MRI-guided mechanical clot retrieval
in vivo. The preliminary in vivo results of balloon angioplasties of the carotid
artery are encouraging but it is expected that significant additional research is re-
quired before MRI becomes a feasible imaging modality for guiding endovascular
interventions in acute ischemic stroke.
One inherent limitation that has to be acknowledged in the context of this
study is that it was not possible to deploy artificial blood clots in the ex vivo and
in vivo models prior to the experiments. A suitable material to mimic blood clots
that does not contain substances of animal or human origin has to be identified
for future investigations. Other limitations of the current study are that only a
smaller number of experiments were performed, in particular in the animal study.
It should also be noted that domestic pigs are frequently used as in vivo models
for interventional research due to the numerous similarities between human and
porcine anatomy and physiology [60, 78] but have significant drawbacks for in-
tracranial endovascular interventions. Most important, the arterial rete prevents
catheterisation of the intracerebral arteries [60]. It is necessary that limitations
related to the in vivo model will be addressed in further studies in order to fully
assess the potential of MRI-guided stroke treatment. Nevertheless, it was the am-
bition of this study to set the stage for future investigations of acute ischemic
stroke treatment using MRI guidance.
7.4.1 Interventional Devices
The small inner diameters of the intracerebral arteries in combination with the
requirement to select MRI safe materials constitute a significant challenge for the
design and production of interventional devices. The presented micro guidewires
and catheters enabled device navigation into the M1 and M2 vessel segments of the
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MCA without macroscopic device breakages. However, further device optimisa-
tions (similar to what has been described in Section 3.4.0.4) and advanced material
processing technologies are required, in particular to improve the mechanical and
handling properties of the micro guidewires and the MRI visualisation of the Bas-
ketrievers (clot retrievers) for future experiments. Furthermore, the amount of
FeO particles has to be adjusted in order to optimize the size of the susceptibil-
ity artefact at the tip of the microcatheter in order to avoid masking of delicate
anatomical structures. One drawback of the presented devices is that guidewires
and micro catheter were both prepared with passive markers, which makes unam-
biguous device identification challenging.
7.4.2 Device Tracking and Navigation
Automated device tracking simplified device navigation in the phantom and ca-
daver experiments, in particular during the initial stages of an intervention (be-
tween access site and carotid arteries). However, the wRC applied to the device
surface permitted catheter navigation in vessel segments with a diameter of 2.5
mm or less. Device exchange to a micro catheter and manual scan plane align-
ments were required above the C4 segment of the internal carotid artery. Manual
scan plane alignments were found feasible but caused significant delays and ham-
pered an efficient iMRI workflow. Thus, a miniaturized wRC design is highly
desirable (see also Section 3.4.0.4) to allow wireless device tracking while being
able to access smaller branches.
7.5 Conclusions
In conclusion, the results of this study demonstrate that rtMRI-guided endovas-
cular recanalization of the MCA were feasible in vitro and ex vivo, indicating that
the presented devices and methods (real-time guidance, interactive MRI remote
control, in-room communication, device tracking and visualisation) have future
potential to decrease delays in initiating endovascular stroke treatment. The de-
vices were furthermore validated in vivo by means of balloon angioplasties of the
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carotid artery in a porcine model. Unique features of MRI for stroke therapy
are the detection of hemorrhages, occlusions of large vessels, irreversibly brain
injuries and areas that are viable but under-perfused [207], which support crit-
ical intra-procedural decision making during the course of an intervention and
be superior to X-Ray at revealing potential complications of a given intervention
[78]. An additional benefit is the predictive value of MRI post reperfusion, not
only for complications but also for recovery [226]. However, device optimizations
and tracking of instruments with a smaller diameter along with further in vivo
studies using suitable materials to mimic blood clots are required before clinical
evaluation. Furthermore it is essential that the potential clinical workflow and the
time benefit of MRI-guided endovascular recanalisation are investigated in future
studies.
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8.1 Summary
Despite considerable research efforts over the past decades, many interventional
applications of MRI such as local injections, tumour ablations, solid tumour biop-
sies and endovascular procedures have not gained sufficient momentum to enter
routine clinical practice. The main objective of the research presented in this the-
sis was to develop a set of tools to address a number of the remaining challenges
in the field of iMRI, specifically for percutaneous and endovascular procedures.
This work proposes novel solutions for device visualisation and tracking, real-time
guidance, interactive remote control and communication for iMRI. Overall, the
presented work allows a conclusion that common endovascular interventions (bal-
loon angioplasty of the common iliac and carotid artery and also clot retrieval
of the MCA) and percutaneous interventions such as biopsies are experimentally
feasible solely using MRI guidance.
The key contributions from the preceding results chapters to the field of iMRI are
summarized in the following:
Device Visualisation and Tracking
In this thesis a set of catheters and a polymer-based guidewire were developed,
optimised and validated. To the authors knowledge this is the only MRI-safe
guidewire to date with regulatory clearance in Europe (CE mark in October 2012),
which is thought to be a milestone for enabling MRI-guided endovascular interven-
tions. This work also demonstrated that interventional devices could be visualized
in MRI using wRCs and passive susceptibility markers without compromising pa-
tient safety due to RF induced heating. MRI visualisation of the profile and
orientation of devices was achieved with multiple wRCs or a combination of wRCs
and passive susceptibility markers. The key problem of wireless device tracking
was addressed and successfully tested by interventionalists during procedures on
in vitro and ex vivo models. This tracking solution provides a feedback loop and
copes with device exchanges, which is crucial for catheter-based procedures.
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Real-time Guidance and MRI Remote Control
Dynamic closed-loop control of image acquisition and in-room display was realised
for iMRI. A dedicated web-browser based UI was developed, which provides the
operating physician the ability to adjust the scan acquisition via wireless consumer
devices such as tablet computers at the patient table allowing changes between
different pulse sequences, each tailored to the particular step of an intervention.
A specialized UI has been developed for interactive scanner control during en-
dovascular and percutaneous needle interventions, which showed to improve the
workflow for iliac angioplasties and liver core biopsies, respectively.
Communication
High acoustic noise levels during MRI scanner operation require the staff and
patient in the scan room to wear noise protection and special solutions for audio
communication were therefore developed and successfully tested for iMRI. Tablet
computers in conjunction with Bluetooth-based headsets were adopted for scanner
operator - physician - assistant communication in conjunction with MRI remote
control. These developments enabled multi-user communication in the MRI scan
room and the results support an improved iMRI workflow for percutaneous and
endovascular interventions compared to previous experiments.
Workflow and Pre-clinical Validation
A substantial hurdle for performing interventions in the complex MR environment
is the lack of dedicated and efficient workflow. The devices and methods, described
in this thesis have been shown to overcome many of the present limitations and
were investigated for MRI-guided interventions as an alternative strategy to the
conventional interventional image guidance methods such as X-Ray fluoroscopy.
In the final part of this thesis, two pre-clinical projects were carried out to validate
the developed framework of technologies (dedicated iMRI soft- and hardware along
with a novel protocol) for common endovascular interventions in vitro, ex vivo
and in vivo. Firstly, the framework was applied to balloon angioplasties of the
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iliac arteries. The experimental results demonstrated that these interventions are
feasible in a reasonable time, which was comparable to X-Ray fluoroscopy-guided
procedures and significantly faster than with the standard MRI user interface
provided by the scanner manufacturer. Secondly, the described methods were
applied to recanalisation in acute ischemic stroke and it was demonstrated that
MRI-guided recanalisation in simulated clotted arteries (middle cerebral artery,
carotid artery) setting were experimentally feasible using the described framework
of technologies.
8.2 Open Issues and Future Work
Research in the field of iMRI is an active area and the results presented in this
thesis have contributed to a number of the key hurdles for enabling MRI-guided
procedures. However, many methods require additional investigations and numer-
ous problems still remain to be solved before translation from small experimental
trials to clinical procedures.
Device Visualisation, Tracking and MRI Remote Control
An essential step for translation into the clinical setting is that it must be shown
that devices are safe and effective for the intended use and the regulatory hurdles
in this context are high (Class III in Europe for minimally invasive devices in direct
contact with the central circulatory system [227]). Although the presented results
are encouraging, to date the only device with regulatory approval (in Europe)
presented in this thesis is the guidewire. Design optimizations of the catheter
markers are required before the presented interventional devices can be used in a
similar fashion as state of the art devices for X-Ray fluoroscopy. The next steps
in research should involve a completely integrated design of wRCs. Collaboration
has been established with the University of Magdeburg to investigate if micro
systems-based technologies could provide a viable solution for integrated wRCs,
which can also be used for wireless device tracking. Moreover, the presented
tracking implementation was found to be satisfactory for balloon angioplasties of
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the iliac artery in vitro and ex vivo but further studies are required to evaluate if
a single tracking coil and thus position is sufficient for more complex navigation
and catheter profiles before animal trials and clinical application. Future research
should focus on a pulse sequence and a tracking algorithm, which locates multiple
resonant markers that inductively couple to the receive coil.
Communication and Real-time Guidance
One important feature, which has not been investigated in this thesis, is com-
munication with the patient during scanner operation. Future research should
be attributed to establishing selective communication between patient, physician,
assisting staff and scanner operator. A complete MRI safety assessment (accord-
ing to ASTM) of all components that have been modified and added to the MRI
scan room (to enable communication and remote control) is another open issue.
This assessment would also allow a conclusion if further controls should be im-
plemented for mitigation of the residual risks i.e. by adding RF shields or by
improving the fixation means of the tablet devices. Another interesting solution
to overcome the high acoustic noise and resulting communication problems during
MRI scanner operation has recently been proposed by Grodzki et al. [228, 229].
The researchers developed a quiet 3D pulse sequence that requires very limited
gradient activity by combining single point imaging (centre of k-space) with radial
projection imaging (outer k-space) and can be used with standard imaging hard-
ware. It is anticipated that inaudible pulse sequences will in future also attract
strong interest in the interventional and surgical community. Future work should
investigate if these pulse sequences can also be adopted for 2D imaging with high
frame rates and achieve sufficient FOV coverage to be suitable for interventional
applications.
Workflow and Pre-clinical Validation
In addition, some limitations of the presented framework of technologies (imaging
and tracking pulse sequences implemented in RTHawk, web-browser based UI,
tablet PCs and multi-user communication) are worth noting. First, only parts
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of the setup could be validated in vivo (tablet PCs and multi-user communica-
tion) due to compatibility issues (RTHawk is currently compatible with GE MRI
scanners only) and only a clinical scanner (Siemens) was available for in vivo ex-
periments. Second, the presented work provides limited quantitative data on the
evaluation of the real-time phase contrast (rtFLOW) implementation. It should
be noted, that no clinical evaluation (diagnostic only) could be performed be-
cause the RTHawk application and related software are currently not approved
for clinical use. Further investigations should validate the rtFLOW and compare
the measurement accuracy and waveforms to Doppler Ultrasound or laser Doppler
flowmetry and correlate the measurements with in vivo data. Work is on-going to
investigate the safety of critical parts of the presented framework of technologies
along with further bridging studies in animal models to prepare a clinical study.
Another inherent limitation worth noting is that the experiments for clot retrieval
of occluded cerebral arteries were performed in vitro and ex vivo with a small
number of repetitions only. Although the cadaver experiments are encouraging,
blood clot removals require further investigation in future in vivo studies.
It should be noted that it is thought to be unlikely that MRI will replace con-
ventional imaging modalities for the majority of interventions (except procedures
that solely depend on unique MRI features such as real-time thermometry). How-
ever, it is expected that with further research iMRI could become an alternative
interventional image guidance method for paediatric or pregnant patients and in
procedures with long intervention times where radiation dose accumulates. One
of the largest hurdles to overcome is the limited access to the patient, which is
a related to current magnet designs required for full body scanners with a field
strength of 1.5 T or higher. This remains a particular challenge for percutaneous
needle interventions where the physician has to advance the needle (close to the
iso-centre of the magnet) and simultaneously monitor the needle progress on a
screen.
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8.3 Potential Directions of Future Research
This final subsection describes certain potential future areas of iMRI research to
augment the work presented in this thesis.
Real-time Guidance and MRI Remote Control
Controlling an MRI scanner and guiding interventional procedures from a web
browser presents many interesting solutions for device integration, educational
demonstrations or collaborative treatment planning and monitoring. In addition,
the presented developments could open the door for using the same user inter-
face across multiple platforms and MRI scanner manufacturers, which should be
investigated in future collaborative studies. One potential application how the pre-
sented methods could be applied to multimodality-guided interventions is currently
investigated in collaboration with a group at the University of St. Andrews, UK.
This research project focuses on combining macro scale MRI with micro scale opti-
cal imaging technologies, which have recently emerged as key tools for biomedical
applications. Promising candidates for intra-operative assessment include optical
coherence tomography, which provides sub millimetre precision [230] and Raman
spectroscopy, which can detect molecular changes [231] and discriminate between
normal and abnormal tissue and in real-time. In this project the developed mobile
device and web technologies are applied to MRI-guided optical biopsies using an
MRI compatible and disposable fibre-based Raman probe1. The iMRI technolo-
gies presented in this thesis are used to monitor and access the UI of the Raman
spectroscopy software in conjunction with the iMRI UI on the monitor and the
tablet PCs in the MRI scan room.
wRC-Based Tracking for Robotic Assisted Interventions
MRI-compatible robotic assistance system such as the Innomotion (Innomedic,
Herxheim, Germany) robotic arm, which has received the CE mark in 2005 [116]
1Initial results of this research will be presented as: Ashok PC, Praveen BB, Rube MA,
Cox BF, Melzer A, Dholakia K. Development of a fibre based Raman probe compatible with
interventional Magnetic Resonance Imaging. Proceedings of SPIE Photonics West 2014, BiOS
Technical Conference, San Francisco, CA, USA
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or the Symbis robot, which is currently under development by IMRIS (Winnipeg,
Manitoba, Canada), have substantial potential for MRI-guided interventions be-
cause they overcome the challenges that are related to the limited patient access.
Device tracking will play an essential role in the context of robotic assisted inter-
ventions and surgical procedures using MRI guidance. For instance, the Innomo-
tion system currently employs passive markers and a post-processing algorithm to
locate the position of the application module. This static position information is
then used to move the robot without further MR-based tracking. However, a sig-
nificant limitation of this robotic system is that there is no feedback loop between
MRI scanner and the robotic system. As a result the patient has to be moved out
of the bore and the needle is inserted in front of the scanner, which is a major
source of motion related targeting errors.
Figure 8.1: Conceptual drawing for combined active and wireless instrument
tip tracking during robotic assisted interventions using MRI guidance - Figure
(a) shows a schematic drawing (not to scale) of a robotic applicator module
for tracking. The tip of an instrument (a needle is shown exemplary) equipped
with a wRC can be tracked (Ptip) according to the method that was described in
Chapter 5. The points P1; P2; P3 and P4 can be obtained with active tracking.
Figure (b) shows how this could in theory be applied to the Innomotion robot
located at IMSaT using a custom applicator module (red). This applicator
module2 with micro coils for active tracking is enlarged in Figure (c).
One aspect of future research in the robotic field is to combine two device-
tracking methods, active tracking and the method proposed in Chapter 5. Inte-
grating active tracking of robotic arms2 or applicator modules and wireless tracking
of a wRC on the tip of a straight instrument (i.e. a cannula) could enable MRI-
guided interventions with a continuous feedback loop. The main advantage of this
concept is that the patient and active tracking cables do not come into contact,
2The results of this research will be published as: Xiao X, Huang Z, Rube MA, Melzer A.
Investigation of active tracking for robotic arm assisted MRgFUS. Int J Med Robot Comput
Assist Surg (Accepted with Revisions)
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which prevents RF induced heating. A conceptual applicator module for this com-
bined tracking approach is illustrated in Figure 8.1. Active tracking according to
[185] can be used to calculate the location of the tracking coils that are attached to
the tracking applicator module. In addition the wireless device tracking method
can be used to track a wRC on the tip of the instrument (Ptip). The point Pn
on the instrument trajectory (a needle is shown exemplary) can then be obtained
indirectly by computing the coordinates P1, P2, P3 and P4. The point (Pn) is then
calculated as intersection of the two lines between the points P1−P3 and the points
P2 − P4. Both pulse sequences can be interleaved (with a temporal resolution of
2x4xTRxN , where N is the number of phase-field k directions) and can also be
interleaved with imaging pulse sequences similar to what has been described in
Chapter 5.
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